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STELLINGEN 
1. Zowel neuronale en gliale celtypen zijn betrokken bij de ontwikkelings-
neurotoxiciteit van PCBs. 
-dit proefschrift 
2. Dalingen in plasma schildklierhormoon niveaus zijn niet betrokken bij PCB-
geinduceerde veranderingen in de hersenen tijdens vroege blootstelling. 
-dit proefschrift 
3. De accumulatie van gehydroxyleerde PCB metabolieten in het foetale brein is 
van groter belang dan de hiermee gepaard gaande schildklierhormoon-verlagingen 
voor de mogelijkheid tot verstoringen van de hersenontwikkeling. 
-dit proefschrift 
4. Eenvoudigweg meten van thyroxine en retinol in plasma geeft geen relevante 
informatie over de gevolgen van PCB blootstelling op weefsel concentraties van 
de biologisch actieve vormen T3 en retinylzuur. 
-dit proefschrift 
5. Vroege blootstelling aan PCBs veroorzaakt veranderingen in hersenontwikkeling, 
die toenemen met de leeftijd van de dieren. De effecten op het serotonerge 
systeem verdienen aandacht vanwege de betrokkenheid van dit systeem in 
stemmings veranderingen. 
-dit proefschrift 
6. Het testen van individuele verbindingen op ontwikkelings- of andere vormen van 
toxiciteit is van beperkt nut voor het voorspellen van effecten van chronische 
blootstelling aan complexe mengsels. Daarom moet onderzoek geinitïeerd worden 
waarbij gebruik wordt gemaakt van relevante extracten of synthetische mengsels. 
7. De mogelijke rol van xenobiotica in dementie en de ziekte van Parkinson is ten 
onrechte verwaarloosd bij experimenteel onderzoek. 
8. Voor verrassend weinig teratogenen zijn de mechanismen opgehelderd ondanks 
de enorme hoeveelheid onderzoekstijd en geld die hieraan besteed zijn. 
9. Er is geen ruimte in Nederland voor motorcross fanaten. 
10. Kinderen van gereformeerde gezinnen hebben een grotere kans om hun creatieve 
vermogens te ontwikkelen omdat ze niet urenlang voor de TV of achter een 
spelcomputer zitten. 
11. Het feit dat 5 mei nog steeds veel geld oplevert is te danken aan valse 
sentimenten. 
12. Promovendi die tijdens het schrijven van een proefschrift te veel spanning 
ondervinden, moeten geen ondernemer worden. 
Stellingen behorende bij het proefschrift "PCB-induced alterations of thyroid hormone 
homeostasis and brain development in the rat", Dennis C. Morse, Wageningen, 26 april, 
1995. 
For my parents, 
who gave me the freedom to make mistakes 
and then taught me how to learn from them 
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CHAPTER 1 
GENERAL INTRODUCTION 
Context of the current study 
The research presented in this thesis was conducted within the framework of the 
Dutch Mother's Milk Study. The Dutch Mother's Milk Study is a cooperative effort 
between clinical and pre-clinical scientists to investigate the effects of placental and 
lactational exposure to polychlorinated biphenyls (PCBs) and dioxins (PCDDs) on 
thyroid hormone homeostasis and neurological development of human infants and rats. 
There is public concern that the current level of human exposure to PCBs and PCDDs 
may result in developmental alterations, in particular in endocrinological and neurologi-
cal systems. The work in this thesis pertains to the metabolism and distribution of PCBs 
in pregnant rats, the effects of maternal PCB exposure on retinoid and brain thyroid 
hormone homeostasis and neurochemical development in the rat. 
Sources of polyhalogenated aromatic compounds 
Polychlorinated biphenyls (PCBs), -dibenzo-para-dioxins (PCDDs) and -dibenzo-
furans (PCDFs) and their brominated analogs are halogenated aromatic compounds that 
are widespread and persistent environmental pollutants. Their chemical structures are 
shown in Figure 1.1. PCBs consist of a biphenyl ring which may be substituted with 
chlorine in the ortho, meta and para positions, yielding 209 different congeners. 
PCBs were produced commercially in mixtures varying in the degree of chorina-
tion, yielding products with a wide range of applications. Their major use was as a 
dielectric fluid in transformers and capacitors. Total production of PCBs is estimated at 
1.5 million metric tons. Through either direct discharge or leakage from discarded 
electrical equipment an unknown quantity of these compounds has entered the environ-
ment (reviewed by De Voogt and Brinkman, 1989). 
In 1966 the Swedish chemist Soren Jensen detected PCBs in environmental 
samples (Jensen, 1966) during routine pesticide analysis and by the early 1970s the 
global extent of the contamination had become apparent (reviewed by Ballschmitter et 
al. 1989). Evidence that PCBs were toxic to wildlife species such as cormorants 
(Koeman et al. 1973) and mink (Auerlich et al. 1971) was also found in the early 
1970s. 
The chemical and physical characteristics that made PCBs a useful chemical 
product (e.g. chemical and thermal stability, and lipophilicity) also resulted in their 
environmental persistence and accumulation in higher trophic levels in the food chain. 
Although their production has now been phased out in western countries, and environ-
mental levels have decreased, the contamination of the environment with PCBs is still 
widespread. The recirculation of PCBs already present in the environment by volatilisati-
on followed by atmospheric deposition may prevent further dramatic decreases in 
environmental PCB levels (Harrad et al. 1994). There is evidence that atmospheric 
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deposition of PCBs in the Baltic Sea has resulted in steady state levels of these 
compounds in cod liver from the Baltic area (Falandysz, 1994). In the North Sea PCB 
levels in cod liver oil also remained constant between 1979 and 1987 (de Boer, 1988). 
The relatively high persistence of PCBs in human tissue and the cross-generatio-
nal transfer of PCBs by breast feeding may slow the decline of PCB levels in humans. 
Several recent studies indicate that currently the levels of PCBs in human blood and 
milk are declining very slowly (Hovinga et al. 1992, Norén and Lundén, 1991, Duarte-
Davidson et al. 1994), and may even be increasing in Eastern European countries, 
(Sikorski et al. 1994). 
Chlorinated dibenzo-para-dioxins and dibenzofurans have never been intentional-
ly produced except in small quantities for analytical and experimental purposes. These 
compounds are formed during combustion processes and some organochlorine synthesis 
as an unwanted byproduct (Rappe and Buser, 1989, review). Like PCBs, variations in 
the degree and site of chlorination result in 75 PCDD congeners and 135 PCDF 
congeners. Because of their similar chemical properties to PCBs, they have also been 
found as wide-spread environmental pollutants, and undergo similar long-range 
atmospheric transport (Eitzer and Hites, 1989). 
The main source of human exposure to PCBs, PCDDs and PCDFs is via the diet 
(Theelen et al. 1993). Major dietary sources are meat, dairy products and fish (Theelen 
et al. 1993, Beck et al. 1989). For several relatively volatile lower chlorinated PCBs the 
major source for humans is likely to be via inhalation or via the consumption of leafy 
3 2 2' 3' 
PCB 
m o o m 
m o 
PCB 
o m 
Figure 1.1 Structure and ring positions of PCDD (polychlorodibenzo-para-dioxin), PCDF 
(polychlorodibenzofuran) and PCB (polychlorobiphenyl). o: ortho, m: meta, p: para. 
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vegetables contaminated by atmospheric deposition (Bush et al. 1985, Harrad et al. 
1994). Human newborns already have a low level of these compounds in their tissues 
(Masuda et al. 1978, Jacobson et al. 1984, Schecter et al. 1990), and subsequent breast-
feeding can significantly increase the levels of PCBs in infants (Yakushiji, 1988). 
PCBs, PCDDs and PCDFs are potent developmental toxins in laboratory animals 
and wildlife species, and following the consumption of rice oil accidentally contamina-
ted with PCBs and PCDFs were also found to be developmental toxins in humans, 
producing delays in physical, neurological and cognitive development. Because of the 
biological persistence and relatively high lactational transfer of these compounds, there 
is concern that the exposure to background levels may also result in developmental 
delays in humans. For risk evaluation of the developmental toxicity of PCBs, PCDDs 
and PCDFs, an understanding of the metabolism, transplacental and lactational transfer, 
toxic mechanisms and structure-activity-relationships of these compounds is necessary. 
Kinetics and metabolism of PCBs during pregnancy and lactation. 
It is important to note that the pattern of individual PCB congeners stored in the 
adipose tissue of environmentally exposed mammals does not match that of commercial 
PCB mixtures (Schultz et al. 1989, Safe et al. 1985, Muir et al. 1988). The differing 
behavior of individual PCB congeners during a variety of physico-chemical processes 
(partitioning, uptake, photolysis) and during metabolism by microbes and animals alters 
the composition of PCB mixtures present in the environment. 
The kinetics and metabolism of PCBs, PCDDs and PCDFs in adult animals have 
been reviewed in detail (Matthews and Dedrick, 1984, Safe, 1989, Van den Berg et al. 
1994). These compounds are readily absorbed from the gastrointestinal tract, and 
depending on the chlorine substitution pattern may be preferentially retained in the liver 
and adipose tissue with a long half-life. Lateral substitution of the rings generally 
increases tissue retention. The presence of two adjacent carbon atoms without a chlorine 
substitution, preferably in the lateral positions, greatly enhances the hydroxylation of 
PCBs by mixed-function oxidases and thereby reduces the tissue half-life of the parent 
compound. The hydroxylated metabolite is not necessarily excreted rapidly, for relative-
ly high levels of para-hydroxylated PCB metabolites have been found in the plasma of 
environmentally exposed humans and marine mammals (Bergman et al. 1994). 
Following hydroxylation, the metabolite can be conjugated with either glutathione 
or glucuronic acid and excreted via the bile into the intestine. In feces, PCB metabolites 
are generally found as unconjugated hydroxylated PCBs, which suggests that the 
glucuronic acid conjugate is deconjugated during intestinal passage. The further 
metabolism of PCB-glutathione conjugates via the mercapturic acid pathway can result 
in the formation of methylsulfonyl metabolites which are highly retained in some 
tissues. 
The bioaccumulation of some lower chlorinated PCBs may have been prevented 
by their metabolism in animals, decreasing their relative contribution to PCB 
concentrations in tissues. This is illustrated by the observation that mothers exposed 
occupationally to the commercial PCB mixture Kanechlor 300 and their children have 
relatively large amounts of tri- and tetrachlorinated PCBs in their blood relative to the 
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general population, who are exposed mainly through the diet (Yakushiji, 1988). Also 
some higher chlorinated PCB congeners lacking para and meta chlorine substitutions in 
one or both rings, like 2,2',3,3',6,6'-hexachlorobiphenyl, can be rapidly eliminated as 
hydroxylated metabolites (Matthews and Tuey, 1980). There also appear to be temporal 
trends in the congener-specific composition of human milk following restictions on the 
production and use of PCBs, which show an increase in the relative amounts of more 
persistent PCB congeners, like 2,2',4,4',5,5'-hexachlorobiphenyl (Norén et al. 1990) 
The alteration of the PCB congener pattern may have toxicological consequences. 
A synthetic, reconstituted PCB mixture based on the major PCB contaminants in milk 
was 7 times more effective in inducing rat hepatic microsomal aryl hydrocarbon 
hydroxylase than the commercial PCB mixture Kanechlor 500 (Parkinson et al. 1980). 
There is some evidence that commercial PCB mixtures contain PCB congeners that have 
an antagonistic effect on some biochemical and toxicological endpoints in rodents (Safe 
etal. 1994). 
Placental transport 
Placental transfer of PCBs has been documented in rodents, monkeys and humans 
(Curley et al. 1973, Takagi et al. 1976, Allen and Barsotti, 1976, Akiyama et al. 1975, 
Masuda et al. 1978b). Dietary exposure of pregnant mice to Kanechlor 500 resulted in 
the transfer of 0.1 to 0.2 % of the dose to late gestational fetuses (Masuda et al. 1978). 
The amount of the administered maternal dose of individual PCB congeners transferred 
to the fetus in mice was less than 0.3% (Masuda et al. 1979). However, when examined 
in terms of the maternal body burden, two lower chlorinated PCBs, 2,4,4'-
trichlorobiphenyl and 2,3',4',5-tetrachlorobiphenyl were transferred relatively efficiently 
to the fetus (4.6 and 13.3%, respectively). Evidence of selective accumulation of PCB 
congeners in the fetal rat has also been reported following dietary exposure of the dams 
to Aroclor 1254 (Shain et al. 1986). There is insufficient data on the total PCB body 
bureden of fetal non-human primates or human fetuses to draw conclusions on the 
degree of transplacental transfer in higher mammals. An estimate by Duarte-Davidson 
and Jones (1994) suggests that currently in the U.K. less than 1.7% of the body burden 
of a 20 year old adult will be transferred to the fetus. Some data is available on the 
levels of individual PCB congeners in fetal cord blood, showing positive correlations 
between maternal serum PCB levels with those in cord sera or in the placenta (Jacobson 
et al. 1984, Bush et al. 1984, Ando et al. 1985). There is also evidence that PCDDs and 
PCDFs cross the placenta and are present in fetal human liver (Schecter et al. 1990). 
The presence of hydroxylated PCB metabolites in fetal mice and rats following 
maternal exposure to a limited number of PCB congeners has been reported (Lucier et 
al. 1978, Darnerud et al. 1986). The presence of significant amounts of hydroxylated 
PCBs in adult human plasma indicates that hydroxylated PCB metabolites may also 
accumulate in the human fetus, but this has not been investigated at present. Methylsul-
phonyl metabolites of 2,4',5-trichlorobiphenyl have been found to accumulate in the 
uterine luminal fluid of pregnant mice (Brandt et al. 1982), indicating transplacental 
transport of these apolar metabolites. 
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Lactational transfer 
The major route of exposure of the developing mammal to PCBs and related 
compounds is via lactation (Curley et al. 1973, Takagi et al. 1976, Masuda et al. 1978, 
Van den Berg et al. 1987, Nau et al. 1986). In humans, the level of PCBs in milk fat 
exceeds that of other foodstuffs, and is regarded as the major source of PCBs to the 
nursing infant (Yakashiji, 1988). PCBs, PCDDs and PCDFs have been shown to be 
readily absorbed from the digestive tract in a nursing infant (McLachlan, 1993). 
Concentrations of total PCBs or PCB congeners reported in human milk vary, and 
comparisons are further complicated by differences in analytical methods and the 
manner of reporting results (on whole milk or lipid basis). PCB concentrations in human 
milk increase with maternal age (Sikorski et al. 1990), and decrease with time spent 
breast-feeding and the number of children nursed (Rogan et al. 1986). 
In Europe, similar levels of total PCBs have been found in milk fat. For example, 
total PCB levels of 0.62, 0.6, 0.9 and 1.2 mg/kg milk fat have been found in Norway, 
the Netherlands, Germany and Poland, respectively (Skaare and Polder, 1990, Koopman-
Esseboom et al. 1994, Fürst et al. 1994, Sikorski et al. 1990). In Canada, Inuit women 
from the Hudson Bay area had significantly higher PCB levels in their milk fat than 
Caucasian women living in Southern Quebec (3.60 vs 0.77 mg PCB/kg milk fat, 
Dewailly et al. 1989). In the Lake Michgan study, children born to mothers with a PCB 
concentration greater than 1.25 mg/kg milk fat exhibited decreased performance in the 
McCarthy memory scales (Jacobson et al. 1990). 
Polychlorinated aromatic compounds and central nervous system development 
Accidental exposure 
PCBs, PCDDs and PCDFs are teratogenic, induce late fetal death, cause 
reproductive disorders in male and female offspring and alter the development of the 
central nervous system in experimental animals (Peterson et al. 1993, review). In 
humans, one of the best documented effects of exposure to PCBs and related compounds 
are delays in central nervous system development. 
The first evidence that PCBs and related compounds may alter neurological 
development was found in Japan after the consumption of rice oil in 1968 which had 
been contam2inated with PCBs and their thermal degradation products, PCDFs and 
polychlorinated quaterphenyls (PCQTs) (Harada et al. 1976, Masuda et al. 1985, 
Kuratsune, 1989). This incident was termed Yusho, which means "oil disease". A similar 
incident occured in Taiwan in 1979, and was termed Yucheng. Exposure to 
contaminated rice oil resulted directly in various symptoms including chloracne, 
pigmentation of the nails and skin thickening, which was attributed to the presence of 
the highly toxic PCDFs (Hara, 1985). Similar mean blood PCB levels were found in 
Yusho and Yucheng patients (45 ppb and 39 ppb) as in occupationally exposed workers 
in Japan (99 ppm in female workers handling KC-300 and KC-500), however, health 
effects were minor in the workers in comparison to the Yusho and Yucheng patients 
(Hara, 1985, Kashimoto et al. 1985). 
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Children born to mothers exposed in the Yucheng incident have been carefully 
followed, revealing a consistent trend of the Yucheng children to score significantly 
lower on intelligence tests than matched controls (Hsu et al. 1989, Chen et al. 1992, 
Chen and Hsu, 1994). Intra-uterine growth was decreased in Yucheng babies (Yen et al. 
1994), and there is evidence of increased respiratory problems and delayed growth in 
early childhood (Rogan et al. 1987). The majority of the Yucheng children were not 
breastfed, so the observed effects are most likely to be due to prenatal exposure to PCBs 
and/or their thermal degradation product, PCDFs (Yu et al. 1991). It is not known what 
the relative contributions of the PCBs and PCDFs were to the observed developmental 
effects (Yu et al. 1990). Occupational exposure to PCBs has been reported to reduce 
birth weight, an effect partially mediated by reduced length of gestation (Taylor et al. 
1989). 
Background exposure: 
In addition to high-level accidental exposure to PCBs and their thermal 
degradation products, the effects of background levels of PCBs on the neurological and 
cognitive development have also been investigated. Research on the relationship between 
the consumption of PCB-contaminated fish from Lake Michigan and neurological 
development (the "Lake Michigan study") revealed a negative association between 
greater fish consumption and neuromuscular maturity in infants (Fein et al. 1984). In the 
same study significant lower birth weight, head circumference and gestational age were 
associated with higher cord serum PCB levels (Fein et al. 1984). A follow-up of the 
Lake Michigan study found that at 7 months the development of visual recognition 
memory (Fagan test) was impaired in infants that had elevated cord serum PCB levels 
(Jacobson et al. 1984). Postnatal exposure from breastfeeding was unrelated to visual 
recognition memory performance at 7 months (Jacobson et al. 1985). 
At 4 years of age prenatal PCB exposure predicted poorer short-term memory 
performance and decreased body weight in a dose-dependent fashion (Jacobson and 
Jacobson, 1993). Maternal body burden estimated as mg PCB/kg milk fat, but not 
cumulative lactational exposure, predicted poorer memory performance, but was a less 
accurate predictor than cord blood PCB levels (Jacobson et al. 1990). The 4-year body 
burden (based on the children's serum PCB levels) was negatively associated with the 
composite activity rating (Jacobson et al. 1990, Jacobson and Jacobson, 1993). 
A second U.S. study based in North Carolina with a different experimental 
design also reported negative associations between "gestational" PCB exposure and 
neuromuscular development (Rogan et al. 1986, Rogan et al. 1988). Actually, the effects 
of gestational exposure were not explicitly examined in the North Carolina study by 
measuring cord blood PCB levels, rather PCB concentrations in milk fat were used to 
estimate gestational exposure (Rogan et al. 1986). Postnatal exposure, estimated by PCB 
levels in milk fat and the duration of breast feeding was not related to neuromuscular 
development (Rogan et al. 1988). Effects on cognitive function were not found, and 
psychomotor alterations were transient (Gladen and Rogan, 1991). 
Recently in the Netherlands, studies have been conducted on the relationship 
between prenatal and postnatal PCB exposure, postnatal PCDD and PCDF exposure and 
neurological and cognitive development in human infants. The results of these studies 
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have not yet been published. 
Laboratory studies 
The developmental neurotoxicity of PCBs has been most intensively examined in 
laboratory animals in relation to behavioral parameters. Only limited information is 
available on the biochemical effects of PCBs in the developing brain and the mecha-
nisms involved are not clear. 
The effect of pre- and postnatal PCB exposure on activity levels have been 
reported in mice, rats and rhesus monkeys (Tilson et al. 1979, Lilienthal et al. 1990, 
Erikson et al. 1991, Bowman et al. 1978, Bowman and Heironimus, 1981). In general, 
pre- and postnatal PCB exposure results in increased activity in the offspring, although 
the effect is dependent on the length of the activity test. In monkeys, pre- and postnatal 
exposure to Aroclor 1248 resulted in hyperactivity in juveniles and hypoactivity in 
adolescents (Bowman and Heironimus, 1981). 
Activity-related behaviors, such as active avoidance learning in mice and rats 
(Storm et al. 1981, Tilson et al. 1979, Lilienthal et al. 1990) and operant behavior in 
rats and monkeys (Pantaleoni et al. 1988, Lilienthal et al. 1990, Mêle et al. 1986) are 
also affected by pre- and postnatal PCB exposure. It has been suggested that the effects 
observed on active avoidance learning and operant behavior may be secondary to PCB-
induced changes in activity levels (Lilienthal et al. 1990). 
Cognitive effects have also been observed in the offspring of PCB-exposed 
monkeys. Maternal dietary exposure to Aroclor 1248 before gestation and lactation 
produced deficits in delayed spatial alternation learning in the offspring at 3-4 years of 
age (Levin et al. 1988). Higher PCB body burdens (Aroclor 1248) in infant monkeys 
had previously been shown to be correlated with increased errors in learning tasks up to 
2 years of age (Bowman et al. 1978). 
Possible mechanisms involved in the developmental neurotoxicity of PCBs 
Ah-receptor 
The mechanisms involved in the developmental neurotoxicity of PCBs and 
related compounds are not clear at present. Almost all of the other known toxic effects 
of PCBs, PCDDs and PCDFs in laboratory animals can be explained by the interaction 
of these compounds with a cytosolic receptor protein, the aryl hydrocarbon (Ah) 
receptor (Safe, 1994). These Ah-receptor dependent effects include teratogenicity, 
hyperkeratinization of epithelia and immunotoxicity. It has been demonstrated that once 
the ligand has bound the Ah-receptor, the ligand-receptor complex translocates to the 
cell nucleus and binds to dioxin responsive enhancers in the DNA (Okey et al. 1994, 
Nebert et al. 1993). It has been proposed that the binding of the ligand-receptor complex 
to DRE sequences results in the transcription of genes that mediate the toxicity of these 
compounds. To date, 26 genes have been identified as having a DRE upstream, although 
the molecular mechanisms involved in toxicity following their transcription remain 
elusive (Sutter and Greenlee, 1992). 
One fundamental aspect of the Ah-receptor theory is that compounds which 
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exhibit the highest binding affinity for the Ah-receptor are the most toxic (Safe 1994). A 
structure-activity relationship has been developed for this interaction. PCBs, PCDDs and 
PCDFs with 4 lateral chlorine substitutions are the most potent, and increasing chlorine 
substitution decreases the affinity of the compound for the Ah-receptor and hence its 
toxic potential. The planarity of the compound is also essential for determining its 
binding to the Ah-receptor. The dioxins and dibenzofurans are by their chemical nature 
planar compounds, while PCBs may rotate around the bond connecting the 2 biphenyl 
rings. Increasing chorine substitution in the ortho postitions around the bond connecting 
the biphenyl rings reduces the planarity of the PCB and hence its affinity for the Ah-
receptor. 
Although the structure activity relationships for developmental neurotoxicity have 
not been elucidated, there is evidence that the Ah-receptor may contribute to but is not 
essential for developmental neurotoxicity. The most toxic polyhalogenated aromatic 
compound with the highest affinity for the Ah-receptor, 2,3,7,8-tetrachlorodibenzo-/?öra-
dioxin (TCDD), induces behavioral alterations in monkeys exposed pre- and postnatally 
(Schantz and Bowman, 1989, Schantz et al. 1992). On the other hand, a commercial 
PCB mixture (Aroclor 1016) which exhibits little Ah-receptor mediated toxicity (Safe, 
1994) may induce behavioral alterations in monkeys which have been exposed via 
gestation and lactation (Levin et al. 1988, Schantz et al. 1989) and transiently alters 
striatal dopamine levels in rats following pre- and postnatal exposure (Seegal, 1994). 
Inhibition of dopamine synthesis 
Seegal and Shain (1992) have proposed that PCBs inhibit dopamine synthesis in 
the basal ganglia of rodents and non-human primates, and suggested that the decreases 
in dopamine levels may also play a role in the developmental neurotoxicity of these 
compounds. In adult rodents and macaques, the dopaminergic system is the most 
sensitive for sub-chronic exposure to PCBs of the neurotransmitter systems studied to 
date (Seegal, review), although other neurotransmitter systems (serotonergic, noradrener-
gic) may be affected (Seegal et al. 1986a, 1986b, 1986c). 
In PC 12 cells, PCB congeners which have little or no affinity for the Ah-receptor 
are remarkably more effective in reducing cellular dopamine levels than the PCB 
congener with the highest affinity for the Ah-receptor, 3,3',4,4',5-pentachlorobiphenyl. 
In adult macaques, the major PCB congeners accumulating in the brain after exposure to 
Aroclor 1016 (2,4,4', 2,2',4,4', and 2,2',5,5') produce no Ah-receptor mediated toxicity 
(Safe, 1994), yet long-term decreases in dopamine levels were observed in the basal 
ganglia. In cell-free homogenates, di-ortho PCBs inhibit dopamine synthesis in a 
concentration-dependent fashion, suggesting that they directly inhibit the activity of 
tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Together, in vitro 
and in vivo data suggest that low chlorinated di-ortho substituted PCB congeners may be 
the most neuroactive congeners in adult animals. However, the in vitro data should be 
interpeted with caution, because the presence or absence of a functional Ah-receptor 
pathway has not been examined in the PC-12 cell cultures used in those studies. 
There is some evidence that PCBs alter dopamine function in laboratory animals 
following pre- and postnatal exposure. Gestational exposure of mice to a relatively high 
dose of 32 mg 3,3',4,4'-tetrachlorobiphenyl per kg body weight resulted in decreased 
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striatal dopamine and dopamine receptor levels in adult offspring (Agrawal et al. 1981). 
Recently, it has been reported that in utero and lactational exposure to Aroclor 1016 
resulted in transient increases in striatal dopamine levels in rats (Seegal, 1994). 
Hormonal alterations 
Several other hypotheses have been proposed to explain the developmental 
neurotoxity of PCBs. The possible involvement of thyroid hormones or estrogens has 
been discussed (Rogan et al. 1986, Lillienthal and Wieneke, 1991). Both hormones play 
a role in neurochemical and behavioral development (McEwen, 1992) and PCBs may 
alter plasma levels of these hormones or influence their action during brain development 
(Collins and Capen, 1980a, Lundkvist and Kindahl, 1989). However, there has been no 
direct assessment of the effects of PCB exposure on the levels and metabolism of these 
hormones in the developing brain. 
Steroid hormones 
The effects of PCBs or PCDDs on estradiol homeostasis has not been intensively 
studied. There is some evidence that coplanar PCBs and TCDD are anti-estrogenic, 
while ortÄo-substituted PCBs and some hydroxylated PCBs are estrogenic (Jansen et 
al. 1992, Korach et al. 1988, Spink et al. 1990). Environmental exposure occurs to a 
mixture of PCDDs, PCDFs, coplanar and ort/ïo-substituted PCBs, followed by metabo-
lism of some of these compounds to hydroxylated metabolites which accumulate in the 
plasma. Due to a lack of information on the relative estrogenic or anti-estrogenic 
potencies of these compounds in vivo and their possible interactive effects, it is currently 
impossible to predict what the net effect of perinatal exposure to a complex mixture of 
these compounds will be on estrogenic systems and subsequently on brain development. 
Thyroid hormones 
There is evidence that reductions in neonatal brain thyroid hormone levels or 
maternal plasma thyroid hormones before the onset of fetal thyroid hormone secretion 
result in permanent alterations in behavior and brain maturation (Porterfield and 
Hendrich, 1993, review). The developmental regulation of thyroid hormone status in the 
rat has been investigated in detail by the group of Morreale de Escobar and Escobar del 
Rey (1993, review). The early fetal period is the most sensitive for alterations in thyroid 
hormone homeostasis. Up to day 18 of gestation the fetus is mainly dependent on the 
transplacental transport of maternal T4. The fetal thyroid begins secreting T4 and T3 
between day 17 and 18 of gestation, and by gestational day 21 is dependent on maternal 
thyroid hormones only to a limited extent. The major source of the biologically most 
active hormone, triiodothyronine T3, in the brain is the local deiodination of T4 to T3 by 
type II 5'-thyroxine deiodinase, an enzyme which catalyses outer ring deiodination of 
iodothyronines. The induction of 5'D-II activity is a compensatory mechanism to 
maintain brain T3 levels when the transport of T4 into the brain is decreased in fetal, 
neonatal and adult rats. After fetal thyroid secretion begins and the hypothalamic-
pituitary axis and the enzyme 5'D-II are able to respond to decreases in brain T4 levels, 
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the fetus becomes less sensitive for decreases in plasma T4 levels (Ruiz de Ona et al. 
1988, 1991, Morreale de Escobar et al. 1988, 1989, 1990). 
The pre- and postnatal administration of compounds (methimazole, propylthioura-
cil) which inhibit the synthesis of T3 and T4 by the thyroid gland can also severely 
reduce brain T3 levels in fetuses and neonates, thereby adversely affect somatic and 
brain development in the rat (Morreale de Escobar et al. 1993, review). Therefore the 
transplacental and lactational exposure of mammals to PCBs which reduce plasma 
thyroid hormone levels during development (Collins and Capen, 1980a) may also 
adversely affect brain thyroid hormone homeostasis and subsequently normal brain 
development. 
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T4 - > T 4 G 
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PLASMA 
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DEIODINATION 
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DEIODINATION 
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Figure 1.2 Schematic representation of thyroid hormone production, transport and metabolism in 
the late gestational maternal and fetal rat. T4: thyroxine, 3,3',5,5'-tetraiodothyronine, T3:, 3,3',5-
triiodothyronine, rT3: reverse T3, 3,3'^'-triiodothyronine, T2: 3,3'-diiodothyronine, T4G: T4-
glucuronide, T3G: T3 glucuronide, 5D-I: type I 5-deiodinase, 5'D-II: type II 5'-deiodinase, 5D-
III: type III 5-deiodinase. 
Mechanisms of altered thyroid hormone homeostasis by PCBs 
The mechanisms of the decrease of plasma thyroid hormones has been extensive-
ly investigated in adult animals. Initial work by Bastomsky (1974, 1977) indicated that 
the PCB or TCDD-mediated induction of hepatic glucuronidation of thyroxine (T4) and 
subsequent elimination of the glucuronide via the bile may play a role in the decrease of 
plasma T4 levels. The role of induced T4 glucuronidation in reducing plasma T4 levels is 
also supported a study in which thyroidectomized rats were implanted with an osmotic 
pump to supply T4 (Barter and Klaassen, 1992). 
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Figure 1.3 Potential mechanisms of PCB-induced reductions in plasma T4 concentrations with 
3,3',4,4'-tetrachlorobiphenyl as model compound. CYP: cytochrome P450. 
However, research by Collins and Capen (1980b) demonstrated that hepatic 
glucuronidation of T4 may be a contributing factor but is not essential for decreases in 
plasma T4 levels. Similar decreases in plasma T4 levels were observed in heterozygous 
Gunn rats (sufficient in T4 glucuronidation) and homozygous Gunn rats (deficient in T4 
glucuronidation) following dietary exposure to the commercial PCB mixture Aroclor 
1254 (1980b). 
Ultrastructural examination of the thyroid following exposure of adult rats to 
Aroclor 1254 revealed that the observed alterations did not resemble the effects of TSH 
stimulation, iodine deficiency or thyroidectomy, indicating a direct effect of PCBs on the 
thyroid gland (Collins and Capen 1980c). The authors suggested that the secretion of 
thyroid hormones by the thyroid gland is inhibited by PCB exposure (Collins and 
Capen, 1980c). 
The role of para-hydroxylated PCB metabolites in the decrease of plasma thyroid 
hormones was demonstrated in vivo and in vitro by several research groups 
(Richenbacher et al. 1986, Brouwer and van den Berg, 1986, Brouwer et al. 1990). 
These metabolites bear a strong structural resemblance to T4 and exhibit competitive 
binding for transthyretin, the major thyroid hormone transport protein in the plasma of 
adult rodents (Lans et al. 1993). Some hydroxylated PCB metabolites have a stronger 
affinity for transthyretin than T4 itself, and therefore displace T4 from the binding 
protein, decreasing total plasma T4 levels (Brouwer et al. 1990, Lans et al. 1993). 
Only limited information is available on the effects of PCBs on thyroid hormone 
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homeostasis in the developing rat. Gestational and lactational PCB exposure results in 
decreases in plasma T4 levels in the newborn and weanling rat (Collins and Capen 
1980a, Ness et al. 1993). Alterations in the ultrastructure of the fetal rat thyroid have 
been observed following prenatal PCB exposure, indicating that the fetal rat is also 
sensitive for PCB-induced alterations in thyroid hormone homeostasis (Collins and 
Capen, 1980a). 
Retinoids 
PCB-induced alterations in retinoid homeostasis may also be involved in the 
developmental neurotoxicity of PCBs. PCBs and related compounds have been shown to 
alter retinoid homeostasis in laboratory animals and diverse wildlife species (reviewed 
by Zile, 1992, review). Retinoids induce malformations in the central nervous system 
when administered during embryogenesis. Functional (behavioral) neuroteratogenicity 
has been observed following the administration of retinoids during organogenesis 
(Adams, 1993, review). However, the administration of PCBs to laboratory animals 
generally results in decreases in retinoid stores in the liver (the major storage organ for 
retinoids) and some other extrahepatic organs. It has been shown that PCB 
administration increases the mobilization of hepatic retinoid stores, which can result in 
an increase of retinoid levels in the kidney. Little is known about the effects of PCBs on 
retinoid homeostasis in the developing mammal. Neonatal exposure of rats to TCDD 
results in the decrease of hepatic retinoid stores. (Hâkansson et al. 1987) 
Scope of the present investigation 
The aim of the present study was to investigate the relationship between the 
metabolism and transport of PCBs in pregnant rats, alterations of thyroid hormone status 
during development and biochemical alterations in brain development. It was 
hypothesized that the metabolism of PCBs to hydroxylated metabolites would result in 
an accumulation of these metabolites in fetal and neonatal rat plasma, resulting in 
reductions in plasma thyroid hormone levels. The reductions in plasma thyroid hormone 
levels could result in a decrease in brain T3 levels, thereby inducing permanent 
alterations in brain development. 
The effect of pre- and postnatal exposure to PCBs (3,3',4,4'-tetrachlorobiphenyl 
and 3,3',4,4',5,5'-hexachlorobiphenyl and the commercial PCB mixture Aroclor 1254) 
on plasma T4 and T3 levels, brain Type II thyroxine 5'-deiodinase activity and hepatic 
T4-UDPGT activity was investigated in rats (Chapter 2, 4 and 5). Brain levels of T4 and 
T3 were investigated in the fetuses and weanling rats from dams exposed to Aroclor 
1254 (Chapter 5). As the effects on retinoids by PCBs can be related to the effects of 
PCBs on plasma thyroid hormones, retinoid homeostasis was investigated in the 
offspring of dams exposed to Aroclor 1254 during gestation (Chapter 6). 
PCB metabolism was first investigated in pregnant rats using 3,3',4,4'-
tetrachlorobiphenyl as a model compound for a rapidly metabolizable PCB (Chapter 2 
and 3), which has been shown to be teratogenic and a developmental neurotoxicant. The 
accumulation of PCBs and hydroxylated PCB metabolites in the plasma of dams and the 
plasma and brains of their offspring was investigated with Aroclor 1254 (Chapter 5). 
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To evaluate the developmental neurotoxicity of Aroclor 1254, the levels of a 
gliotypic protein (glial fibrillary acidic protein) and a neurotypic protein (synaptophysin) 
were measured in discrete brain regions following maternal exposure to Aroclor 1254. 
Glial fibrillary acidic protein and synaptophysin have been previously used to 
invesitigate the developemntal neurotoxicity of alkyltins (O'Callagan and Miller, 1988, 
O'Callaghan and Miller, 1989, O'Callaghan and Jensen, 1992). In addition the effect of 
maternal exposure to Aroclor 1254 on regional brain levels of biogenic amines in the 
offspring was investigated. 
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METABOLISM AND BIOCHEMICAL EFFECTS OF 3,3',4,4'-TETRACHLORO-
BIPHENYL IN PREGNANT AND FETAL RATS 
Abstract 
The metabolism and distribution of a single oral dose of 25 umol [14C]-3,3',4,4'-
tetrachlorobiphenyl (TCB) were investigated in pregnant female Wistar rats and their 
fetuses. TCB was administered on day 13 of gestation and the elimination was followed 
for 7 days. Non-pregnant rats were treated similarly for comparison. Fecal elimination of 
[14C]-TCB derived radioactivity was significantly lower in pregnant rats than in non-
pregnant rats. The major metabolite found in adult liver and plasma, placental tissue, 
whole fetuses and fetal plasma was 3,3',4',5-tetrachloro-4-biphenylol (4-OH-tetraCB). 
Tissue levels (liver, abdominal fat, skin, skeletal muscle, kidney and plasma) of [14C]-
TCB-derived radioactivity declined by 65 to 85% over a 7 day period following 
administration in the adult animals. However, [14C]-TCB-derived radioactivity 
accumulated more than 100-fold in the fetuses over the same time period, and GC/MS 
analysis revealed that the fetal accumulation in radioactivity was due primarily to 4-OH-
tetraCB, and not the parent compound. On day 20 of gestation, concentrations of 4-OH-
tetraCB were 14 times greater in fetal plasma than maternal plasma. 
Treatment with [14C]-TCB significantly reduced plasma thyroxine levels by at 
least 28% up to 7 days after administration in non-pregnant animals and up to 4 days 
after administration in pregnant rats (31% decrease). By 7 days after administration 
plasma thyroxine levels had returned to control levels in the TCB-treated pregnant rats. 
However, fetal plasma thyroxine levels were significantly decreased by 35% in fetuses 
from [14C]-TCB-treated dams 7 days after TCB administration. Hepatic microsomal 
ethoxyresorufin-O-deethylase (EROD) activity was significantly induced in TCB-treated 
dams relative to controls at 4 and 7 days after administration, while no EROD activity 
was detected in hepatic microsomes from control or TCB treated fetal rats at day 20 of 
gestation. These data suggest that hydroxylated metabolites of polychlorinated biphenyls 
may play a role in the development toxicity of these compounds. 
Dennis C. Morse, Eva Klasson Wehler, Maribel van de Pas, Albert Th.H.J. de Bie, 
Peter J. van Bladeren, Abraham Brouwer 
Chemico-Biological Interactions, in press 
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Introduction 
Polychlorinated biphenyls are widespread environmental contaminants which are 
also found in human breast milk and can cross the placenta to a minor extent 
(McFarland and Clarke, 1989, Bush et al. 1984). These compounds have been shown to 
be developmental toxins in both laboratory animals and man, and the effects include 
congenital malformations, increases in fetal mortality and neurobehavioral alterations 
(Peterson et al., 1993, review). 3,3',4,4'-Tetrachlorobiphenyl (TCB) is one of the most 
toxic PCB congeners (Safe, 1990, review) and has been shown to be a developmental 
neurotoxin (Tilson et al., 1979, Agrawal et al., 1981, Eriksson, 1988, Eriksson et al. 
1991). 
The excretion and metabolism of TCB has been extensively examined in adult 
rats (Abdel-Hamid et al., 1981, Yoshimura et al., 1987, Koga et al, 1989) and mice 
(Klasson Wehler et al., 1989), but there is only one report on the identification of TCB 
metabolites in pregnant mice and their fetuses, which shows that phenolic and methyl 
sulfonyl metabolites accumulated in the fetal compartment (Darnerud et al., 1986). TCB 
is rapidly metabolized in rodents, and it is not clear whether the parent compound or a 
metabolite is responsible for developmental neurotoxicity. A metabolite of TCB, 
3,3',4',5-tetrachloro-4-biphenylol, (4-OH-tetraCB) has a high affinity to transthyretin, 
the major thyroid hormone binding protein in the rat (Lans et al., 1993, Brouwer et al., 
1990). This 4-OH-tetraCB has been found in the plasma of both adult mice and rats 
treated with TCB (Brouwer et al., 1990, Klasson Wehler, 1989). Because of the struc-
tural resemblance of 4-OH-tetraCB to thyroxine (T„), this metabolite can displace T4 
from TTR, resulting in decreased plasma T4 concentrations (Brouwer et al., 1986). There 
is some evidence that prenatal administration of TCB to rats can reduce fetal plasma 
thyroid hormone levels and alter fetal brain thyroid hormone metabolism (Morse et al., 
1993). Since thyroid hormones are essential for normal brain development, decreases in 
circulating thyroid hormone levels during development can have long-lasting adverse 
neurological effects (Smith, 1981, Hendrich et al., 1984). 
The aim of this study was to examine the metabolism of TCB in pregnant and 
non-pregnant rats along with effects on plasma thyroid hormone concentrations in the 
dams and fetuses. Ethoxyresorufin-O-deethylase activity (EROD) activity was 
determined in fetal and maternal hepatic microsomes as an indication of hepatic 
metabolic activity for TCB. 
Materials and Methods 
Chemicals 
The [14C]-3,3',4,4'-tetrachlorobiphenyl (TCB, 37.1 |aCi/nmol, radiochemical 
purity > 95%) was purchased from Sigma Chemical Company, St Louis, MO. 
Unlabelled TCB (> 99% pure, dibenzofuran and dibenzo-p-dioxin free) was obtained 
from Promochem, Germany. The TCB metabolite standards, 3,3',4,4'-tetrachloro-2~ 
biphenylol, 3,3',4',5-tetrachloro-4-biphenylol, 3,3',4,4'-tetrachloro-5-biphenylol and 
3,3',4,4'-tetrachloro-6-biphenylol were synthezised as described by Klasson Wehler et 
al. (Klasson Wehler et al., 1989, Klasson Wehler et al., 1990). 
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Animals 
Non-pregnant and timed pregnant Wistar WU rats, 12 weeks old, were obtained 
from Charles River Wiga GmbH, Sulzfeld, Germany. The animals were maintained at 
21°C, 50% humidity with a 12 h light cycle, food (TNO stock diet) and tap water were 
supplied ad libitum. After an acclimatization period of 1 week the rats were housed in 
metabolism cages 3 days prior to administration of TCB or the vehicle. On day 13 of 
gestation 15 pregnant rats were given a single oral dose of 25 uCi [14C]-TCB per kg 
body wt diluted with unlabelled TCB for a total dose of 25 umol TCB/kg body weight. 
The [14C]-TCB was dissolved in corn oil, 25 umol/2ml. After a similar acclimatization 
period 12 non-pregnant rats recieved an identical dose of [14C]-TCB in cornoil. Control 
rats (n=9) for biochemical assays were housed identically and received the vehicle only. 
Three rats per group were sacrificed by bleeding via the aorta under ether 
anesthesia 1, 2, 4 and 7 days after [14C]-TCB administration, (with the exception that 5 
pregnant rats treated with [14C]-TCB were sacrificed 7 days after treatment). The 
following tissues or organs were removed from the adult rats: liver, kidneys, spleen, 
lungs, heart, thymus, brain, skeletal muscle and a strip of abdominal skin (including 
subcutaneous fat). In addition, abdominal fat was quantitatively collected by trimming 
fat from organs from the abdominal cavity and from the abdominal wall. Organs, fetuses 
and placentas were rinsed with 0.9% NaCl, blotted dry with tissue paper, weighed and 
stored at -20° C. The carcass of the adult rats was stored at -20° C. Feces and urine 
were collected daily and cages were rinsed with 200 ml of 0.1% Triton X-100 at the end 
of the experiment to determine losses of [14C]-TCB derived radioactivity. 
In a parallel experiment to determine the effect of TCB on maternal and fetal 
hepatic microsomal EROD induction, pregnant rats were treated with 25 umol 
unlabelled TCB/kg body weight on day 13 of gestation. The rats were sacrificed 4 and 7 
days after TCB administration. Livers were rapidly removed, stored at -80°C until 
microsomes were prepared as previously described and stored at -80 °C until analysis 
(Morse et al, 1993). 
Analysis of total [HCJ radioactivity 
The concentration of [14C] radioactivity in fecal samples and individual organs 
was determined using a Packard 307 sample oxidizer and liquid scintillation counting 
(LSC) with a LKB Wallac 1410 scintillation counter. Samples were weighed and then 
dried overnight in a stove at 35° C prior to sample oxidation. Feces was homogenized 
with 4 parts water (w/w) prior to sample drying. Radioactivity in cage washes, urine and 
plasma samples was determined directly with LSC by mixing 500 ul cage wash or urine 
and 100 ul plasma with 4.5 ml scintillation fluid (Safe-Fluor, Packard). Particulate 
matter in the urine was allowed to settle before taking a sample for LSC. The carcass 
was dissolved overnight in 1.5 M NaOH containing 45% ethanol (v/v). After homogeni-
zation a 500 ul aliquot was added to 10 ml scintillation fluid compatible with high ionic 
solutions (Hionic-Fluor, Packard) and counted with LSC. Three fetuses and placentas 
were pooled for each pregnant rat for determination of total [14C] radioactivity. Total 
[14C] radioactivity per organ was analysed separately for each non-pregnant and pregnant 
rat. In order to estimate total plasma, skin and skeletal muscle radioactivity the 
following assumptions were made for both the pregnant and non-pregnant rats: skeletal 
muscle is 40%, skin is 10% and plasma is 4% of the total body weight. 
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Analysis of TCB and metabolites 
The amount of TCB and its major metabolites were determined in the plasma and 
liver from the pregnant and non-pregnant rats, as well as in the fetuses and placentas. 
One volume of methanol was added to plasma which was then extracted three times 
with two volumes of diisopropylether. The ether was evaporated under nitrogen and the 
residue was methylated with diazomethane. The plasma extract was then resuspended in 
hexane and partitioned with concentrated sulfuric acid. The hexane phase was washed 
with water, passed over sodium sulfate and evaporated to dryness with nitrogen. 
Fetal or maternal tissues from 3 animals were pooled for each sacrifice point and 
freeze-dried. TCB and its metabolites were extracted from the adult and fetal rat tissues 
as described by Klasson Wehler et al. (Klasson Wehler et al., 1990). Briefly, freeze 
dried tissues were ground with a mortar and pestle and then extracted by Sohxlet 
extraction for 5 h with chloroform-ethanol (1:1). The extraction efficiency was 
determined from the [14C] contents of the extracts and the dried tissue residue. The 
compounds of interest were separated from lipids by gel permeation chromatography 
(GPC) with Bio-Beads SX-3 (BioRad) using cyclohexane-dichloromethane (1:1, v/v) as 
a mobile phase. The level of [,4C]-TCB derived radioactivity was monitored in the GPC 
fractions with LSC and the lipid-free fractions containing [14C] were pooled and 
methylated with diazomethane and then analyzed with GC/ECD and GC/MS. 
Gas chromatography/mass spectrometry (GC/MS) was performed on an ITS40 
instrument (Finnigan). The GC (Varian 3400) was equiped with a fused silica capillary 
column (DB5, 30 m x 0.25 mm i.d., J&W, Scientific Inc., CA, USA). The temperature 
program was 80°C for 2 min, then 10°C/min to 240°C and maintained at 240°C for 20 
min. The injector temperature was 260°C and the injections were made in the splitless 
mode, using an autosampler (CTC A200S, Finnigan MAT). The mass spectrometer was 
operated in the electron impact mode and the manifold temperature was 220°C. 
Gas chromatography/electron capture detection (GC/ECD) analyses were 
performed with a Varian 3770 gas Chromatograph equipped with an on column injector 
(Okla and Wesén, 1984), a DB5+ fused silica capillary column (30 m x 0.32 mm i.d., 
J&W Scientific Inc.) and a 63Ni electron capture detector opertated at 300°C. The 
column temperature was programmed as follows: initial temperature 60°C, then 
20°C/min to 160°C, then 160°C for 5 min, followed by 5°C/min to 280°C and 
maintained at 280°C for 10 min. The chromatograms were recorded and stored by a 
Shimadzu R-C3A integrator. 
Thyroid Hormone Analysis 
Plasma total T4 (TT4), total T3 (TT3) and free T4 (FT4) were determined with the 
Amerlite chemiluminesence assay (Amersham, UK) according to the protocol of the 
supplier with the following modification: the TT4 assay buffer was diluted five times 
with demineralized water; the standard curve for TT4 ranged from 0 to 120 nmol 
TT4/liter. 
Ethoxyresorufin-O-deethylase (EROD) activity 
EROD activity was measured in maternal and fetal hepatic microsomes according 
to the method of Burke et al. (1977), with slight modifications. The reaction was carried 
out at 37° C with a final concentration of ethoxyresorufin and NADPH of 2 and 0.1 
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uM, respectively. The final microsomal protein concentration was 100 ug/ml for 
pregnant and non-pregnant rats, and 1 mg/ml for fetal rats. To detect the deethylation 
product, resorufin (RR), the excitation wavelength of the fluorimeter was set at 530 nm, 
while the emission wavelength was 580 nm. Protein concentrations were determined 
using the Bio-Rad coomassie blue assay (Bio-Rad, Richmond, CA). 
Results 
Fecal and urinary [,4C]-TCB excretion 
The average total recovery of radioactivity per rat (feces, urine, cage washings, 
organs and carcass) was 90.3 + 5.5 %. Cumulative fecal excretion of [14C]-TCB derived 
radioactivity over 1 week, shown in Figure 2.1 A, was significantly lower in pregnant 
rats than in non-pregnant animals. The difference in cumulative fecal excretion was due 
primarily to the excretion during the first 24 h after TCB administration: non-pregnant 
rats excreted 43 + 3% of the dose, while pregnant rats excreted 30 + 2% of the dose. 
Seven days after [14C]-TCB administration, the fecal elimination of [14C]-TCB in non-
pregnant and pregnant rats was 85 + 1.3% and 78 + 1.5% of the total dose, respectively. 
Cumulative urinary excretion of radioactivity was also lower in pregnant rats than 
in non-pregnant rats, however the differences were not significant for all time points 
(Figure 2.IB). The elimination of [14C]-TCB derived radioactivity in the urine was only 
a small fraction (<5%) of the total radioactivity eliminated from the rats. 
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Figure 2.1 A and B. 
Cumulative fecal (A) and urinary (B) excretion of [14C]-TCB derived radioactivity from 
pregnant and non-pregnant rats after an oral dose of 25 umol [14C]-TCB/kg, * indicates 
a significant difference between values from pregnant and non-pregnant rats, P<0.05, 
student's t-test, see Materials and Methods for number of animals per time point. 
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[l4C]-TCB tissue levels: 
The significantly higher retention of radioactivity in the residual carcass of 
pregnant rats than non-pregnant rats 1 and 2 days after [l4C]-TCB administration (Table 
2.1) is in accordance with the slower fecal excretion of radioactivity by pregnant rats 
compared to with non-pregnant rats. Levels of radioactivity (dpm/g) from tissues with 
the highest concentration of radioactivity (abdominal fat and skin, including 
subcutaneous fat) were not significantly different between pregnant and non-pregnant 
rats at any time point (Table 2.2). However, when corrected for total tissue wt the 
amount of [l4C]-TCB derived radioactivity (% dose per tissue or organ) was 
significantly higher in the abdominal fat of the pregnant rats than non-pregnant rats 
either 1 and 2 days after [14C]-TCB-administration (Table 2.1). 
Table 2.1 
Tissue distribution of [,4C]-TCB derived radioactivity in pregnant and non-pregnant rats 
(expressed as percentage of dose) 
Day after [14C]-TCB administration 
1 2 4 
Plasma 
Non-pregnant 
Pregnant 
Liver 
Non-pregnant 
Pregnant 
Kidney 
Non-pregnant 
Pregnant 
Abdominal Fat 
Non-pregnant 
Pregnant 
Skin 
Non-pregnant 
Pregnant 
Skeletal Muscle 
Non-pregnant 
Pregnant 
Carcass 
Non-pregnant 
Pregnant 
1.06+0.03 
0.87±0.23 
1.47±0.02 
1.33+0.05 
0.10+0.03 
0.10+0.01 
2.47+0.56 
3.51±0.27* 
5.55+2.22 
7.64+3.42 
1.88+0.60 
1.15+0.73 
40.9+5.0 
50.1+2.0* 
0.63+0.07 
0.50+0.03 
0.69+0.23 
0.74+0.09 
0.06+0.02 
0.06+0.01 
1.47+0.21 
3.15+0.39* 
2.74+1.64 
4.68+2.24 
0.83+0.15 
0.55+0.20 
13.3+2.8 
27.7+2.6* 
0.43+0.09 
0.34+0.03 
0.48+0.02 
0.43+0.03 
0.04+0.00 
0.03+0.00 
2.00+0.18 
1.93+0.44 
1.35+0.20 
1.49+0.13 
0.70+0.21 
0.30+0.15* 
8.4+0.8 
11.4+1.0 
0.37+0.12 
0.15+0.03 
0.31+0.03 
0.22+0.04* 
0.04+0.01 
0.02+0.00* 
0.91+0.08 
1.34+0.51 
0.85+0.15 
0.74+0.34 
0.65+0.55 
0.17+0.08* 
4.1+0.7 
5.1+0.5 
Pregnant and non-pregnant rats received an oral administration of 25 umol [HC]-TCB/kg. Data 
are the mean+S.E.M., * indicates a significant difference between values from pregnant and non-
pregnant rats, n=3, P<0.05, 2 sided student's t-test. 
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Table 2.2 
Tissue distribution of [14C]-TCB derived radioactivity in pregnant and non-pregnant rats 
(expressed as dpm x 103 per g tissue) 
Tissue/Organ 
Day after [14C]-TCB administration 
2 4 7 
Plasma 
Non-pregnant 
Pregnant 
Liver 
Non-pregnant 
Pregnant 
Kidney 
Non-pregnant 
Pregnant 
Spleen 
Non-pregnant 
Pregnant 
Lung 
Non-pregnant 
Pregnant 
Heart 
Non-pregnant 
Pregnant 
Brain 
Non-pregnant 
Pregnant 
Abdominal Fat 
Non-pregnant 
Pregnant 
Skin 
Non-pregnant 
Pregnant 
Skeletal Muscle 
Non-pregnant 
Pregnant 
18.3+0.2 
11.8+1.9* 
21.0+0.9 
15.5+0.4* 
9.5+1.8 
8.0+0.3 
4.0+1.5 
1.8+0.1 
6.9+1.1 
3.9+0.1 
3.5+0.3 
4.0+0.4 
1.1+0.1 
0.6+0.0* 
109+13.9 
105+5.3 
38.6+9.2 
41.5+10.1 
3.3+0.7 
1.9+0.7 
11.0+0.9 
7.1+0.2* 
10.2+2.1 
9.5+0.5 
5.5+1.0 
5.1+0.4 
2.2+0.6 
1.2+0.1 
3.1 ±0.6 
2.7+0.0 
2.4+0.4 
1.8+0.1 
0.4+0.1 
0.4+0.0 
73.1+11.5 
82.4+13.0 
25.3+5.4 
26.6+7.1 
1.5+0.2 
0.8+0.2* 
6.2+1.6 
4.7±0.2 
6.8+0.5 
4.8+0.2* 
3.9+0.1 
2.6+0.1* 
1.2+0.1 
0.7+0.0* 
2.1+0.2 
1.6+0.1 
1.2+0.0 
0.9+0.0* 
0.4+0.1 
0.2+0.0 
68.2+3.4 
58.3+1.8* 
9.1+.7 
8.3+0.5 
1.2+0.2 
0.4+0.1* 
6.5+1.3 
2.1+0.2* 
4.7+0.2 
2.6+0.2* 
2.9+0.4 
1.5+0.1* 
1.1+0.0 
0.5+0.0* 
1.8+0.3 
0.8+0.1* 
1.2+0.1 
0.5+0.0* 
0.3±0.0 
0.1+0.0* 
2.7+3.5 
35.4+2.3 
6.0+0.6 
4.1+0.8 
0.6+0.0 
0.2+0.0* 
Pregnant and non-pregnant rats received an oral administration of 25 umol [14C]-TCB/kg with a 
specific activity of 1 uCi/umol TCB. The data are the mean + SEM, * indicates a significantly 
lower concentration of radioactivity in tissue from pregnant compared with non-pregnant rats, 
n=3, P<0.05, student's t-test. 
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Despite an initial lower fecal elimination of radioactivity, some tissue levels of 
radioactivity were generally lower in the pregnant than non- pregnant animals. In 
pregnant rats significantly lower concentrations of [14C]-TCB derived radioactivity (dpm 
per g tissue) were found in the plasma, skeletal muscle, liver and kidneys than in non-
pregnant rats 7 days after [14C]-TCB administration (Table 2.2). Tissue concentrations of 
radioactivity were also significantly lower in the spleen, brain, heart and thymus of 
pregnant rats than in non-pregnant rats 7 days after [14C]-TCB administration (Table 
2.2). 
The only compartments showing accumulation of radioactivity from 1 to 7 days 
after TCB administration, as expressed as % of dose were the placenta and fetus (Figure 
2.2A). The percentage of the dose in the fetus increased more than 100 fold and in the 
placenta 5 fold by the end of the experiment. Also the concentration of [,4C]-TCB 
derived radioactivity in the fetus increased from 880 + 290 to 2390 + 540 dpm/g fresh 
wt between 1 and 7 days after [14C]-TCB administration (Figure 2.2b). No increase was 
observed in the concentration of placental [14C]-TCB derived radioactivity during the 
experiment (Figure 2.2b). Seven days after [14C]-TCB administration, the percent of the 
[14C] dose present in the pooled fetuses (0.410% + 0.153) had increased to above the 
amount retained in the maternal liver (0.218% + 0.036), even though the liver is the 
maternal organ (aside from adipose tissue) exhibiting the highest concentration (dpm/g) 
and total amount (% of dose) of radioactivity. 
Identification of [NCJ-TCB metabolites: 
The relative amount of chloroform/ethanol unextractable compounds in livers 
increased with time after [14C]-TCB administration (Table 2.3). In pregnant rats 
unextractable [14C]-TCB derived radioactivity in the liver increased from 13 % of the 
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Figure 2.2 A and B. 
A: Percentage of dose of [l4C]-TCB derived radioactivity in pooled fetuses, placentas and 
maternal liver from pregnant rats administered an oral dose of 25 umol [14C]-TCB on day 13 of 
gestation, B: Concentration of [14C]-TCB derived radioactivity (dpm/g) fresh wt in fetuses and 
placentas from pregnant rats, n=3. 
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Figure 2.3. Levels of 4-OH-
[14C]-TCB in the plasma of non-
pregnant and pregnant rats as 
well as fetuses (day 20 of 
gestation only) after oral 
administration of 25 umol [14C]-
TCB. Pregnant rats were dosed 
on day 13 of gestation, * 
indicates a significant difference 
between values from pregnant 
and non-pregnant rats, P<0.05, 
student's t-test. 
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Table 2.3 
Percentage of [14C]-TCB derived radioactivity extracted from tissue 
Day after 
treatment 
Fetus Placenta Liver 
Pregnant 
Liver 
Non-pregnant 
1 
2 
4 
7 
60 
87 
70 
51 
55 
54 
87 
68 
72 
53 
76 
65 
55 
59 
The data are the results of chloroform/ethanol extractable [14C]-TCB derived 
radioactivity in pooled tissue samples. 
total radioactivity in the sample 24 h after exposure to 47 % at 7 days after exposure. In 
non-pregnant rats the increase in unextractable compounds in the liver was from 24% to 
41% of total radioactivity between day 1 and 7 after exposure, respectively. 
GC-MS analysis of the extracts of pooled fetal samples revealed that the major 
compound (> 95%) accumulating in the fetuses and placenta was 3,3',4',5-tetrachloro-4-
biphenylol (4-OH-tetraCB) at 4 and 7 days after [14C]-TCB administration (Table 2.4). 
Traces of the parent compound and 3,3',4,4'-tetrachloro-5-biphenylol (5-OH-TCB) were 
present in the placenta according to GC/ECD analysis although the presence of 5-OH-
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Table 2.4 
Levels of [14C]-TCB and metabolites (nmol/g lipid) in livers from non-pregnant 
and pregnant rats and their fetuses and placentas. 
Day after TCB administration 
1 2 4 
Compound 
TCB 
4-OH-tetraCB 
5-OH-TCB 
Ratio 4-OH-
tetraCB/TCB 
Tissue 
liver, NP 
liver, P 
placenta 
fetus 
liver, NP 
liver, P 
placenta 
fetus 
liver, NP 
liver, P 
placenta 
fetus 
liver, NP 
liver, P 
placenta 
fetus 
Concentration (nmol/g lipid) 
43 
89 
17 
18 
3.4 
3.4 
0.32 
0.20 
32 
31 
10 
9.1 
1.1 
1.2 
0.31 
0.29 
9.9 
12 
ND 
ND 
3.8 
6.5 
23 
58 
0.2 
0.2 
ND 
ND 
0.38 
0.54 
3.1 
7.5 
6.7 
1.5 
2.5 
7.5 
4.7 
16 
65 
0.4 
ND 
ND 
ND 
1.0 
0.7 
26.0 
The data are from analysis of pooled samples (n=3) for each time point. The calculations are 
based on the relative amount of the compounds determined by GC/ECD analysis in the 
extractable radioactivity from the tissue sample. NP:non-pregnant rats, P:pregnant rats, ND: not 
detected, 4-OH-tetraCB:3,3',4',5-tetrachloro-4-biphenylol, 5-OH-TCB: 3,3',4,4'-tetrachloro-5-
biphenylol. 
TCB could not be confirmed by GC/MS analysis due to a low concentration. In the 
plasma of non-pregnant and pregnant rats only 4-OH-tetraCB was detected by GC/ECD 
at all time points. GC/ECD analysis of fetal plasma from day 20 of gestation revealed 
that only 4-OH-tetraCB was present, and that the amount of 4-OH-tetraCB in fetal 
plasma was more than 14 times greater than that in maternal plasma (14 nmol/ml versus 
0.95 nmol/ml, Figure 2.3). The level of 4-OH-tetraCB was significantly lower in the 
plasma of pregnant rats compared to non-pregnant rats at all time points (Figure 2.3). 
Livers from both non-pregnant and pregnant rats contained an increasing amount 
of 4-OH-tetraCB relative to TCB after treatment when results are expressed as nmol 4-
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OH-tetraCB/g extracted lipid (Table 2.4). Seven days after [14C]-TCB administration a 
large fraction of the extractable compounds present in the liver were in the form of 4-
OH-tetraCB in both pregnant and non-pregnant rats (50 and 41%, respectively). Only 
minor amounts of 5-OH-TCB and 3,3',4,4'-tetrachloro-2-biphenylol (2-OH-TCB) were 
detected in liver samples (data not shown). The amount of 4-OH-tetraCB nmol/g lipid is 
greater in the placenta (3 fold) and fetus (13 fold) than in the maternal liver on day 20 
of gestation. Also the amount of 4-OH-tetraCB relative to TCB on day 20 of gestation 
increases greatly from the materai liver (0.7) through the placenta (3.1) to the fetus 
(26.0). 
Hepatic ethoxyresorufin-O-deethylase (EROD) activity: 
Maternal hepatic EROD activity was significantly elevated relative to cornoil-
treated controls on day 17 and 20 of gestation following TCB exposure (12 fold and 10 
fold, respectively, Table 2.5). The level of EROD activity was significantly lower (48%) 
in TCB-treated pregnant rats on day 20 of gestation than on day 17 of gestation. EROD 
activity was undetectable in microsomes from control and TCB-treated fetuses on both 
day 17 and day 20 of gestation. 
Table 2.5 
Hepatic EROD activity in pregnant rats 
Gestation EROD (nmol RR/min*mg protein) 
Day Treatment 
Maternal Fetal 
17 
20 
Control 
TCB 
Control 
TCB 
0.027+0.005a 
0.330±0.042b 
0.017+0.004a 
0.170+0.043c 
ND 
ND 
ND 
ND 
RR: resorufin, values with different superscripts are significantly different from each 
other, Tukey's honest difference test, P< 0.05. Three to 5 animals per group recieved 25 
Hmol 3,3',4,4'-tetrachlorobiphenyl per kg or cornoil alone on day 13 of gestation. 
ND: not detected. 
Plasma thyroid hormone levels: 
Plasma TT4 levels were significantly depressed 4 days after TCB administration 
in pregnant rats and 7 days after TCB administration in non-pregnant rats (Table 2.6). 
Control plasma TT4 levels decreased during gestation from 44.2 + 6.9 nmol/liter to 22.1 
+ 2.6 nmol/liter, while levels of TT4 in non-pregnant rat plasma remained constant after 
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vehicle administration. Plasma TT3 concentrations were significantly decreased in non-
pregnant rats relative to controls 1 and 2 days after TCB administration and were 
significantly increased in pregnant rats at the same time points. Plasma FT4 levels were 
significantly decreased relative to controls in pregnant rats treated with TCB from 1 to 4 
days after TCB exposure. Fetal FT4 and TT4 levels were significantly reduced relative to 
controls on day 20 of gestation by maternal TCB administration. Fetal plasma TT3 was 
undetectable in the assay as performed. 
Table 2.6 
Effect of [14C]-TCB administration on thyroid hormone levels in non-pregnant, pregnant 
rats and fetuses 
Animal Treatment Day after [14C]-TCB administration 
2 4 7 
TT„ nM 
NP 
NP 
P 
P 
F 
F 
Control 
TCB 
Control 
TCB 
Control 
TCB 
49.8+6.5 
14.5+1.6* 
44.2+6.9 
18.7+2.7* 
NA 
NA 
50.3+6.5 
18.7+3.9* 
31.9+5.0 
15.2+2.5* 
NA 
NA 
51.6+3.6 
24.5+4.7* 
28.4+1.1 
19.5+2.8* 
NA 
NA 
42.5+5.0 
30.8+2.8* 
25.0+2.4 
25.4+7.8 
5.9+0.6 
3.8+0.9* 
TT„ nM 
NP Control 
NP TCB 
P Control 
P TCB 
1.40+0.07 
0.67+0.12* 
0.75+0.08 
1.34+0.28 
0.66+0.11 
0.54+0.02 
1.08+0.14 
1.29+0.08 
0.83+0.01 
1.13+0.27* 0.98+0.14* 0.63+0.10 
1.36+0.02 
1.39+0.20 
0.79+0.16 
0.91+0.24 
FT4, pM 
p 
p 
F 
F 
Control 
TCB 
Control 
TCB 
25.2+1.7 
15.3+2.0* 
NA 
NA 
16.4+7.3 
9.8+1.0* 
NA 
NA 
16.5+1.6 
9.2+0.8* 
NA 
NA 
14.3+0.6 
14.9+4.8 
4.5+0.1 
2.0+0.5* 
Pregnant and non-pregnant rats received an oral administration of 25 umol [14C]-TCB/kg. 
Pregnant rats were dosed on day 13 of gestation. Data are the means+S.E.M., NP: non-pregnant, 
P: pregnant, F: fetus, TT4: total thyroxine, TT3, total triiodothyronine, FT4: free thyroxine, * 
significantly different from controls, n=3, P<0.05, 2 sided student's t-test, NA: data not 
available. 
34 
Chapter 2 
Discussion 
[14C]-TCB was rapidly eliminated from both non-pregnant and pregnant rats 
mainly via the feces, although fecal and urinary excretion was lower in pregnant rats 
than in non-pregnant rats. Previous studies have also shown that TCB is rapidly 
metabolized and excreted via the feces in mice and rats (Yoshimura et al., 1987, 
Klasson Wehler et al., 1990). The significantly lower fecal and urinary elimination of 
[14C]-TCB-derived radioactivity in pregnant rats compared to non-pregnant rats may be 
due to the increase in body weight and adipose tissue and hence distribution volume 
during pregnancy. Another explanation is that hepatic metabolism of TCB during 
pregnancy may be decreased, although we did not address this issue in our experiments. 
Sinjari et al. reported that basal EROD activity is significantly lower in control pregnant 
C57BL mice on day 17 of gestation compared to non-pregnant mice, however the 
induction of EROD activity by TCB was not affected by gestation. 
The results demonstrate that there is extensive metabolite formation in both 
pregnant and non-pregnant rats following TCB exposure. A large portion of the [14C] 
radioactivity in the livers was not extractable, and 7 days after administration of [MC]-
TCB, 50% of the extractable radioactivity was in the form of metabolites. The 
percentage of non-extractable [14C] radioactivity in the livers of pregnant rats increased 
from 13% to 47% of the total radioactivity from 1 to 7 days after [14C]-TCB 
administration, which can be consistent with the observed covalent binding of TCB-
metabolites to hepatic proteins (Shimada and Sawabe, 1984). 
The major metabolite found in the plasma and livers of non-pregnant and 
pregnant rats, placentas and fetuses is 3,3',4',5-tetrachloro-4-biphenylol (4-OH-tetraCB). 
Low amounts of 5-OH-TCB were found in the livers of non-pregnant and pregnant rats, 
and the ratio of 4-OH-tetraCB/5-OH-TCB increased with time, indicating that 4-OH-
tetraCB is either produced in a greater amount or is selectively retained. There is some 
evidence that supports both of these possibilities. The amount of 4-OH-tetraCB produced 
in incubations of TCB with rat hepatic microsomes is more than two times greater than 
that of 5-OH-TCB (Ishida et al., 1991), while similar amounts of both metabolites are 
excreted in rat feces after TCB administration (Yoshimura et al., 1987). Furthermore, 
when either metabolite is administered to rats, 5-OH-TCB is excreted much more 
rapidly than 4-OH-tetraCB (Yoshimura et al, 1987). It should be noted that the livers 
analysed in the current experiments were not perfused, so that part of the 4-OH-tetraCB 
present in the liver extracts is due to the presence of blood in the livers prior to 
homogenization. 
Although 4-OH-tetraCB is found to bind to transthyretin, the plasma thyroid 
hormone transport protein, this cannot in itself explain its increased retention relative to 
5-OH-TCB, because both compounds exhibit similar binding affinities for transthyretin 
(Lans et al., 1993). A possible explanation for the difference in excretion is that 5-OH-
TCB is readily conjugated with glucuronic acid in the liver, while the chlorines flanking 
the hydroxy group in 4-OH-tetraCB form a steric hinderence for conjugation. 
Surprisingly high levels of [14C] radioactivity accumulated in the fetus with time, 
and the extractable radioactivity was present mainly as 4-OH-tetraCB, with negligible 
levels of TCB itself. This is in contrast to a previous study, in which was reported that 
the major phenolic metabolite accumulating in mouse fetuses was 3,3',4,4'-tetrachloro-2-
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biphenylol (Darnerud et al, 1986). This metabolite was not detected in any of the 
tissues examined in our study. However, a re-evaluation of the mouse study shows 
results more similar to our study, in that 4-OH-tetraCB is the major fetal metabolite and 
the ort/zo-hydroxylated metabolite is present in only small amounts (Dr. P.O. Darnerud, 
personal communication). 
It is unlikely that the hydroxylated metabolites are formed in the fetal 
compartment, because EROD activity was undetected in fetal microsomes after maternal 
TCB exposure. In vitro metabolism studies with TCB have shown that EROD activity is 
closely related to TCB metabolism (Mills et al., 1985), and that the enzyme CYP1A, 
which catalyzes the deethylation of ethoxyresorufin, is able to hydroxylate TCB (Ishida 
et al., 1991). 
Since hepatic EROD activity was induced more than 10-fold in TCB-treated 
pregnant rats and undetectable in fetuses, it is most likely that maternal production of 
TCB metabolites is the main source of hydroxylated metabolites found in the fetus. The 
13 fold greater concentration of 4-OH-tetraCB in the whole fetus as compared to the 
maternal liver on a lipid weight basis and the 14 fold greater concentration in the fetal 
plasma on day 20 of gestation suggests a specific mechanism of accumulation. 
In a previous study, it was suggested that hydroxylation of PCBs in the maternal 
compartment and glucuronidation in the fetal liver was necessary for the accumulation 
of PCB metabolites in the fetal rat intestine (Lucier et al., 1978). Various PCBs 
hydroxylated in either the para or meta position exhibit a high affinity for TTR (Lans et 
al., 1993). 4-OH-tetraCB has a higher affinity for human TTR in vitro than T4 itself, and 
was found to be bound to TTR in the plasma of rats treated with TCB (Brouwer et al., 
1990, Brouwer et al., 1986). It is therefore plausible that the accumulation of 
hydroxylated PCBs in the rat fetus is dependent in part on TTR for transplacental 
transport. The study from Lucier et al. (1978) also revealed a high ratio of fetal to 
maternal blood radioactivity after prenatal TCB administration. 
Plasma TT4 levels were decreased in TCB treated non-pregnant and pregnant rats, 
as well as their fetuses, when compared with cornoil treated controls. The decreases in 
maternal plasma T4 concentrations may be due to the binding of 4-OH-tetraCB to TTR, 
thereby displacing T4. The selective retention of 4-OH-tetraCB in maternal plasma 
further supports the role of this metabolite in the reduction of maternal plasma T4 levels. 
Also other mechanisms are probably involved, for it has been shown that the 
coplanar PCBs 3,3'4,4',5,5'-hexachlorobiphenyl and 3,3',4,4'-TCB can induce hepatic 
T4-glucuronyltransferase activity in pregnant rats (Morse et al., 1993), which may also 
contribute to decreases in plasma T4 levels by increased excretion of T4 (Bastomsky, 
1977, Barter and Klaassen, 1991). Furthermore, there is ultrastructural and biochemical 
evidence that PCBs inhibit the release of thyroid hormones from the thyroid gland itself 
in adult rats (Collins and Capen, 1980b, Collins and Capen, 1980c). 
The response of plasma TT3 levels to TCB treatment was markedly different in 
pregnant and non-pregnant rats. While plasma TT3 concentrations increased in pregnant 
rats following TCB exposure, they decreased in non-pregnant rats relative to controls. 
The mechanism for these differences is unclear. 
TCB-induced reductions were observed in fetal plasma TT4 and FT4 
concentrations when the plasma TT4 and FT4 concentrations in the TCB-treated dams 
had returned to control levels, which suggests that reduced transplacental transport of 
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maternal T4 was not involved in the reduction of fetal plasma thyroid hormones. 
Furthermore, the thyroid gland in the fetal rat begins to secrete thyroid hormones 
between day 17 and 18 of gestation, and at 21 days of gestation only 18% of the 
extrathyroidal T4 pool of the fetuses is of maternal origin (Morreale de Escobar et al., 
1990). Previous results provide evidence that in the rat the increased hepatic 
glucuronidation of T4 is related to decreases in maternal or neonatal circulating T4 
concentrations, but not to fetal T4 concentrations following maternal PCB exposure 
because the levels of fetal hepatic microsomal T4 glucuronidation are 5-10 fold lower 
than maternal or neonatal levels (Morse et al., 1993). Therefore the decreases in fetal 
plasma TT4 and FT4 concentrations following maternal TCB exposure are probably a 
consequence of the accumulation of 4-OH-tetraCB in the fetal compartment, in 
particular the fetal plasma. 
While the hydroxylated metabolites of TCB, 4-OH-tetraCB and 5-OH-TCB, have 
been shown to be relatively non-toxic compared to the parent compound in adult rats 
(no alteration of organ weights) following a bolus injection (Yoshimura et al, 1987), 
and in chicken embryos (no increased mortality) (Klasson Wehler et al, 1990), they are 
not biologically inactive compounds. The capacity of 4-OH-tetraCB to reduce plasma 
thyroid hormone levels by binding specifically to TTR and the high accumulation in the 
fetal compartment, especially the blood, poses a threat to the maintainance of sufficient 
brain triiodothyronine concentrations derived from T4. As thyroid hormones are essential 
for normal brain development, the accumulation of 4-OH-tetraCB in fetal plasma could 
adversely affect neurological parameters. 
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ß-NAPHTHOFLAVONE- AND SELF-INDUCED METABOLISM OF 3,3\4,4'-
TETRACHLOROBIPHENYL IN HEPATIC MICROSOMES OF THE MALE, 
PREGNANT FEMALE AND FETAL RAT 
Abstract 
The in vitro metabolism of 3,3',4,4'-tetrachloro-[14C]-biphenyl ([14C]-TCB) by 
hepatic microsomes from Wistar rats was investigated with liver microsomes from the 
male, pregnant female and fetal Wistar rat. Three hydroxylated metabolites (4-OH-
3,3',4,5'-tetrachlorobiphenyl, 5-OH-3,3',4,4'-tetrachlorobiphenyl and 6-OH-3,3',4,4'-
tetrachlorobiphenyl) were identified by high performance liquid chromatography and gas 
chromatography-mass spectometry after incubations of liver microsomes from ß-
naphthoflavone pretreated male rats and TCB-treated pregnant rats. No metabolites of 
[14C]-TCB were found after incubation with fetal liver microsomes from dams pretreated 
with TCB. The results indicate that the in vivo accumulation of 4-OH-tetraCB in the 
fetal compartment is probably due to transplacental transport rather than the formation of 
this metabolite in the fetus. 
Pretreatment of male rats with ß-naphthoflavone substantially induced the 
formation of hydroxylated metabolites, but pretreatment with phénobarbital and 
dexamethasone was without effect. Based on in vitro incubations of liver microsomes 
from ß-naphthoflavone pretreated male rats, an apparent Km and Vmax of 4.5 uM and 
240 pmol/mg protein/min), respectively, was determined for the metabolism of [14C]-
TCB. The formation of phenolic metabolites of [14C]-TCB was most likely dependent on 
cytochrome P4501A induction. 
Dennis C. Morse, Peter J. van Bladeren, Eva Klasson Wehler, Abraham Brouwer 
Xenobiotica, in press 
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Introduction 
The wide range of biological activity exhibited by polychlorinated biphenyls may 
be caused by a variety of mechanisms involving the interaction of the parent compound 
or a metabolite thereof with a specific receptor protein (Safe, 1994). The most toxic 
PCB congeners, 3,3',4,4'-tetrachlorobiphenyl (TCB), 3,3',4,4',5-pentachlorobiphenyl and 
3,3',4,4',5,5'-hexachlorobiphenyl have a coplanar structure and have a high affinity for 
the Ah (arylhydrocarbon) receptor (Bandiera et al. 1982), which mediates most of the 
toxic effects of these coplanar PCBs (Safe, 1994). The binding of coplanar PCBs to the 
Ah receptor can result in the induction of cytochrome P4501A enzymes and the 
associated ethoxyresorufin-O-deethylase (EROD) activity in microsomes of animal 
tissues (Safe, 1994). 
Several reports indicate that the cytochrome P4501A1 isoenzyme may catalyze 
the hydroxylation of PCBs, including TCB (Mills et al. 1985, Ishida et al. 1991). TCB 
is readily metabolized to phenolic metabolites in vivo as well as in vitro (Ishida et al. 
1991, Yoshimura et al. 1987, Klasson Wehler et al. 1989). In contrast, 3,3',4,4',5-
pentachlorobiphenyl and 3,3',4,4',5,5'-hexachlorobiphenyl are hardly metabolized in 
animals (Koga et al 1990, Mills et al. 1985). Other non-planar, ortAo-substituted PCBs 
may also be metabolized, resulting in the formation of hydroxylated (Bergman et al. 
1994) or methylsulfonated compounds (Mitzutani et al. 1978, Bergman et al. 1992). 
These metabolites have a wide range of biological activity, including interactions of 
hydroxylated PCBs with thyroid hormone binding proteins (Lans et al. 1993) and the 
eostrogenic activity of hydroxylated PCBs (Jansen et al. 1993, Korach et al. 1988) or 
the binding of methylsulfonyl PCBs to a2M-globulin (Larsen et al. 1990). Moreover, the 
induction of several cytochrome P450 isoenzymes by methylsulphone derivatives of 
PCBs has been demonstrated (Kato et al. 1993). 
Both mice and rats rapidly metabolize TCB, resulting in the formation of three 
major metabolites, namely the 1,2-shift metabolite, 4-OH-3,3',4',5-tetrachlorobiphenyl 
(4-OH-tetraCB), 5-OH-3,3',4,4'-tetrachlorobiphenyl (5-OH-TCB) and 6-OH-3,3',4,4'-
tetrachlorobiphenyl (6-OH-TCB) (Yoshimura et al. 1987, Klasson Wehler et al. 1989, 
Morse et al. 1995). Interestingly only 4-OH-tetraCB accumulates in both mouse and rat 
plasma (Morse et al. 1995a, Klasson Wehler, 1989, Brouwer et al. 1990), whereas 5-
OH-TCB is excreted in greater amounts than 4-OH-tetraCB in the feces (Yoshimura et 
al. 1987). A re-evaluation of a previously published study which demonstrated the 
accumulation of phenolic metabolites of TCB in fetal mice (Darnerud et al. 1986) 
revealed that the major hydroxylated metabolite of TCB in the fetus was 4-OH-tetraCB 
(Eva Klasson Wehler, personal communication). Recent research from our laboratory 
has confirmed that 4-OH-tetraCB is the major compound accumulating in late 
gestational rat fetuses following maternal TCB exposure (Morse et al. 1995a). The 
selective retention of 4-OH-tetraCB in rat plasma is explained by competitive binding to 
transthyretin (TTR), the major plasma thyroid hormone binding protein in the rat and 
mouse (Brouwer and Van den Berg, 1986, Savu et al. 1989, Vrancks et al. 1990), as a 
result of the structural resemblance of 4-OH-tetraCB to thyroxine (T4) (Lans et al. 1993) 
. The accumulation of 4-OH-tetraCB in the fetal plasma results in a decrease of the 
binding capacity of TTR for T4 (unpublished observations, P.O. Darnerud and D.C. 
Morse) and consequently in decreases in plasma T4 levels (Morse et al. 1995a). 
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However, it was not clear from the in vivo studies above if 4-OH-tetraCB in the fetus is 
maternally derived or formed in the fetus itself. 
The aim of the present study was to enable the use of [14C]-TCB as a model 
compound to investigate the metabolic capacity of adult, fetal and maternal tissues. 
Moreover, it was considered to be of interest to determine which pretreatment with 
inducers of hepatic mono-oxygenases resulted in the greatest induction of [14C]-TCB 
metabolism. ß-Naphthoflavone and phénobarbital (inducers of PCB metabolism, Mills et 
al. 1985) and dexamethasone (inducer of chlorinated benzene metabolism, (den Besten et 
al. 1991) as well as TCB itself were used as pretreatments in vivo. The reaction 
conditions for the incubation of [14C]-TCB with hepatic microsomes from male rats were 
validated using high performance liquid chromatography (HPLC). Gas chromatography -
mass spectrometry was used to confirm the identity of the extractable radioactive 
products. The HPLC technique was then used to determine the source of phenolic 
metabolites found in the fetus in vivo by examining [14C]-TCB metabolism with hepatic 
microsomes obtained from TCB-exposed pregnant rats and their fetuses . 
Material and Methods 
Materials 
3,3',4,4'-tetrachloro-[14C]-biphenyl (37.1 |aCi/|amol, radiochemical purity 95%) 
and bovine serum albumin (96-99% pure) were obtained from Sigma Chemical Co., St. 
Louis, MO, U.S.A. Unlabelled 3,3',4,4'-tetrachlorobiphenyl (>99% pure) was obtained 
from Promochem, Wesel, Germany. 2-OH-3,3',4,4'-tetrachlorobiphenyl, 4-OH-3,3',4',5-
tetrachlorobiphenyl, 5-OH-3,3',4,4'-tetrachlorobiphenyl and 6-OH-3,3',4,4'-tetrachloro-
biphenyl (chemical purity >99%) were synthesised according to Klasson Wehler et al. 
(1990). The following chemicals were purchased from Merck, Darmstadt, Germany: 
Tris, NaOH, Folin-Ciocalteu phenol reagent, MgCl2, acetone, diisopropyl ether, 
methanol, ethanol, ethyl acetate, and diethyl ether (all solvents were analytical grade). 
Methanol (HPLC quality) was purchased from Janssen Chimica, Tilburg, The Nether-
lands. Glucose-6-phosphate, glucose-6-phosphate-dehydrogenase, NADP+ and NADPH 
were obtained from Boehringer Mannheim, Almere, The Netherlands. 
Animals 
Hepatic microsomes were prepared from Wistar rats from two different experi-
mental situations. 
Experiment 1. Male Wistar WU rats (300 g) were treated with dexamethasone 
(DEX, 4 consecutive daily oral administrations of 300 mg/kg body weight dissolved in 
2% Tween 80), ß-naphthoflavone (ß-NF, 3 daily ip injections of 30 mg/kg dissolved in 
cornoil) or phénobarbital (PB, 0.1% w/v, in the drinking water for 7 days). Control rats 
were of a similar weight but were untreated. One day after the last treatment, the rats 
were sacrificed under ether anesthesia and the livers removed. The livers of three rats 
per treatment group were pooled. Microsomes were prepared as previously described 
and stored at -80°C (Morse et al. 1993). Two different batches of ß-NF microsomes 
were used for the experiments, and are designated as ß-NF(l) and ß-NF(2). The specific 
enzyme activity (ethoxyresorufin-O-deethylase) of both batches are presented in the 
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results. 
Experiment 2. Pregnant female Wistar WU rats (16 weeks old) were treated with 
25 umol 3,3',4,4'-tetrachlorobiphenyl per kg body wt dissolved in corn oil (2 ml/kg 
body wt) on day 13 of gestation. On day 20 of gestation the pregnant rats were 
sacrificed under ether anesthesia and both the fetal and maternal livers removed. Fetal 
livers were pooled from each dam. Microsomes were prepared and stored as above. 
Purification of fNCJ-3,3',4,4'-tetrachlorobiphenyl (TCB) 
[14C]-TCB was purified using semi-preparative high performance liquid chroma-
tography. Fifty uCi of [,4C]-TCB was dissolved in 400 jLtl methanol and injected in 200 
jj.1 aliquots on a Zorbax ODS reverse phase column (Dupont, 4.6 mm i.d. x 25 cm) and 
eluted with a mixture of 85% methanol (v/v) and 15% water at a flow rate of 2 ml/min. 
Fractions were collected every minute for 30 minutes and uv absorbance monitored at 
262 run. A 100 ul aliquot of each fraction was counted by liquid scintillation counting 
(LSC) using Ultima Gold (Packard) as the scintillation fluid and the main fractions 
containing [14C]-TCB radioactivity were pooled. The recovery of total radioactivity from 
the column was greater than 99%. The column had previously been calibrated using 
unlabelled TCB as a standard. 
The water content of the pooled HPLC fractions was adjusted to 50% and a final 
volume of 90 ml. The methanol:water (1:1) phase was then extracted 4 times with 10 ml 
hexane by thorough mixing in a volumetric flask and removing the hexane after the 
phases had separated. Extraction efficiency for [14C]-TCB in this latter case was greater 
than 99%. The hexane extract was evaporated under nitrogen, redissolved in 2 ml 
toluene and stored at 4°C. In order to check the purification, 1 uCi of the purified 
extract was redissolved in 100 ul methanol and 50 ul was injected on the same column 
using the same mobile phase conditions as described above. Fractions were collected 
every 30 seconds and when counted by LSC the radiochemical purity was greater than 
99.8%. No contaminating peaks were found by monitoring the absorbance at 262 nm. 
Incubation of [l4C]-TCB with hepatic microsomes 
Initial experiments were carried out with ß-NF(l) microsomes because previously 
published research indicated that inducers of cytochrome P4501A activity resulted in an 
induction of TCB metabolism in rat hepatic microsomes (Ishida et al. 1991). Incubations 
were carried out in glass tubes at 37 °C in a shaking water bath with 0.5 uCi [14C]-TCB 
per tube in a total volume of 2 ml with a 0.1 M (final concentration) Tris-HCl buffer, 
pH 7.5. Microsomal protein concentrations were varied between 0.1 and 2.0 mg 
protein/ml. The final concentration of TCB used varied between 1 and 50 uM. 
Unlabelled TCB was added to [14C]-TCB to obtain the desired stock solution, which was 
dissolved in acetone and added to the pre-incubation mixture containing the microsomes 
and buffer (25 ul acetone/ml of incubation mixture) and vortexed for 1 min. NADPH 
was used as a cofactor in concentrations of 1 and 2 mM. An NADPH regenerating 
system was also used which consisted of 0.3 mM NADP+, 10 mM glucose-6-phosphate, 
0.25 units of glucose-6-phosphate dehydrogenase and 7.5 mM MgCl2 (final 
concentrations). The incubation mixtures were prepared in tubes placed in an ice water 
bath. Incubations were pre-incubated for 2 minutes at 37°C and the reaction initiated by 
addition of NADPH, or in the case of the NADPH regenerating system with glucose-6-
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phosphate. Reaction time was varied between 0 and 30 min. In order to investigate the 
effect of glucuronidation on the appearance of phenolic metabolites in the incubation 
mixture, ß-NF(2) microsomes (1 mg/ml) were incubated for 15 minutes with 10 uM 
[14C]-TCB, 1 mM NADPH, with and without 1 mM uridine-diphosphoglucuronic acid. 
Reactions were stopped by the addition of 2 ml of ice-cold methanol to the 
incubation mixture and vortexed for 30 sec. After the addition of methanol, the incubati-
on mixtures were extracted 3 times with 4 ml of diisopropyl ether by vortexing for 30 s, 
centrifuged at 1000g for 5 minutes and then removal of the diisopropyl ether. Blanks 
were carried out by performing identical incubations with heat-inactivated microsomes 
(boiling water bath for 10 min). The ether extracts were pooled and dried under nitrogen 
and stored at 4°C until analysis. The lower phase containing the microsomal pellet and 
the water/methanol mixture was also stored at 4°C until further analysis. For HPLC 
analysis of the water/methanol phase it was first centrifuged at 1000g for 5 min, the 
supernatant removed, evaporated under nitrogen and resuspended in 100 ul water:metha-
nol (1:1). 
HPLC analysis of extractable radioactivity 
Metabolite analysis was conducted using a Gilson 300 series HPLC system fitted 
with a Perkin-Elmer 3 um C-18 column (4.6 mm i.d. x 83 mm). The uv absorbance was 
monitored at 262 nm, which yielded the best average response of the standards used 
according to a wavelenth scan (200-400 nm) in 78% methanol/22% water with a 
Beekman DU-64 spectrophotometer. The diisopropyl ether extracts were redissolved in 
100 ul methanol containing 2.5 ug of the following standards: 2-OH-3,4,3',4'-tetrachlo-
robiphenyl, 4-OH-3,3',4',5-tetrachlorobiphenyl, 5-OH-3,4,3',4'-tetrachlorbiphenyl and 6-
OH-3,4,3',4'-tetrachlorobiphenyl. Twenty ul of the ether extract or the concentrated 
water/methanol phase was injected on the column. The mobile phase was 78% (v/v) 
methanol, 22% water (containing 0.01% w/v Na-azide) for 20 minutes, followed by a 
gradient to 100% methanol in 5 minutes, and 100% methanol for another 10 minutes. 
The flow rate was 1 ml/min. The column was allowed to equilibrate at 78% v/v 
methanol, 22% water (0.01% w/v Na-azide) for at least 10 minutes between injections. 
Fractions were collected every 0.4 minutes for 35 minutes with a Redifrac fraction 
collector (Pharmacia). Five ml of scintillation fluid (Ultima Gold, Packard) was added to 
each fraction and was then counted in a liquid scintillation counter (Tri-Carb 1600, 
Packard). Identification of the metabolites was based on the coelution of radioactivity 
with authentic standards. 
Gas-chromatographic-mass spectrometric analysis of extractable metabolites 
Once the pattern of the metabolites formed had been firmly established on the 
basis of coelution with authentic standards using HPLC analysis, further confirmation of 
the identity of the metabolites formed in the in vitro incubations of hepatic microsomes 
with [14C]-TCB was provided by gas chromatography with electron-capture detection 
(GC-ECD) and gas chromatography-mass spectrometry (GC-MS). The ether extracts 
from 3 incubations were pooled. The incubation conditions were: 2 ml final volume with 
10 uM [14C]-TCB, 1 mg microsomal protein (ß-NF(2)) per ml, 1 mM NADPH in 1 mM 
Tris-HCl buffer, pH 7.5 and a 10 minute incubation time. The pooled extracts were 
resuspended in 200 ul methanol and 20 ul was injected on the C-18 column that was 
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routinely used for analysis of the extracts. One ml fractions were collected in glass tubes 
and 50 ja.1 of each fraction was counted using LSC as above. The fractions containing 
the radioactivity were pooled separately for each peak and the solvent was evaporated 
under nitrogen. The dried residue was redissolved in 1 ml n-hexane and methylated with 
diazomethane. Unreacted diazomethane and the hexane were then evaporated under 
nitrogen. 
GC-MS was performed on an ITS40 instrument (Finnigan). The GC (Varian 
3400) was equipped with a fused silica capillary column (DB5, 30 m x 0.25 mm i.d., 
J&W Scientific Inc. CA, USA) and a split-splitless injector. The temperature program 
was 80°C for 2 min, then 10°C/min to 240°C and maintained at 240°C for 20 min. The 
injector temperature was 260°C and the injections were made in the splitless mode, 
using an autosampler (CTC A200S, Finnigan). The mass spectrometer was operated in 
the electron impact mode and the manifold temperature was 220°C. GC-ECD analyses 
were performed with a Varian 3400 gas Chromatograph equipped with a DB5+ fused 
silica column (30 m x 0.25 mm i.d., J&W Scientific Inc. CA, USA), a split-splitless 
injector operated at 250°C, and a 63Ni electron capture detector (ECD) operated at 
300°C. The samples were injected in the splitless mode and the column temperature was 
programmed as follows: initial temperature 80°C for 2 min, followed by 10°C/min up to 
300°C. 
Covalent binding to microsomal protein 
Covalent binding of metabolites to microsomal protein was determined as 
previously described (den Besten et al. 1991) after diisopropyl ether extraction of the 
incubation mixture. The water/methanol phase containing the microsomal proteins was 
centrifuged at 1000g for 5 min and the supernatant removed. The pellet was resuspended 
and washed succesively with 2 ml of solvent of declining polarity (water, methanol, 
ethanol and ethyl acetate). The microsomal pellet was recovered by centrifugation at 
1000g for 5 min and removal of the solvent. After the final wash with ethyl acetate, the 
pellet was resuspended in 1 ml 1 N NaOH. Radioactivity was determined in the wash 
solvents and 500 ul of the resuspended pellet by LSC. The remaining 500 ul of the 
resuspended pellet was used for a protein determination with bovine serum albumin as a 
standard (Lowry et al. 1951). 
The radioactivity in the water/methanol phase was analysed for the presence of 
glucuronic acid conjugates and phenolic metabolites by incubation of 50 ul aliquots of 
the watenmethanol phase (after concentration to 200 ul) with and without 150 ul of a ß-
glucuronidase solution (1000 units/ml 0.1 potassium phosphate buffer, pH 6.8) for 30 
minutes at 37°C (Shen et al. 1991) or 4 N HCl at 100°C for 1 h (6), followed by 
diisopropyl ether extraction and HPLC analysis as described above. 
Ethoxyresorufin-O-deethylase (EROD) activity 
EROD activity was determined using a final concentration of 1 uM ethoxyresoru-
fin, 0.1 raM NADPH and 100 p.g microsomal protein per ml at 37°C (Burke et al. 
1977). To detect the deethylation product resorufin, the excitation wavelength of the 
fluorimeter was 530 ran, and the emission wavelength was 580 nm. Initial reaction 
velocities were used to calculate EROD activity. 
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Results 
Optimization of incubation conditions 
Incubations were first optimized for cofactor requirements, length of incubation, 
microsomal protein concentration and TCB concentration by examining the total amount 
of extractable metabolites formed with HPLC. Calculations of total extractable metaboli-
tes formed were based on the percentage of the total radioactivity in the HPLC radio-
chromatogram eluting in the metabolite fractions, adjusted for the total amount of TCB 
(unlabelled and labelled) present in the incubation. Recoveries in the diisopropyl ether 
extracts were always greater than 95% for 5 minute incubations. 
In order to determine whether the addition of NADPH or an NADPH regenera-
ting system yielded the highest activity, ß-NF(l) microsomes (1 mg/ml) were incubated 
for 15 and 30 minutes with 1 or 2 mM NADPH and an NADPH regenerating system 
with 1.7 uM [14C]-TCB. Since the amount of extractable metabolites formed at both 
time points was highest with 1 mM NADPH (data not shown), this concentration was 
therefore used for further experiments. Because the reaction was non-linear over 30 
minutes, a second experiment was conducted with 1 mM NADPH, 1 mg microsomal 
protein/ml and 1.5 uM [14C]-TCB and the amount of extractable metabolites formed was 
determined at 1, 5, 10, 15 and 30 minutes, and revealed that the reaction was linear for 
the first 5 minutes at this TCB concentration (data not shown). 
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Figure 3.1 A and B. 
A) The influence of substrate concentration on the formation of diisopropyl ether-
extractable metabolites (TCB-OH) of [14C]-TCB with microsomes from ß-naphthoflavo-
ne-treated rats (1 mg protein/ml) with 1 mM NADPH and an incubation time of 5 min. 
The results (mean + range) are the average of duplicate incubations. If no error bar is 
visible it is smaller than the marker. The curve is fitted by computer for first order 
kinetics with an apparent Km and Vmax of 4.5 uM and 240 pmol/mg protein/min), 
respectively. B) Lineweaver-Burke plot of the mean data from Figure 3.1A. 
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In order to determine the effect of substrate concentration on metabolite 
production, incubations were performed with 1 to 50 uM [14C]-TCB, 1 mg microsomal 
protein/ml and 1 mM NADPH for 5 minutes. At 50 uM [14C]-TCB the solubility of the 
substrate was poor, yielding large variations in the amount of extractable metabolites 
formed. The poor solubilty of 50 uM [,4C]-TCB was confirmed by the finding that there 
were large variations in the amount of radioactivity recovered when five 100 ul aliquots 
of the incubation mixture were quantified with liquid scintillation counting (LSC) prior 
to extraction, and therefore the data from the incubations with 50 uM [14C]-TCB were 
not used for the Lineweaver-Burke plot. Saturating concentrations of [l4C]-TCB were 
not completely achieved by 32 uM (Figure 3.1 A). From the Lineweaver-Burke plot 
(Figure 3.IB) the apparent K,,, and Vmax values were determined to be 4.5 uM and 240 
pmol/mg protein/ min), respectively, as calculated from the amount of diisopropyl ether-
extractable metabolites formed. 
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Figure 3.2. 
A typical histogram of reversed-phase HPLC analysis of diisopropyl ether-extractable 
metabolites of 10 uM [14C]-TCB with microsomes from ß-naphthoflavone-treated rats (1 
mg protein/ml) with 1 mM NADPH and an incubation time of 5 minutes. A: 4-OH-
3,3',4',5-tetrachlorobiphenyl, B: 5-OH-3,3',4,4'-tetrachlorobiphenyl, C: 6-OH-3,3',4,4'-
tetrachlorobiphenyl, D: unidentified peak in the HPLC radiochromatogram. 
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The effect of microsomal protein concentration on the formation of extractable 
metabolites was examined at 2.5 and 10 uM [14C]-TCB, 1 mM NADPH and an 
incubation time of 5 minutes (data not shown). At 10 uM [14C]-TCB, the formation of 
extractable metabolites (pmol/min) increased linearly with the protein concentration up 
to 1 mg microsomal protein/ml. At the lower substrate concentration used (2.5 uM), the 
formation of extractable metabolites was not a linear function of the protein 
concentration. 
Identification of metabolites 
HPLC fractionation followed by LSC of the ether-extractable radioactivity 
revealed four radioactive metabolite peaks. A typical histogram of a reverse-phase 
HPLC fractionation of the ether extractable radioactivity following the incubation of 
[,4C]-TCB with ß-NF-microsomes is shown in Figure 3.2. The first three radioactive 
peaks coeluted with the metabolite standards 4-OH-tetraCB, 5-OH-TCB and 6-OH-TCB, 
respectively. The fourth radioactive peak did not coelute with any of the authentic 
metabolite standards and no radioactive peak coeluted with 2-OH-TCB. 
GC-ECD and GC-MS analysis of the methylated fractionated peaks after HPLC 
separation of pooled incubation extracts confirmed the identity of the radioactive peaks 
that coeluted with the authetic standards for 4-OH-tetraCB, 5-OH-TCB and 6-OH-TCB, 
both the retention time and mass spectra of the isolated metabolites after methylation 
corresponded to the methylated authentic standards (data not shown). No 2-OH-TCB 
was detected by GC-ECD as its methylated derivative in the HPLC fraction collected 
where the authentic standard would elute or in an unfractionated diisopropyl ether 
extract of incubation with ß-NF microsomes (data not shown). The radioactive peak that 
did not coelute with any of the authentic standards (Peak D, Figure 3.2) yeiled two 
compounds after methylation when analysed with GC-MS with molecular ions of 320 
and 306, both with an isotopic cluster corresponding to 4 chlorine ions (data not shown). 
Extracting the incubations 3 times with diisopropyl ether effectively removed all 
phenolic metabolites and TCB from the aqueous lower phase. When the lower phase 
was evaporated and resuspended in methanol, followed by reversed phase HPLC 
analysis, only one radioactive peak was observed that eluted close to the front of the 
chromatogram and comprised approximately 10% of the total metabolites formed. 
Treatment of the lower phase with ß-glucuronidase or 4 N HCl did not change the 
position of this peak in the radiochromatogram (data not shown). 
The formation of ether-extractable, polar and covalently bound metabolites was 
followed over a period of 15 minutes in an incubation of ß-NF(2) microsomes (1 
mg/ml) with 10 uM [14C]-TCB and 1 mM NADPH. Over 15 minutes the rate of 
formation of 4-OH-tetraCB (17.1 + 0.5 pmol/mg protein/min) was more than 50% 
greater than that of the other two identified phenolic metabolites, 5-OH-TCB and 6-OH-
TCB (11.4 + 0.6 and 12.5 + 0.5 pmol/mg protein/min), (Figure 3.3A). The radioactive 
peak containing unidentified extractable metabolites was formed at a rate similar to that 
of 5-OH-TCB and 6-OH-TCB (13.3 pmol/mg protein/min). 
Of the metabolites that were non-extractable in ether, the largest amount formed 
was in the form of one or more water soluble compounds (23.4 + 0.1 pmol/mg 
protein/min) during the first 5 min (Figure 3.3B). The formation rate of water soluble 
compounds was even higher during the second five minutes of incubation (36.4 + 5.3 
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pmol/mg protein/min). However, between 10 and 15 minutes the concentration of water 
soluble compounds present in the incubation mixture decreased from 150 + 2.6 pmol/ml 
to 106 + 22.3 pmol/ml. Although we were unable to demonstrate the presence of 
phenolic metabolites in the water/methanol phase by acid or enzymatic hydrolysis, the 
addition of 1 mM UDGPA to the incubation mixture significantly reduced the amount of 
5-OH-TCB in the incubation mixture after 15 minutes from 86 + 4.4 to 59 + 7.3 
pmol/ml (PO.05, student's t-test, n=3). The levels of the other phenolic metabolites in 
the incubation mixture were unaffected by the addition of 1 mM UDPGA (data not 
shown). 
Covalently bound metabolites were formed over the first 5 minutes of the 
incubation at a low rate (4.3 + 0.9 pmol/mg protein/min) which increased to 9.3 + 3.9 
pmol/mg protein/min) in the second 5 minutes of the incubation and remained at the 
same rate (9.3 + 0.4 pmol/mg protein/min) during the third 5 minutes. 
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Figure 3.3 A and B. 
A: The formation of individual diisopropyl ether-extractable metabolites of 10 |iM [14C]-TCB 
with microsomes from ß-naphthoflavone-treated rats (1 mg protein/ml) with 1 mM NADPH and 
an incubation time of 5, 10 and 15 min. The results (mean + SD) are the average of three 
incubations. For the clarity of the figure, error bars are presented only for 4-OH-tetraCB. 4-OH-
tetraCB: 4-OH-3,3',4\5-tetrachlorobiphenyl, 5-OH-TCB: 5-OH-3,3',4,4'-tetrachlorobiphenyl, 6-
OH-TCB: 6-OH-3,3',4,4'-tetrachlorobiphenyl, unknown: unidentified peak in the HPLC 
radiochromatogram. 
B: The formation of diisopropyl ether-extractable, water soluble and covalently bound and total 
metabolites of 10 \ùA [14C]-TCB with microsomes from ß-naphthoflavone-treated rats (1 mg 
protein/ml) with 1 mM NADPH and an incubation time of 5, 10 and 15 min. The results (mean 
+ SD) are the average of three incubations. If no error bar is visible, it is smaller than the 
marker. 
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Figure 3.4A and B. 
A: Influence of substrate concentration on the formation of covalently bound metabolites of 
[14C]-TCB with microsomes from ß-NF-treated rats (1 mg protein/ml) with 1 mM NADPH and 
an incubation time of 5 min. The results are the mean + range of duplicate incubations. 
B: The influence of microsomal protein concentration on the formation of covalently bound 
metabolites of 2.5 and 10 uM [14C]-TCB with microsomes from ß-naphthoflavone-treated rats 
with 1 mM NADPH and an incubation time of 5 min. The results (mean + range) are the 
average of duplicate incubations. If no error bar is visible, it is smaller than the marker. 
The production of metabolites covalently bound to microsomal proteins was 
investigated in relation to substrate concentration and protein concentration. After 5 
minute incubations of 1-32 uM [14C]-TCB with 1 mg microsomal protein (ß-NFl)/ml 
and 1 mM NADPH, the amount of covalently bound metabolites formed increased in a 
non-linear fashion with the [14C]-TCB concentration (Figure 3.4A). When the 
microsomal protein concentration was varied in 5 minute incubations with 10 uM [14C]-
TCB and 1 mM NADPH, the amount of covalently bound metabolites in the microsomal 
pellet increased linearly bewteen 0.5 and 2.0 mg protein/ml (Figure 3.4B). However, at a 
lower substrate concentration (2.5 uM [14C]-TCB), the amount of covalently bound 
metabolites did not increase in a linear fashion (Figure 3.4B). 
Influence of pretreatment and development 
The induction of TCB metabolism by various inducers of hepatic mono-
oxygenases was investigated in male Wistar rats. The incubation conditions were 1 mg 
microsomal protein/ml, 10 uM [14C]-TCB, 1 mM NADPH and an incubation time of 5 
min. The only pretreatment that resulted in the induction of TCB metabolism (formation 
of extractable metabolites) was ß-naphthoflavone (Table 3.1). ß-NF treatment also 
resulted in the greatest induction of EROD activity relative to untreated rats. Although 
pretreatment with phénobarbital induced EROD levels 4-fold relative to controls, neither 
treatment with phénobarbital nor dexamethasone had any effect on hepatic microsomal 
TCB metabolism. 
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Table 3.1 
Microsomal metabolite production from [l4C]-TCB after different pretreatments of male 
Wistar rats. 
Treatment 
Control 
Phénobarbital 
Dexamethasone 
ß-Naphthoflavone (1) 
ß-Naphthoflavone (2) 
TCB Metabolism 
pmol OH-TCB/mg 
protein/min 
3.9+0.4 
3.6+0.7 
2.1+0.4 
157+7.2 
62.9+3.8 
EROD activity 
nmol RR/mg 
protein/min 
0.05+0.01 
0.20+0.05 
0.06+0.01 
6.13+0.60 
2.29+0.24 
The incubation conditions were: 10 (iM [14C]-TCB, 1 mg microsomal protein/ml, 1 mM 
NADPH, 37°C for 5 minutes. The rate of metabolism is based on the amount of ether-
extractable metabolites formed in the incubations. The results are the mean+SD of 
triplicate incubations. EROD: ethoxyresorufin-O-deethylase, RR: resorufin 
Table 3.2 
Microsomal metabolite production from [14C]-TCB in control and TCB-treated pregnant 
Wistar rats and fetuses. 
Treatment TCB Metabolism 
pmol OH-TCB/mg 
protein/min 
EROD activity 
nmol RR/mg 
protein/min 
Control dams 
Control fetuses 
TCB-dams 
TCB-fetuses 
ND 
ND 
43.9+8.5 
ND 
0.02+0.00 
ND 
1.70+0.43 
ND 
The incubation conditions were: 10 |aM [14C]-TCB, 1 mg microsomal protein/ml, 1 mM 
NADPH, 37°C for 5 minutes. The rate of metabolism is based on the amount of ether-
extractable metabolites formed in the incubations. The results are the mean+SD of 
duplicate incubations of microsomes from 4 individual dams or their fetuses. ND: not 
detected. EROD: ethoxyresorufin-O-deethylase, RR: resorufin 
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4-OH-tetraCB 
5-OH-TCB 
6-OH-TCB 
Unknown 
13.5+2.3 
7.1+1.1 
8.7+1.3 
6.1+1.1 
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Table 3.3 
Comparison of the production of phenolic metabolites of [14C]-TCB by microsomes 
from ß-NF-treated male and TCB-treated pregnant female Wistar rats. 
Metabolite ß-NF(2)-treated males TCB-treated dams 
pmol OH-TCB/mg protein/min 
20.7±2.0 
10.9+0.7 
12.1+0.6 
13.1+1.4 
The incubation conditions were: 10 uM [14C]-TCB, 1 mg microsomal protein/ml, 1 mM 
NADPH, 37°C for 5 minutes. The rate of metabolism is based on the amount of ether-
extractable metabolites formed in the incubations. The results are the mean+SD of 
duplicate incubations of microsomes from 4 individual dams or triplicate incubations of 
ß-NF(2) microsomes. ß-NF: ß-naphthoflavone. 
The capacity of fetal and maternal rat microsomes from day 20 of gestation to 
metabolize [14C]-TCB or ethoxyresorufin after pretreatment on day 13 of gestation with 
either unlabelled TCB (25 umol/kg) or the vehicle alone (corn oil, 2 ml/kg) was also 
investigated. The incubation conditions were 1 mg microsomal protein/ml, 10 uM [14C]-
TCB, 1 mM NADPH and an incubation time of 5 min. There was no detectable 
formation of extractable metabolites in incubations with microsomes from corn oil-
treated dams and fetuses or with microsomes from TCB-exposed fetuses. Only 
incubations of [l4C]-TCB with microsomes from TCB-treated dams resulted in the 
production of ether-extractable metabolites (Table 3.2). The level of EROD activity with 
microsomes from TCB-treated dams was 100-fold higher than that of corn oil-treated 
dams, and fetal EROD activity was undetectable irrespective of the pretreatment. EROD 
activity was also 3-fold lower with microsomes from corn oil-treated dams (17 pmol/mg 
protein/min) than untreated male rats (53 pmol/mg protein/min). The relative amounts of 
phenolic PCB metabolites and the extractable unknown compound(s) formed was nearly 
identical in incubations of [,4C]-TCB with microsomes from ß-NF-treated male Wistar 
rats and TCB-treated pregnant female Wistar rats (Table 3.3). 
Discussion 
The major phenolic metabolites of TCB formed in the incubation mixture (4-OH-
3,3',4',5-tetraCB, 5-OH-TCB and 6-OH-TCB) were resolved by HPLC and their identity 
confirmed by coelution with authentic standards on a reverse-phase HPLC column. 
Definite confirmation of the identity of the phenolic compounds in the HPLC fractions 
was given by GC-ECD and GC-MS analysis after methylation of the fractions. The 
reaction conditions were partially optimized for cofactor requirements, substrate and 
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microsomal protein concentration. Ideally a substrate concentration should be chosen 
which will result in Vmax conditions, however, at 30 uM [14C]-TCB this Vmax conditions 
was not attained and at 50 uM [14C]-TCB the solubility of the substrate in the incubation 
mixture was poor at a microsomal protein concentration of 1 mg/ml. The use of 10 uM 
[14C]-TCB forms a reasonable compromise, for the production of metabolites was a 
linear function of time (up to 15 minutes) at 10 uM [14C]-TCB using highly induced 
microsomes (1 mg protein/ml). 
In male rats, only treatment with the cytochrome P4501A inducer, ß-NF, resulted 
in a significant induction of [14C]-TCB metabolism relative to control microsomes. This 
is in agreement with previous studies (Mills et al. 1985, Ishida et al. 1991), which 
demonstrated the cytochrome P4501A1 dependence of TCB metabolism. Phénobarbital 
treatment has been shown to induce the metabolism of 2,2',5,5'-tetrachlorobiphenyl, but 
not 3,3',4,4'-tetrachlorobiphenyl (Ishida et al. 1991). In rats dexamethasone is an 
extensive inducer of cytochrome P4503A1 (Wrighton et al. 1985) and the hydroxylation 
of various chlorinated benzenes such as hexachlorobenzene (Van Ommen, 1987), 
pentachlorobenzene and 1,2,4-trichlorobenzene (den Besten et al. 1991), 1,2-
dichlorobenzene and 1,4-dichlorobenzene (den Besten et al. 1992). However, in the 
current study the pretreatment of rats with dexamethasone did not result in the increased 
hepatic microsomal metabolism of [14C]-TCB, indicating that the presence of a phenyl 
ring in place of a chlorine (as in 1,2,4-trichlorobenzene) effectively inhibits the 
hydroxylation of [14C]-TCB by cytochrome P4503A1. 
In the current study, 3 phenolic metabolites, 4-OH-3,5,3',4'-tetraCB, 5-OH-TCB 
and 6-OH-TCB, were positively identified in the ether extracts. A fourth radioactive 
peak in the in the HPLC fractions of the ether-extracts appeared to contain two 
compounds upon GC-MS analysis, although we were unable to identify the structure of 
these latter compounds. 
Interestingly, two in vivo studies (Yoshimura et al. 1987, Koga et al. 1989), and 
one in vitro study (Ishida et al. 1991), all using male Wistar rats or microsomes, did not 
find any fecal excretion or in vitro production of 6-OH-TCB, despite the use of an 
authentic standard. 6-OH-TCB is one of the most lipophillic of the phenolic metabolites, 
as judged by its relatively long retention time on a C-18 HPLC column relative to the 
other phenolic metabolites formed, and may thus be poorly excreted into the feces 
following its formation. This hypothesis is supported by the report that when C57BL 
mice were treated with [14C]-TCB, only trace amounts of 6-OH-TCB were detected in 
the feces, but 6-OH-TCB comprised 16% of total radioactivity in the adipose tissue 
(Klasson Wehler, 1989). It is unclear why the production of 6-OH-TCB was not 
detected in the study using microsomes from 3-methylcholanthrene-treated Wistar rats 
(Ishida et al. 1991). One significant difference in the analytical methods is that in this 
study high resolution capillary GC-ECD and GC-MS was used and in the previous study 
(Ishida et al. 1991) packed column GC was used, which could result in a difference in 
the resolution of the metabolites on the column. 
One minor metabolite previously identified in vivo in chicken embryos and 
mouse urine, 2-OH-TCB (Klasson Wehler, 1989,Klasson Wehler et al. 1990), was not 
found in the ether extracts of incubations with highly induced microsomes, either by 
HPLC or GC-MS analysis. Similarly 2-OH-TCB was also not found in the feces of 
Wistar rats treated with TCB (Yoshimura et al. 1987), which may indicate species 
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specific metabolism of TCB. 
In the current study the nature and relative amounts of the ether-extractable 
metabolites formed in incubations with hepatic microsomes from TCB-treated dams 
were identical to those formed in incubations with microsomes from male rats pretreated 
with ß-NF. 4-OH-tetraCB and 5-OH-TCB have been also been found in the livers of 
pregnant rats treated with TCB (Morse et al. 1995). 
When we examined the metabolism of [14C]-TCB with microsomes from TCB-
treated pregnant rats and their fetuses, the formation of phenolic metabolites was 
observed only in incubations of maternal microsomes. Even when the incubation time 
was extended to 30 minutes, no phenolic metabolite production was observed in 
incubations with fetal microsomes. In addition, no induction of fetal hepatic microsomal 
EROD activity was observed following maternal TCB treatment. This data supports the 
hypothesis that 4-OH-tetraCB and other phenolic metabolites are produced in the 
maternal liver, only 4-OH-tetraCB is selectively retained in the maternal plasma bound 
to TTR, then crosses the placenta and accumulates in the fetal compartment. A recent 
study has shown that the accumulation of 4-OH-tetraCB in fetal rats is associated with 
decreases in fetal plasma TT4 levels in the absence of effects on maternal TT4 levels at 
the same time of gestation (Morse et al. 1995). This finding suggests that maternally 
produced metabolites may affect fetal thyroid hormone status, although there are no 
obvious effects on maternal thyroid status. 
Although TCB is only a minor component of commercial PCB mixtures and 
environmental extracts, other PCBs may be metabolized to hydroxylated metabolites, of 
which a limited number, mainly with an 1,2-shift hydroxy-substitution in the para-
position, are selectively retained in the blood of rats and environmentally exposed 
animals (Bergman et al. 1994). Recent research has shown that, analogous to the fetal 
accumulation of 4-OH-tetraCB in the rat, the major metabolite (4-OH-2,3,5,3',4'-
pentachlorobiphenyl) found in adult rat, mouse and mink plasma following Aroclor 1254 
exposure (Bergman et al. 1994, Klasson Wehler et al. 1993) also accumulates in fetal rat 
plasma following Aroclor 1254 exposure to pregnant rats (Dr. Eva Klasson Wehler, 
personal communication). 
We were unable to identify the nature of the water soluble metabolites formed in 
incubations of [14C]-TCB with ß-NF microsomes. Although no compounds coeluting 
with the metabolite standards were produced by acid hydrolysis or ß-glucuronidase 
treatment of the lower phase, the addition of UDPGA to the incubation mixture 
selectively reduced the amount of 5-OH-TCB present in the ether-extracts, which may 
indicate the formation of glucuronic acid conjugates. The presence of conjugated 
metabolites of TCB has been indicated in the urine of mice after an oral dose of TCB 
(Klasson Wehler et al. 1989). 
The covalent binding of [14C]-TCB metabolites to microsomal or erythrocyte 
membrane proteins has been previously demonstrated in in vitro studies (Shimada and 
Sawabe, 1983, Shimada et al. 1985). Metabolites of [14C]-TCB also bind to cellular 
macromolecules in several organs of the rat in vivo (Shimada and Sawabe, 1984), 
although the significance of this covalent binding for toxicity is not clear. It has been 
suggested that the high retention of [14C]-TCB derived radioactivity in the blood 
(Shimada et al. 1985) is due to covalent binding to blood components and that the 
retention in the blood is related to the high toxicity of TCB. However, in a recent study, 
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it has been demonstrated that there is a selective accumulation of one metabolite, 4-OH-
3,5,3',4'-tetrachlorobiphenyl in the plasma of rats following [,4C]-TCB exposure (Morse 
et al, 1995a), which is due to competitive binding of this metabolite to TTR, the major 
thyroid hormone transport protein in rat plasma (Brouwer et al. 1990, Brouwer et al. 
1986). 
Although the metabolism of TCB appears to be largely similar between rats and 
mice and is related to the induction of P4501A enzymes, this may not be the case for 
some other species. A qualitative interspecies variation in the production of phenolic 
metabolites of TCB by hepatic microsomes from mammals and birds has recently been 
observed (Murk et al. 1994). The most notable result was that environmentally exposed 
marine mammals (seal and porpoise) showed a very similar metabolite pattern to ß-NF-
treated rats, whereas eider duck microsomes (exposed to either Clophen A50 or TCB) 
produced almost exclusively 5-OH-TCB. 
In conclusion, we have developed a technique for the HPLC analysis of ether-
extracts of hepatic microsomes with [14C]-TCB which can provide qualitative and 
quantative information on the formation of hydroxylated metabolites of TCB. The 
reaction kinetics of [14C]-TCB with hepatic microsomes have been partially characterised 
to allow for optimal incubation conditions. The technique is useful for the investigation 
of the metabolic capacity in different developmental stages, following various 
pretreatments (this study), or in different animal species (Murk et al. 1994). 
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CHAPTER 4 
INTERFERENCE OF POLYCHLORINATED BIPHENYLS IN HEPATIC AND 
BRAIN THYROID HORMONE METABOLISM IN FETAL AND NEONATAL 
RATS 
Abstract 
The effects of prenatal oral administration of 0.2, 0.6 and 1.8 mg/kg body weight 
of 3,3',4,4',5,5'-hexachlorobiphenyl (HCB) on day 1 of gestation and a combination of 
1 mg/kg 3,3',4,4'-tetrachlorobiphenyl (TCB) from day 2 to day 18 with 0.6 mg HCB/kg 
bw on day 1 of gestation on thyroid hormone status and peripheral thyroid metabolism 
were studied in pregnant Wistar rats, their fetuses and offspring. Plasma total thyroxine 
(TT4) and free thyroxine (FT4) levels were reduced by the highest HCB dose in pregnant 
rats (day 12 and 20 of gestation) and neonates (day 21 post partum), while only a 
combined dose of HCB and TCB were effective in decreasing fetal thyroid hormone 
levels by 65 % on day 20 of gestation. The activity of type II thyroxine 5'-deiodinase 
(5'D-II), the enzyme responsible for the deiodination of thyroxine (T4) to biologically 
active triiodothyronine (T3) in the brain, was examined in whole brain homogenates in 
fetuses and neonates. Decreases in plasma thyroid hormones were accompanied by 
significant increases, up to 100%, in 5'D-II activity in brain homogenates from fetuses 
(day 20 of gestation, combined dose only) and neonates (day 7 and 21 post partum). 
Increases in 5'D-II activity in female neonates were observed in the high HCB and 
combined dose groups, while the increases in male neonatal 5'D-II were restricted to the 
high HCB group. The glucuronidation of 125I-T4 by hepatic microsomes was increased 
by at least 100% relative to control levels by all treatments in fetuses (day 20 of 
gestation) and increased at least 40% in neonates (day 7 and 21 post partum) by a dose 
of 0.6 and 1.8 mg HCB/kg and the combined dose. These data indicate that prenatal 
HCB and/or TCB administration result in increased peripheral T4 metabolism. The 
increase in 5'D-II activity suggests that local hypothyroidism occurs in the brains of 
fetal and neonatal rats exposed to HCB and/or TCB. Since these effects occur during a 
period in which thyroid hormones play an important role in brain maturation, they may 
help explain the mechanism of developmental neurotoxicity induced by polychorinated 
biphenyls. 
D.C. Morse, D. Groen, M. Veerman, C.J. Van Amerongen, H.B.W.M. Koeter, 
A.E. Smits Van Prooije, T.J. Visser, J.H. Koeman, A. Brouwer, 
Toxicology and Applied Pharmacology 122, 27-33 (1993) 
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Introduction 
Polychlorinated biphenyls (PCBs) are persistent environmental contaminants 
found in human adipose tissue and mother's milk, which can also cross the placenta to a 
minor extent (Jensen and Sundstro'm 1974, Mes et al. 1984, Bush et al. 1984, Bush et 
al. 1985). The pre- or postnatal exposure of mice, rats, monkeys and humans to PCBs 
results in neurodevelopmental changes in the offspring (reviewed by Tilson et al. 1990). 
Prenatal high-level exposure of humans to a mixture of PCBs and their thermal 
degradation products in Japan and Taiwan resulted in a variety of physical problems and 
developmental delay in motor and mental function (Rogan et al. 1988). Two U.S. 
studies on the effects of perinatal exposure to background levels of PCBs revealed an 
association between elevated cord serum PCB levels and smaller birth size in one study, 
while in both studies there was an effect on neurodevelopmental parameters (Fein et al. 
1984, Jacobson et al. 1985, Gladen et al. 1988, Rogan et al. 1986). 
However, the mechanism by which PCBs interfere with neurological de-
velopment remains unknown. Lower chlorinated di-ortho PCB congeners, such as 2,4,4'-
trichlorobiphenyl, lead to reductions in dopamine levels in pheochromocytoma cells 
(Shain et al., 1991) or in specific brain regions in macaque monkeys (Seegal et al., 
1990). These di-ortho PCBs do not have the structural characteristics of the most potent 
coplanar PCB congeners with a dioxin-like toxicity (e.g. cytochrome P4501A1 
induction, thymus atrophy, body weight loss). Nonetheless, coplanar compounds are not 
devoid of developmental neurotoxicity, for perinatal exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin leads to neurotoxicity in monkeys (Schantz et al. 1989) and 
prenatal (Tilson et al. 1979) and postnatal (Eriksson et al. 1991) administration of 
3,3',4,4'-tetrachlorobiphenyl results in neurotoxicity in mice. 
In view of the significant role thyroid hormones play in brain maturation in man 
and other species (Smith 1981), a possible explanation is that alterations in thyroid 
hormone transport and metabolism caused by PCBs may lead to abnormal brain 
development. The dietary administration of Aroclor 1254 to pregnant rats has been 
shown to reduce plasma thyroxine (T4) levels and induce thyroid hyperplasia in newborn 
and neonatal rats (Collins and Davis 1980). In adult rats, plasma T4 levels were de 
creased not only by PCBs, but also by polybromobiphenyl (PBB, Byrne et al. 1987) 
mixtures as well as by individual congeners, such as 3,3',4,4'-tetrachlorobiphenyl (TCB, 
Brouwer and van den Berg 1986), 3,3'4,4',5,5'-hexabromobiphenyl (HBB, Spear et al. 
1990) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, Bastomsky 1977), compounds 
which also induce hepatic glucuronidation of T4. In addition to the rat, reduced plasma 
T4 levels caused by exposure to TCB has been documented in marmoset monkeys and 
by PBBs in the mouse (Van den Berg et al. 1988, Gupta et al. 1983) In man, the effects 
of occupational exposure to PBBs or prenatal exposure to thermally degraded PCBs 
suggest interference in thyroid function (Bahn et al. 1980, Murai et al. 1987). 
Fetal and neonatal rats respond to hypothyroidism with an increase in brain Type 
II thyroxine 5' deiodinase (5'D-II), the enzyme responsible for the local conversion of 
thyroxine to triiodothyronine (T3), the biologically most active hormone (Ruiz de Ona et 
al. 1988, Silva and Larsen 1982, Silva and Matthews 1984). It is therefore of interest to 
determine if PCB-induced decreases in plasma T4 levels in fetal and neonatal rats result 
in increased 5'D-II activity in the brains of fetal and neonatal rats, as plasma T3 can not 
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protect the fetal or neonatal rat brain from hypothyroidism (Calvo et al. 1990, Silva and 
Matthews 1984). 
In this investigation we have examined the effects of the prenatal administration 
of 3,3',4,4',5,5'-hexachlorobiphenyl (HCB) alone and in combination with 3,3',4,4'-
tetrachlorobiphenyl (TCB) to pregnant rats on maternal, fetal and neonatal plasma total 
and free thyroxine hormones and hepatic microsomal T4 glucuronidation. We also 
studied the effects of HCB and TCB administration on brain 5'D-II activity, a specific 
response of the developing rat brain to hypothyroidism. The combined dose of HCB and 
TCB was used to determine if the additional exposure to a rapidly metabolizable PCB 
congener like TCB would elicit effects on thyroid homeostasis in the fetus. Due to the 
short biological half life of TCB (Yoshimura et al. 1987), we used multiple low doses 
during gestation. HCB is a congener that is poorly metabolized, thus a single dose at the 
beginning of pregnancy should be sufficient to induce effects during pregnancy and 
lactation. 
Material and Methods 
Chemicals. 
The 3,3',4,4',5,5'-hexachlorobiphenyl and 3,3',4,4'-tetrachlorobiphenyl (99% 
pure, dibenzo-p-dioxin and -furan free) were obtained from Promochem, Wesel, 
Germany. 
Animals 
One hundred and twenty female and 60 male Wistar W.U. rats (Charles River 
Wiga GmbH, Sulzfeld, Germany) were allowed at least a 5 day acclimatization period. 
When the rats were about 14 weeks old, they were paired by placing one male with 2 
females per disposable plastic cage. The animals were kept on a 12 hr light cycle, the 
temperature was 22 + 3 °C and relative humidity was 30-70%. A powdered stock diet 
(TNO Toxicology and Nutrition Institute, Zeist, The Netherlands) and tap water were 
offered ad libitum. When sperm was found in a vaginal smear the female was housed 
individually and this was termed as day 0 of gestation. Animals were distributed into 5 
dose groups on a rotating basis. Pregnant rats were dosed orally by gavage with either 
0.2, 0.6 or 1.8 mg HCB per kg body weight or the vehicle (corn oil, 2 ml/kg body 
weight) on day 1 of the gestation. A fifth group of pregnant rats received a single dose 
of 0.6 mg HCB/kg body weight on day 1 and then 1.0 mg/kg of TCB daily from day 2 
to day 18 of the gestation. 
Autopsy and sample preparation 
Three to 5 pregnant rats per dose group were sacrificed on day 12 and 20 of ge-
station, and 4 to 8 nests were sacrificed per group 7 and 21 days after birth under ether 
anesthesia. Fetal (day 20 of gestation) and neonatal trunk blood was collected by de-
capitation in heparinized tubes and maternal blood was drawn from the vena cava. 
Plasma was prepared by centrifugation at 1000 g and stored at -20 °C. 
Fetal brains, livers and plasma were pooled for each pregnant animal, while 
tissues from male and female neonates of each nest as well as maternal samples were 
collected separately. 
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Fetal and neonatal whole brains were homogenized on ice in a Potter tube with 
0.1 M Tris-HCl buffer, pH 7.5 containing 1 mM dithiothreitol (DTT, 8 ml buffer per g 
tissue) and stored at -80 °C until analysis. Livers were immediately frozen in 0.1 M 
Tris-HCl buffer, pH 7.5 containing 0.25 M sucrose (3 ml/g liver) at -80 °C until 
microsomes were prepared within 1 week. Microsomes were prepared by centrifuging 
liver homogenates at 9,000 g, for 30 min, the resulting supernatant was centrifuged at 
105,000 g for 90 min, and the pellet was resuspended in 0.1 M phosphate buffer, pH 
7.5. Microsomes were stored at -80 °C until further analysis. 
Hormone analysis 
Plasma total T4 (TT4) and free T4 (FT4) were determined with the Amerlite 
system (Amersham, UK) according to the protocol of the supplier with slight modifi-
cations. The TT4 assay buffer was diluted 5 times with demineralized water, the standard 
curve for TT4 ranged from 0 to 120 nmol TT4/1. 
Brain Type II thyroxine 5 '-deiodinase 
Brain 5'D-II activity was measured essentially as described by Visser et al. 
(1982). The final reaction conditions were 100 mM phosphate buffer pH 7.2, 25 mM 
DTT, 1 mM propyl-2-thiouracil, 1 mM EDTA, 2 nM T4 with 105 cpm 125I-T4 
(Amersham, U.K.), 100 nM triiodothyronine and brain homogenate (0.8 mg protein) in a 
total volume of 200 ul. The addition of 100 nM triiodothyronine (T3) was necessary to 
inhibit the inner-ring deiodination of T4 by type III deiodinase, which is present in 
significant amounts in fetal and neonatal rat brains (Kaplan and Yaskoski 1981, 1982). 
T3 is the preferred substrate for type III deiodinase (Kaplan et al., 1983). Incubations 
were carried out at 37 °C for 60 min. The reaction was stopped on ice by the addition of 
100 ul BS A (70 mg/ml) in order to bind the remaining substrate and T3, followed by 
500 ul of 10% TCA w/v to precipitate the protein. The tubes were then centrifuged at 
4000 rpm in an eppendorf centrifuge for 5 min, then 500 ul supernatant containing 
mainly 125I" liberated from the '25I-T4 was removed. The amount of 125I" present in the 
supernatant was determined using Sephadex LH-20 chromatography (Otten et al. 1984). 
Blanks were carried out using brain homogenates inactivated by boiling for 10 min. 
Results are expressed as fmol T4 deiodinated per hour per mg protein. 
Hepatic microsomal T4 glucuronyltransferase (Tfi) 
Hepatic T4G activity was determined according to Beetstra et al. (1991). The 
final reaction conditions were 0.1 M Tris-HCl buffer, pH 7.8, 5 mM uridine-5'-
diphosphoglucuronic acid, 3.75 mM MgCl2, 0.25% (w/v) 3-[(3-cholamidopropyl)-
dimethylammonio]-l-propane-sulfonate (CHAPS), 0.125% (w/v) BSA, 1 uM T4 with 
50,000 cpm '25I-T4 and 0.2 mg microsomal protein in a total volume of 200 ul. The 
reaction was carried out at 37 °C for 30 minutes because preliminary experiments 
showed that the reaction was linear for up to 30 minutes for microsomes exhibiting the 
greatest induction in T4G activity. The reaction was stopped with 200 ul ice-cold 
methanol and after centrifugation 200 ul supernatant was combined with 750 ul 0.1 N 
HCl. The amount of 125I-T4 glucuronide in the supernatant was analyzed with Sephadex 
LH-20 chromatography (Rutgers et al. 1989). Protein levels were determined using the 
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Bio-Rad assay (Richmond, California). 
Ethoxyresorufin- O-deethylase activity 
Ethoxyresorufin-O-deethylase (EROD) activity was measured in fetal hepatic 
microsomes according to the method of Burke et al. (1977), with slight modifications. 
The reaction was carried out at 37° C with a final concentration of ethoxyresorufin and 
NADPH of 2 \iM and 0.1 mM, respectively. The final microsomal protein concentration 
was 100 ng/ml for all dose groups. To detect the deethylation product, resorufin (RR), 
the excitation wavelength of the fluorimeter was set at 530 nm while the emission 
wavelength was 580 nm. 
Statistics 
The statistical evaluation of plasma thyroxine levels and thyroid hormone 
metabolism was made with a one sided Student's t-test. The t-values were adjusted for 
non-homogeneity of the variances. 
Results 
Effects on plasma T4 levels. 
Maternal plasma TT4 and FT4 levels were significantly reduced at a dose of 0.6 
and 1.8 mg HCB/kg bw on day 12 of gestation and by the combined dose of 0.6 mg 
HCB/kg bw with 1 mg/kg bw TCB daily (Figure 4.1 and 4.2). The combined dose of 
HCB and TCB resulted in a significantly larger decrease in plasma TT4 levels (25% of 
controls) than the same dose of HCB alone (75% of controls,) or the highest HCB dose 
group (65% of controls, Figure 4.1). On day 20 of gestation only the highest HCB dose 
and the combined dose of HCB and TCB significantly decreased maternal plasma TT4 
and FT4 levels (Figure 4.1 and 4.2) , while 7 days after giving birth, plasma TT4 levels 
had recovered in all groups except for the high HCB dose group (Figure 4.1). 
Fetal plasma TT4 and FT4 levels on day 20 of gestation (Figure 4.3 and 4.4) exhibited a 
similar response to the treatments as the maternal levels, although only the combined 
dose of HCB and TCB resulted in a significant reduction of plasma TT4 levels (Figure 
4.3 and 4). Control levels of both TT4 and FT4 were 6 times lower in the fetus than in 
the maternal rat. 
Neonatal plasma TT4 and FT4 levels increased to adult levels by day 21, and 
there was essentially no difference between male and female values within a given 
group (Figure 4.3 and 4.4). Relative decreases in plasma TT4 7 days after birth were 
greatest (66% of controls) in the group recieving the combined dose of HCB and TCB, 
while 21 days after birth the largest decreases in TT4 levels (68% of controls) were ob-
served in the highest HCB dose group (Figure 4.3). Decreases in plasma FT4 levels were 
similar on day 7 and day 21 postpartum for both the 1.8 mg HCB/kg bw and combined 
HCB and TCB dose groups (66-78% of controls, Figure 4.3). The prenatal 
administration of 0.2 and 0.6 mg HCB/kg bw had no effect on neonatal plasma TT4 and 
FT4 levels at the time of observation (Figure 4.3 and 4.4). 
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Figure 4.1 
Plasma levels of maternal total thyroxine (TT4) in pregnant and lactating rats following prenatal 
HCB/TCB exposure, (a) indicates values significantly different from control values (P<0.05), (b) 
indicates a significant difference between the combined dose group of 0.6 mg HCB/kg and TCB 
and the group that recieved 0.6 mg HCB alone (P<0.05), GD: gestation day, PND: postnatal day. 
Figure 4.2 
Plasma levels of maternal free 
thyroxine in pregnant and 
lactating rats following prenatal 
HCB/TCB exposure, (a) indicates 
values significantly different 
from control values (P<0.05), (b) 
indicates a significant difference 
between the combined dose 
group of 0.6 mg HCB/kg and 
TCB and the group that recieved 
0.6 mg HCB alone (P<0.05). 
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Figure 4.3 
Plasma levels of total thyroxine (TT4) in fetal and neonatal rats following prenatal HCB/TCB 
exposure, (a) indicates values significantly different from control values (P<0.05), (b) indicates a 
significant difference between the combined dose group of 0.6 mg HCB/kg and TCB and the 
group that recieved 0.6 mg HCB alone (P<0.05), GD: gestation day, PND: postnatal day. 
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Figure 4.4 
Plasma levels of free thyroxine (FT4) in fetal and neonatal rats following prenatal HCB/TCB 
exposure, (a) indicates values significantly different from control values (P<0.05), (b) indicates a 
significant difference between the combined dose group of 0.6 mg HCB/kg and TCB and the 
group that recieved 0.6 mg HCB alone (PO.05), GD: gestation day, PND: postnatal day. 
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Hepatic T4 Glucuronidation. 
Specific maternal hepatic microsomal T4 glucuronyl transferase (T4G) activity 
(pmol T4 glucuronide formed per min per mg protein) was measured only on day 12 of 
gestation. The induction of T4G increased from 150% in the 0.2 mg HCB/kg bw group 
to over 400% in the 1.8 mg HCB/kg bw and the combined HCB and TCB dose group 
(Figure 4.5). The daily administration of 1 mg TCB/kg bw resulted in a significant 
additional induction of T4G than 0.6 mg HCB/kg bw alone (Figure 4.5). 
Fetal T4 glucuronyl transferase activity on day 20 of gestation was significantly 
increased relative to controls in all dose groups (Figure 4.6). Levels of fetal T4G were 
15-20% of maternal T4G for each dose group. There was a dose dependent increase in 
neonatal T4G activity by prenatal HCB administration 7 and 21 days after birth (Figure 
4.6) similar to that observed in microsomes from maternal livers from day 12 of 
gestation. The co-administration of TCB and HCB resulted in additional induction of 
T4G relative to the administration of HCB alone on day 7 postpartum in both male and 
female neonates, but not on day 21 postpartum for female neonates. Control levels of 
T4G activity were similar for male and female neonates on day 7 to day 21 postpartum, 
and were 5 times higher than fetal control levels (Figure 4.6). 
Brain Type II thyroxine 5 '-deiodinase 
Maternal type II thyroxine 5'-deiodinase (5'D-II) activity was significantly 
increased relative to controls in whole brain homogenates from pregnant rats (day 20 of 
gestation) which had recieved 1.8 mg HCB/kg or the combined dose of HCB and TCB 
(Figure 4.7). On day 7 postpartum levels of maternal 5'D-II were generally lower than 
day 20 of gestation. Maternal 5'D-II levels on day 7 postpartum remained increased 
relative to controls in the highest HCB dose group and the combined dose group. 
Figure 4.5 
Specific T4 glucuronidation 
activity in hepatic microsomes 
from pregnant rats on day 12 of 
gestation following HCB/TCB 
administration, (a) indicates 
values significantly different 
from control values (P<0.05), (b) 
indicates a significant difference 
between the combined dose 
group of 0.6 mg HCB/kg and 
TCB and the group that recieved 
0.6 mg HCB alone (P<0.05). 
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Figure 4.6 
Specific T4 glucuronidation activity in hepatic microsomes from fetal and neonatal rats following 
maternal HCB/TCB administration, (a) indicates values significantly different from control 
values (P<0.05), (b) indicates a significant difference between the combined dose group of 0.6 
mg HCB/kg and TCB and the group that recieved 0.6 mg HCB alone (P<0.05), GD: gestation 
day, PND: postnatal day). 
Figure 4.7 
Specific type II thyroxine 5'-
deiodinase activity in whole 
brain homogenates from pregnant 
and lactating rats following 
prenatal administration of 
HCB/TCB. (a) indicates values 
significantly different from 
control values (P<0.05), (b) 
indicates a significant difference 
between the combined dose 
group of 0.6 mg HCB/kg and 
TCB and the group that recieved 
0.6 mg HCB alone (PO.05). 
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An effect on 5'D-II activity in whole brain homogenates of fetuses from 
gestational day 20 was observed only in the combined HCB/TCB dose group (Figure 
4.8). The increase (110%) was significant compared to controls as well as the group that 
received 0.6 mg HCB/kg alone. Neonatal brain 5'D-II was increased in whole brain 
homogenates from male neonates from the highest HCB group, while female neonatal 
5'D-II was increased in both the highest HCB dose group as well as in the combined 
63 
Maternal PCB exposure and T4 metabolism 
400 
X 
O) 
. § , 300 
O 
E 200 
> 
O 
cd 
Q 
Co 
100 
GD20 PND7 PND21 
FEMALE 
PND7 PND21 
MALE 
Figure 4.8 
Specific type II thyroxine 5'-deiodinase activity in whole brain homogentes from fetal and 
neonatal rats following prenatal administration of HCB/TCB.(a) indicates values significantly 
different from control values (PO.05), (b) indicates a significant difference between the 
combined dose group of 0.6 mg HCB/kg and TCB and the group that recieved 0.6 mg HCB 
alone (P<0.05), GD: gestation day, PND: postnatal day. 
dose group on postnatal day 7 and 21 (Figure 4.8). Seven days after birth, female 
neonatal 5'D-II activity was significantly higher than controls) in the highest HCB and 
combined dose group, while for males the only relative increase (130% of controls) was 
in the 1.8 mg HCB/kg dose group. On postnatal day 21, the greatest increase in brain 
5'D-II was observed in female neonates in the combined dose group (100%) while in 
male neonates only the 1.8 mg HCB group exhibited a significant increase in 5'D-II. 
Ethoxyresorufin- O-deethylase activity. 
EROD activity was not detected with fetal microsomes from the control and the 
lowest dose level. Low levels of EROD activity (0.002 + 0.001 nmol RR per mg per 
min) were detected in fetal microsomes from the group that recieved 0.6 mg HCB/kg, 
while relatively high similar EROD activities were detected in fetal microsomes from 
the highest HCB dose (0.069 + 0.015 nmol RR per mg per min) and the combined HCB 
and TCB dose group (0.081 + 0.021 nmol RR per mg per min). 
Discussion 
Exposure of pregnant rats to either a single dose of HCB alone or to a 
combination of HCB and daily doses of TCB caused significant, but differential 
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reductions in fetal and neonatal plasma thyroid hormones, and increases in hepatic T4 
glucuronidation as well as brain 5'D-II activity. 
One reason for the apparent differential effects between the single and combined 
exposure may be that highly chlorinated, poorly metabolizable PCBs, like 3,3',4,4',5,5'-
HCB and 2,2',4,4',5,5'-hexachlorobiphenyl are efficiently transferred to the neonate by 
lactation, while placental transfer is limited (Vodicnik and Lech 1980, 1982). This 
suggests that HCB exerts its major effects after lactational transfer to the neonate. 
However, the combined total of the TCB dose, 17 mg, is higher than the HCB dose, and 
the TCB was administered for the greater part of the gestation, which may in part 
explain the effect of the combined dose on the rat fetus. Nonetheless, the observation 
that EROD levels were comparable in the high HCB dose group and the combined HCB 
and TCB dose group suggests that the toxic potency of parent compound reaching the 
fetus was similar. 
On the other hand, TCB is rapidly metabolized in Wistar rats (Yoshimura et al. 
1987), and quickly eliminated from neonatal mice (Lucier et al. 1978a and Eriksson 
1988). Phenolic metabolites accumulate in late gestational fetal C57BL mice (Darnerud 
et al. 1986) and TCB-derived radioactivity accumulates in CD-I fetal rat plasma (Lucier 
et al. 1978b). Unpublished results from our laboratory indicate that prenatal 
administration of TCB leads to a substantial accumulation of 3,3',4',5-tetrachloro-4-
biphenylol in the fetal Wistar rat. This metabolite, which competes with T4 for tra-
nsthyretin binding sites, has been indicated as the causitive agent of the severe plasma 
thyroid hormone reductions observed in TCB-exposed adult rats (Brouwer and Van den 
Berg 1986, Brouwer et al. 1990). 
In fetuses, only the combined dose of HCB and TCB caused a severe reduction 
of plasma TT4 levels, while induction of hepatic microsomal T4G activity reached a 
plateau by the lowest dose group, 0.2 mg HCB/kg bw. The levels of T4G in the fetus are 
5 times lower than in neonates and 10 times lower than in pregnant rats from day 12 of 
gestation. These results suggest that T4 glucuronidation plays a minor role in the reduc-
tion of plasma T4 levels in the fetus. The severe reductions in maternal TT4 levels in-
duced by the combined dose of TCB and HCB may have contributed to low fetal TT4 
levels due to a reduction of transplacental T4 delivery, while the transport of phenolic 
metabolites of TCB to the fetus will aggrevate this effect. 
However, in the maternal and neonatal situation, HCB concentrations should be 
much higher than in the fetus, which in combination with higher basal levels of T4G 
leads to much higher T4G activities in HCB-treated animals. Therefore it is anticipated 
that the observed decline in neonatal and maternal plasma TT4 levels by HCB are caused 
by increased T4 glucuronidation. 
The observed induction of 5'D-II activity in fetal and neonatal rats following 
prenatal HCB and TCB administration suggests a compensatory mechanism to maintain 
brain T3 levels while plasma and tissue T4 levels are depressed (Ruiz de Ofîa et al. 1988, 
Silva and Matthews 1984). Fetal rat brain T3 levels are entirely dependent on local deio-
dination of T4 (Ruiz de Ona et al. 1988, Calvo et al. 1990). The treatment of maternal 
rats with methimazole (MMI), a compound which inhibits thyroid hormone synthesis 
and can cross the placenta, results in decreased fetal brain T4 and T3 levels accompanied 
by increased 5'D-II activities (Ruiz de Ona et al 1988). Only when dams were infused 
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with T4 did the fetal brain T3 levels from MMI treated dams reach control levels. It is 
therefore possible that situations may occur where an increase in 5'D-II activity 
following maternal HCB and/or TCB administration is insufficient to maintain normal T3 
levels in the developing rat brain unless extra-physiological T4 is supplied. In this 
experiment, since we did not measure levels of brain thyroid hormones, we can only 
suggest that the observed increase in 5'D-II activity indicates a local hypothyroidism in 
the brain. 
Since these effects are observed during a period when thyroid hormones play an 
essential role in brain development, it is proposed that alterations in fetal and neonatal 
thyroid hormone levels may be involved in some of the developmental neurotoxicity of 
PCBs and related chemicals. Further studies are in progress to relate low brain thyroid 
hormone levels and selected neurochemical parameters indicative of structural and 
biochemical aspects of brain development. 
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ALTERATIONS IN RAT BRAIN THYROID HORMONE STATUS FOLLOWING 
PRE- AND POSTNATAL EXPOSURE TO POLYCHLORINATED BIPHENYLS 
Abstract 
The effects of oral maternal exposure to 0, 5 or 25 mg/kg body weight of a 
polychlorinated biphenyl (PCB) mixture (Aroclor 1254) on day 10 to 16 of gestation on 
plasma and brain thyroid hormone concentrations and peripheral thyroid hormone 
metabolism were examined in fetal and weanling rats. Plasma thyroid hormone levels 
and hepatic microsomal thyroid hormone glucuronidation were also examined in 
pregnant rats and the adult offspring. Plasma and brain levels of PCBs and hydroxylated 
PCB metabolites were analysed in fetal, weanling and adult offspring. 
Maternal exposure to Aroclor 1254 significantly decreased fetal and neonatal 
plasma total thyroxine (T4) and free thyroxine levels in a dose dependent manner. 
Effects of maternal Aroclor 1254 exposure on plasma total and free T4 concentrations 
were less pronounced in offspring at 21 days of age and absent 90 days after birth. 
Plasma concentrations of thyroid stimulating hormone were unaltered in the offspring 
following maternal treatment with Aroclor 1254. The concentration of T4 was severely 
depressed in the forebrain and cerebellum of fetal rats on day 20 of gestation following 
maternal Aroclor 1254 exposure. Brain triiodothyronine (T3) concentrations in the 
Aroclor exposed fetuses were significantly decreased relative to control values only in 
the low dose group. On day 21 postpartum T4 concentrations were significantly 
decreased in the forebrains of female weanling rats from the 25 mg Aroclor 1254/kg 
dose group, and no reductions were observed in forebrain T3 concentrations in male or 
female neonates. 
The deiodination of T4 to T3 was significantly increased by both PCB treatments 
in fetal forebrain homogenates. In female weanling brain homogenates the deiodination 
of T4 to T3 was significantly decreased in the low dose group, and unaltered in the high 
dose group. No alterations in brain thyroid hormone metabolism were observed in 
forebrain homogenates from adult offspring exposed pre- and postnatally to Aroclor 
1254. Hepatic microsomal T4 glucuronidation was significantly decreased in fetal 
microsomes following perinatal PCB exposure, and significantly increased in weanling 
hepatic microsomes in a dose dependent manner. 
A significant accumulation of one PCB metabolite, 2,3,3',4',5-pentachloro-4-
biphenylol was observed in fetal plasma and forebrain on gestation day 20, and in 
neonatal and weanling rat plasma on postnatal day 4 and 21. Although PCB levels were 
relatively high in the weanling rat forebrain, no hydroxylated PCB metabolites were 
detected. On day 90 postpartum, plasma levels of PCBs and 2,3,3',4',5-pentachloro-4-
biphenylol were still elevated in the offspring of PCB-treated dams relative to controls. 
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These results indicate that the accumulation of hydroxylated PCB metabolites in 
fetal plasma can reduce fetal plasma T4 levels and accordingly fetal brain T4 levels. 
However, in late gestational fetuses, the induction of brain 5'D-II activity compensates 
for decreases in brain T4 levels, so that reductions in brain T3 levels are minimal. 
Dennis C. Morse, Eva Klasson Wehler, Wendelien Wesseling, Jan H. Koeman and 
Abraham Brouwer 
Submitted to Toxicology and Applied Pharmacology 
Introduction 
It has been hypothesized that the ability of polychlorinated biphenyls to induce 
hypothyroxinemia in mammals may be related to some aspects of the developmental 
neurotoxicity of these compounds (Rogan et al. 1986, Morse et al. 1993a). PCB 
exposure has been associated with alterations in thyroid function in transformer repair 
workers (Emmert et al. 1988) and in human infants (Pluim et al. 1992, and Koopman-
Esseboom et al. in press). Both PCB mixtures, such as Aroclor 1254 (Collins and 
Capen, 1980a) and individual PCB congeners of varying structure, such as 3,3',4,4'-
tetrachlorobiphenyl, 2,3',4,4',5-pentachlorobiphenyl, 2,2',4,4',5,5'-hexachlorobiphenyl 
and 3,3',4,4',5,5'-hexachlorobiphenyl (Ness et al. 1993, Morse et al, 1993) are capable 
of reducing plasma thyroxine in neonatal and weanling rats. 
Recent research from this laboratory (Morse et al. 1993a) has shown that 
perinatal exposure to coplanar PCBs (3,3',4,4',5,5'-hexachlorobiphenyl and 3,3',4,4'-
tetrachlorobiphenyl) results in decreased fetal, neonatal and weanling plasma total 
thyroxine (T4) and free T4 concentrations accompanied by an increase in the activity of 
type II thyroxine 5'-deiodinase (5'D-II) in brain homogenates, the enzyme responsible 
for the conversion of T4 to triiodothyronine (T3, Visser et al. 1982, Kaplan et al. 1983). 
The observed increase in activity of 5'D-II is a compensatory response of the brain to 
maintain brain T3 levels when T4 concentrations are decreased, for the brain is dependent 
on the local deiodination of T4 for the production of T3 (Calvo et al. 1990). We 
therefore suggested that following pre- or postnatal PCB exposure a situation can occur 
in which the increase in 5'D-II can no longer compensate for decreased T4 levels in the 
brain, resulting in decreases in T3 concentrations. T3 is currently regarded as the 
biologically most active hormone (Davis, 1991). 
In order to test our hypothesis, we administered the technical PCB mixture 
Aroclor 1254 to pregnant rats on day 10 to 16 of gestation and examined the effects on 
brain T4 and T3 levels in fetuses and weanlings, as well as plasma thyroid hormone 
levels and brain thyroid hormone metabolism in fetuses, weanlings and adult offspring. 
We chose to use a technical PCB mixture instead of individual PCB congeners, because 
a wide range of PCB congeners can reduce plasma T4 concentrations. To gain insight in 
the mechanisms involved in the decrease of plasma thyroid hormone levels we measured 
hepatic microsomal T4 glucuronidation and the plasma and brain levels of PCBs and 
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hydroxylated PCB metabolites. 
Material and Methods: 
Animals 
Wistar WU rats, 100 females and 50 males, (14 weeks old) were purchased from 
Charles River Sutzfeld, Germany. The rats were allowed to acclimatize for 2 weeks and 
were maintained at 50% humidity and 21°C on bedding in plastic cages with a 12 hour 
light cycle. Rat chow (Hope Farms, Woerden, the Netherlands) and tap water were 
supplied ad libitum. After the acclimatization period two females were placed in a cage 
with one male overnight from 17:00 to 9:00 the next day. The females were examined 
each morning by vaginal smear. When spermatozoa were found the animal was housed 
separately and this was termed day 0 of gestation. Animals were pre-assigned to a 
particular dose group on a rotating basis. Maternal body weight gain was monitored 
throughout gestation and lactation. On day 10 of gestation the pregnant female rats were 
transferred to a macrolon cage with a grated steel support to facilitate the collection of 
PCB-contaminated feces and to prevent contamination of the animal facilities. Pregnant 
females received a daily oral dose of 0, 5 or 25 mg Aroclor 1254 per kg body weight 
dissolved in cornoil (2 ml/kg body weight) from day 10 of gestation to day 16 of 
gestation. Rats were weighed each day before administration of Aroclor 1254 or corn oil 
alone. 
On day 20 of gestation 6 rats were sacrificed per treatment group under ether 
anesthesia, maternal blood was collected from the vena cava. Fetuses were removed, 
washed in 0.9% NaCl, blotted dry and weighed. Fetal blood was collected by decapita-
tion and the fetal livers were removed, blotted dry, weighed and frozen on dry ice. Fetal 
brains were removed, the forebrain was separated from the cerebellum. Both brain 
regions were weighed and then frozen on dry ice. Fetal cerebella were pooled for 
thyroid hormone analysis. One fetal forebrain was saved separately for thyroid hormone 
analysis, the remaining forebrains were pooled for analysis of thyroid hormone meta-
bolism. Fetal blood was pooled for thyroid hormone analysis. Blood was collected in 
heparinized tubes and stored on ice until plasma was prepared by centrifugation. Livers 
and brain tissue were stored at -80 °C and plasma at -20 °C until analysis. 
The remaining rats were transferred to bedding material on day 20 of gestation 
and were given paper tissues to make a litter. The rats were inspected each morning at 
8:00 and afternoon at 18:00 for litters. Pups found during the morning inspection were 
termed 1 day old, pups born between the morning and afternoon inspection were 
termed 0 day old. Pups were examined for sex, weighed on day 0 postpartum when 
possible, and always on day 1, 4, 7 postpartum and thereafter on a weekly basis. On day 
4 postpartum litters were reduced to 4 males and 4 females. When this was not possible, 
litters were made up of a total of 8 males and females from the same dam, and if 
necessary, an extra pup from another litter from the same treatment group and same age 
was used to achieve a total of 8 pups per litter. Pups were individually marked by 
incision in the ear, and pups transferred from one litter to another were never used for 
any analysis. Plasma was collected from pups sacrificed on day 4 postpartum for 
analysis of thyroid hormones. 
On day 21 postpartum, 8-10 litters were sacrificed per treatment group. Dams 
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and weanlings were sacrificed by decapitation, trunk blood was collected in heparinized 
tubes, and livers were removed and stored as described above. Weanling livers were 
pooled per sex for analysis. Trunkblood was collected separately for each weanling. 
Weanling brains were rapidly removed, and the forebrains were separated from the 
cerebellum and stored separately at -80°C. 
The offspring from the remaining litters were weaned on postpartum day 21 and 
male and female rats were housed separately in groups of 2-4 rats per cage. The 
remaining animals (10 litters per treatment group) were sacrificed 90 days after birth by 
decapitation. Forebrains, cerebella and trunk blood were collected separately for each 
rat, and 1 liver per sex was analysed per litter. 
Thyroid hormone analysis 
Plasma total T4 (TT4), free T4 (FT4) and total T3 (TT3) were analysed in duplicate 
using a chemiluminesence kit and plasma thyroid stimulating hormone (TSH) concentra-
tions were analysed in duplicate with a specific rat TSH radioimmunoassay kit, both kits 
were purchased from Amersham, Amersham, U.K. 
Brain concentrations of T4 and T3 were determined by extraction and purification 
of the hormones, followed by a radioimmunoassay according to Morreale de Escobar et 
al. (1985). Briefly, tissues were homogenized in methanol containing approximately 
2000 cpm of [l31I]T4 and [125I]T3 as internal standards. Tissue lipids were removed by 
extraction of the homogenate with chloroform, followed by a back-extraction of thyroid 
hormones with an aqueous phase. The aqueous phase was further purified on Bio-Rad 
AG 1-X2 resin, 200-400 mesh (Bio-Rad, Richmond, CA), and the iodothyronines were 
eluted with 70% acetic acid, which was then evaporated to dryness. Each sample was 
then analysed in duplicate at two dilutions in a highly specific radioimmunoassay for T4 
or T3. The limit of sensitivity was 2.5 pg T4 and 1.5 pg T3 per tube. 
In this experiment, fetal brains from 6 dams per treatment group were analysed 
for T3 and T4. One fetal forebrain from two different dams from the same treatment 
group were pooled prior to extraction, while all fetal cerebella were pooled from each 
dam and each pool was extracted separately. One male and one female weanling 
forebrain (postnatal day 21) per litter (8-10 litters per group) were extracted separately. 
Thyroid hormone metabolism 
Brain type II thyroxine 5'-deiodinase activity was analysed essentially as 
described by Visser et al. (1982) with slight modifications (Morse et al. 1993a). The 
final incubation conditions were 100 mM phosphate buffer, pH 7.2, 25 mM dithiotreitol, 
1 mM propyl-2-thiouracil, 1 mM EDTA, 2 nM T4 with 105 cpm [125]I-T4, 500 nM T3 
and brain homogenate (0.8 mg protein/ml) in a total volume of 200 ju.1. Preliminary 
experiments using reversed phase high preformance liquid chromatography and Sepha-
dex LH-20 analysis of the reaction products revealed that the addition of 500 nM T3 to 
the incubation mixture inhibited the inner-ring deiodination of T4 to reverse triiodothy-
ronine (rT3) without decreasing the outer-ring deiodination of T4 to T3. 
Inhibition experiments were carried out by adding the rT3, or the PCBs (Aroclor 
1254, 3,4,3',4'-tetrachlorobiphenyl (PCB 77), or hydroxylated PCB metabolites, 
3,3',4',5-tetrachloro-4-biphenylol (metabolite of PCB 77, Yoshimura et al. 1987) and 
2,3,3',4,5'-pentachloro-4'-biphenylol (metabolite of PCB 105, Klasson Wehler et al. 
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1993) (0.1 and 1 uM, final concentration) in 10 ul methanol to 400 jxl incubations with 
homogenates of forebrains pooled from control female neonates (day 21 postpartum) and 
the activity was compared with that of incubations with methanol only. The addition of 
2.5% methanol (v/v) had no effect on the deiodinase activity compared to control 
incubations. 
Hepatic microsomal T4 uridine diphosphoglucuronyl transferase (T4-UDPGT) 
activity was determined in microsomal incubations with [125I]-T4 as described by 
Beetstra et al. (1991) with slight modifications (Morse et al. 1993a). 
Analysis of PCBs and hydroxy-PCB metabolites in plasma and brain 
Trunk blood was collected from the dams and offspring and plasma was prepared 
as described above and pooled per treatment group for the dams and fetuses. Plasma 
from neonatal, weanling and adult offspring were pooled per sex and treatment group. 
Forebrain homogenates prepared for deiodinase activity measurements was pooled per 
treatment group for fetuses and per sex and treatment group for weanling and adult 
offspring. Plasma and forebrain homogenates were freeze-dried prior to extraction. 
Freeze-dried plasma (ca. 1 g dry weight, corresponding to ca. 20 ml) was 
dissolved in 5 ml water, then 5 ml methanol was added and the samples were extracted 
and analysed according to a previously described method (Bergman et al. 1994). The 
freeze-dried brains (ca. 7 g dry weight) were soaked in water (5 ml) and extracted and 
analysed by the same procedure as the plasma samples. Total PCB levels were calcula-
ted on the basis of the following peaks: CB-99, CB-118/149, CB-146, CB-153, CB-105, 
CB-138, CB-128, CB-180, CB-170 and when the concentration was sufficient CB-183 
and CB-187 were included. Since all chromatograms were nearly identical with respect 
to the congener pattern, the PCB data are presented as the level of CB-153 in the plasma 
or brain. CB-153 constituted 20.3 + 3.7% (mean + SD) of total PCBs (mass basis) in 
plasma samples and 20.6 + 3.9% (mean + SD) in brain samples. 
Statistics 
Dose dependent effects were first examined with a one-way analysis of variance 
followed by a modified least significant difference test, and correlations between hepatic 
glucuronidation and plasma thyroid hormone levels were evaluated using Pearson 
correlation coefficients. The statistical software package SPSS was used for the analysis. 
Results 
Plasma and brain PCB and hydroxy-PCB levels 
The major hydroxylated PCB metabolite, determined as its methylated derivative, 
found in all plasma samples and the fetal brain samples, was 4-MeO-2,3,5,3',4'-
pentachlorobiphenyl (4-MeO-pentaCB). 4-MeO-pentaCB constituted more than 73% of 
all phenolic metabolites (mass basis) present in the samples until day 90 postpartum. 
Plasma levels of 4-MeO-pentaCB and CB-153 are presented in Table 5.1 and brain 
levels of 4-MeO-pentaCB and CB-153 are presented in Table 5.2. 
There was a substantial accumulation of 4-MeO-pentaCB in the fetal compart-
ment, with a fetal/maternal plasma ratio of 3.5 in the 5 mg/kg dose group and of 2.1 in 
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Table 5.1 
Pooled plasma levels (ppb fresh weight) of 4-MeO-2,3,3'4',5-pentachlorobiphenyl (4-MeO-
pentaCB) and 2,2\4,4',5,5'-hexachlorobiphenyl (CB-153) in dams, fetuses, neonates, weanling 
rats and young adult offspring. 
Dose (mg Aroclor 1254/kg per day) 
0 5 25 
Fetus (GD20) 
4-MeO-pentaCB 
CB-153 
Dam (GD20) 
4-MeO-pentaCB 
CB-153 
Male (PND4) 
4-MeO-pentaCB 
CB-153 
Female (PND4) 
4-MeO-pentaCB 
CB-153 
Male (PND21) 
4-MeO-pentaCB 
CB-153 
Female (PND21) 
4-MeO-pentaCB 
CB-153 
Dams (PND21) 
4-MeO-pentaCB 
CB-153 
Male (PND90) 
4-MeO-pentaCB 
CB-153 
Female (PND90) 
4-MeO-pentaCB 
CB-153 
2 
3 
<1 
1 
8 
5 
<2 
10 
150 
26 
94 
31 
15 
8 
<0.1 
0 
<0.2 
0 
600 
40 
170 
45 
510 
120 
410 
140 
260 
26 
300 
31 
45 
4 
5 
3 
4 
1 
1600 
110 
750 
170 
1600 
590 
1200 
670 
120 
52 
150 
56 
100 
13 
Pregnant rats were treated with Aroclor 1254 on day 10-16 of gestation. GD20: gestation day 20, 
PND4: postnatal day 4, PND21: postnatal day 21, PND90: postnatal day 90. 
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the 25 mg/kg dose group. In the fetal plasma the concentration of 4-MeO-pentaCB (0.6 
and 1.6 ppm, fresh wt. basis in 5 and 25 mg/kg dose groups, respectively) exceeded the 
concentration of the persistent PCB congener 2,4,5,2',4',5'-hexachlorobiphenyl (CB 153) 
by a factor of 15. Although the concentration of 4-MeO-pentaCB was approximately 10-
fold lower in the fetal brains than plasma (fresh wt. basis), it was still 4.2 and 2.4 fold 
greater than the concentration of CB-153 in the brain in the 5 and 25 mg/kg dose 
groups, resepectively. On day 20 of gestation maternal plasma also exhibited a high ratio 
of 4-MeO-pentaCB to CB 153 (3.8 and 4.4 in the low and high exposure groups, 
respectively). 
The highest plasma concentrations of CB 153 were observed in neonatal plasma 
from day 4 postpartum (approximately 0.13 and 0.63 ppm, fresh weight basis, 5 and 25 
mg/kg dose group, respectively). Plasma concentrations of 4-MeO-pentaCB were similar 
in 4 day old pups and fetuses from day 20 of gestation. 
Table 5.2 
Brain levels of 4-MeO-pentaCB and CB-153 in pooled samples from fetuses, weanling 
rats and young adult offspring. 
Fetus 
Male 
Female 
Male 
Female 
Dose 
Aroclor 
(mg/(kg x day) 
0 
5 
25 
0 
5 
25 
0 
5 
25 
0 
5 
25 
0 
5 
25 
CB-153 
ppm lipid 
0.04 
1.0 
3.9 
0.08 
1.2 " 
3.9 
0.04 
1.1 
4.0 
0.003 
0.15 
0.15 
0.006 
0.12 
0.45 
GD20 
PND2 
CB-153 
ppb fw 
0.8 
24 
66 
3.2 
36 
156 
1.9 
55 
200 
PND90 
0.1 
13 
13 
0.4 
7.3 
35 
4-MeO-
pentaCB 
ppm lipid 
nd 
4.2 
9.3 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
4-MeO-pentaCB: 4-MeO-2,3,3'4',5-pentachlorobiphenyl, CB 153: 2,2',4,4',5,5'-
hexachlorobiphenyl, nd: not detected, less than 2 ppb lipid weight, GD20: gestation day 20, 
PND21: postnatal day 21, PND90: postnatal day 90. 
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Both plasma CB 153 and 4-MeO-pentaCB concentrations decreased 10-fold 
between day 4 and day 21 postpartum in neonates from the high exposure group and 
decreased 5-fold in neonates from the low exposure group (plasma 4-MeO-pentaCB 
concentrations: 0.28 and 0.14 ppm fresh wt. in the 5 and 25 mg/kg dose groups, 
respectively). However, control plasma CB 153 and 4-MeO-pentaCB levels increased 
over the same period, and were similar to concentrations observed in PCB-exposed 
animals from the 5 mg/kg exposure group. Furthermore, 4-MeO-pentaCB plasma levels 
were a factor 2 higher in the low dose group than in the high exposure group. Weanling 
levels of CB 153 (1.1 and 4.0 ppm lipid wt basis, 5 mg/kg and 25 mg/kg dose group, 
respectively) on day 21 postpartum were similar to fetal brain levels. 4-MeO-pentaCB 
was below the limit of detection (< 2 ppb) in weanling brains 21 days after birth from 
all treatment groups. 
A 10-fold decrease in plasma CB 153 and 4-MeO-pentaCB concentrations in 
both Aroclor exposed groups was observed between postnatal day 21 and 90, resulting 
in concentrations in the low ppb range (2 and 4 ppb, fresh wt. in the 5 and 25 mg/kg 
dose groups, respectively). Brain levels of CB 153 remained elevated in the Aroclor 
1254 exposed groups, averaging 140 ppb and 300 ppb on a lipid wt. basis in the 5 
mg/kg and 25 mg/kg dose groups, respectively. 
Plasma thyroid hormones 
The results of plasma thyroid hormone analysis are presented in Table 5.3. 
Maternal plasma total thyroxine (TT4) and free thyroxine (FT4) levels were unaffected 
by the low PCB dose and significantly reduced relative to controls (TT4: 50%, FT4: 
58%) only by the highest PCB dose on day 20 of gestation. Maternal plasma total 
triiodothyronine (TT3) levels were reduced by 27% relative to controls in the highest 
PCB exposure group. Fetal plasma thyroid hormone levels were more sensitive to 
maternal PCB exposure than maternal thyroid hormone levels. Significant reductions of 
50% and 74% were observed in fetal TT4 levels and fetal plasma FT4 was reduced by 
70% and 80% relative to controls in the low and high PCB dose group, respectively. 
Four days after birth, male and female neonatal TT4 levels were significantly 
reduced relative to controls by both PCB treatments. FT4 levels were not affected by 
PCB treatment in male neonates on day 4 postpartum, while female neonatal FT4 levels 
were significantly decreased by 50% relative to controls by the high PCB dose. Plasma 
TT3 levels were decreased in both male and female neonates from the highest PCB 
treatment group on day 4 postpartum, but this reduction was significant only in the 
males. 
On day 21 postpartum, maternal TT4 and FT4 levels were unaffected by the 
administration of PCB during gestation, and a slight but significant decrease in plasma 
TT3 concentrations was observed only in dams from the low PCB exposure group. 
Plasma TT4 were significantly reduced by 36% and 32% respectively in male and female 
weanlings from the highest PCB dose group 21 days postpartum. Plasma FT4 levels 
were significantly reduced (25%) only in female weanlings from the highest dose group 
on day 21 postpartum. Male and female weanling TT3 concentrations were significantly 
reduced by approximately 16% in the high PCB dose group, and female weanling TT3 
was also significantly decreased (10%) in the low PCB dose group. 
Plasma thyroid hormone levels were generally unaltered relative to controls in 
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Table 5.3 
Effect of maternal Aroclor 1254 exposure on thyroid hormone levels in the dams and 
offspring. 
Age 
Dose Aroclor 1254, mg/kg body weight per day 
0 5 25 
TT4nM 
maternal 
fetal 
male 
female 
maternal 
male 
female 
male 
female 
GD20 
GD20 
PND4 
PND4 
PND21 
PND21 
PND21 
PND90 
PND90 
25.3+1.24 
5.4+0.1 
21.9+1.9 
22.9+2.1 
34.5+2.5 
42.3+4.2 
41.9+3.6 
63.4+2.2 
52.3+3.3 
23.5+2.0 
2.6+0.4* 
17.4+0.8* 
15.7+1.9* 
33.7+1.6 
38.4+2.1 
39.9+1.2 
71.0+2.3* 
50.8+3.5 
12.7+1.2* 
1.4+0.3* 
11.7+0.8* 
8.2+1.2* 
31.4+2.3 
26.9+3.3* 
28.5+3.6* 
67.6+2.0 
48.3+3.7 
FT4pM 
maternal 
fetal 
male 
female 
maternal 
male 
female 
male 
female 
GD20 
GD20 
PND4 
PND4 
PND21 
PND21 
PND21 
PND90 
PND90 
13.4+1.3 
3.7+0.1 
4.4+0.3 
6.7+1.2 
13.9+1.2 
14.2+1.5 
16.5+0.6 
21.2+1.0 
20.4+1.5 
10.6+1.4 
1.0+0.1* 
4.1+0.4 
3.8+0.6* 
13.1+0.6 
14.5+0.5 
16.8+0.4 
21.1+0.7 
19.1+1.1 
5.6+1.3* 
0.7+0.1* 
3.9+0.5 
3.3+0.4* 
12.7+1.1 
11.5+1.1 
12.3+1.5* 
21.2+0.8 
18.4+1.5 
TT, nM 
maternal 
male 
female 
maternal 
male 
female 
male 
female 
GD20 
PND4 
PND4 
PND21 
PND21 
PND21 
PND90 
PND90 
0.95+0.03 
0.32+0.02 
0.28+0.03 
0.83+0.03 
1.28+0.07 
1.29+0.05 
1.03+0.06 
1.05+0.04 
0.86+0.06 
0.27+0.03 
0.19+0.05 
0.71+0.02* 
1.18+0.05 
1.15+0.02* 
1.10+0.07 
0.95+0.05 
0.70+0.06* 
0.15+0.02* 
0.18+0.03 
0.79+0.04 
1.05+0.04* 
1.09+0.05* 
1.03+0.05 
1.05+0.04 
The data are presented as the mean+SEM, an asterix (*) indicates a statistically significant 
difference with controls (P<0.05). N=6 on gestation day 20 (GD20), N=6-10 on postnatal day 4 
(PND4), N=8-10 on postnatal day 21 (PND21), N=10 on postnatal day 90 (PND90). 
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Table 5.4 
Plasma concentration of thyroid stimulating hormone following perinatal exposure of 
rats to Aroclor 1254. 
Dose Aroclor 1254, mg/kg body weight per day 
0 5 25 
Gestation day 20 
fetal 
Postnatal day 4 
male 
female 
Postnatal day 21 
male 
female 
Postnatal day 90 
male 
female 
The data are presented as 
N=8-10 on postnatal day 
6.13+0.05 
5.74+0.11 
6.69+0.19 
5.38+0.37 
5.51+0.25 
9.10+0.50 
7.35+0.61 
TSH 
the mean+SEM. N=6 on 
21, N= 10 on postnatal day 
(ng/ml plasma) 
6.09+0.56 
4.45+0.35 
7.10+0.56 
5.52+0.18 
5.46+0.27 
9.50+0.67 
6.71+0.43 
gestation day 20, 
90. 
5.96+0.12 
5.43+0.23 
6.67+0.25 
5.12+0.28 
5.64+0.34 
9.40+0.56 
6.07+0.54 
N=6-10 on postnatal day 4, 
adult offspring (postnatal day 90) exposed pre- and postnatally to PCB, with the 
exception of a slight, but statistically significant elevation of plasma TT4 concentrations 
(12%) in male offspring from the lowest PCB treatment group. 
Plasma levels of thyroid stimulating hormone (TSH) in fetal, neonatal and adult 
offspring were unaltered by maternal exposure to Aroclor 1254, despite severe 
reductions in fetal TT4 and FT4 levels (Table 5.4). Male levels of plasma TSH were 
significantly higher than female levels on day 90 postpartum. 
Brain thyroid hormone concentrations 
T4 concentrations were reduced by 50% in the fetal cerebella exposed to the low 
PCB dose, and were below the limit of detection in the cerebella of fetuses exposed to 
the high PCB dose (Table 5.5). T3 concentrations in cerebella of control fetuses were 5 
fold lower than T4 concentrations in the fetal cerebella. No significant effect was 
observed of PCB exposure on T3 concentrations in the fetal cerebella, although T3 levels 
were lower with an increasing dose of Aroclor 1254. In the forebrain T4 concentrations 
were also decreased by 60% and 85%, although these decreases were not analysed 
statistically due to the small group size. One sample in the control group was 
76 
Chapter 5 — 
Table 5.5 
Fetal and neonatal brain levels of thyroid hormones 
Dose Aroclor 1254, 
0 
mg/kg body weight 
5 
per day 
25 
Gestation day 20 
ng T4 or T3/g tissue 
Fetal Forebrain T4 1.83+0.70(2) 0.67+0.34(3) 0.24+0.01(3) 
Fetal Forebrain T3 0.53+0.02(3) 0.43+0.01(3)* 0.49+0.02(3) 
Fetal Cerebella T4 0.36+0.05(6) 0.17±0.02(6)* ND(6) 
Fetal Cerebella T3 0.07+0.02(6) 0.06+0.01(6) 0.05+0.01(6) 
Postnatal day 21 
Female Forebrain T4 2.03+0.17(8) 1.64+0.14(7) 1.13+0.15(8)* 
Female Forebrain T3 3.34+0.14(8) 3.22+0.16(7) 3.58+0.25(8) 
Male Forebrain T4 2.68+0.12(8) 2.42+0.15(7) 2.38+0.15(8) 
Male Forebrain T3 3.45+0.19(8) 3.15±0.29(7) 3.11+0.19(8) 
The data are presnted as mean+SEM, followed by the number of samples in parentheses, ND: 
not detected, an asterix (*) indicates a statistically significant difference with controls (P<0.05). 
contaminated with T4 during processing and excluded from the data analysis, resulting in 
N=2. The concentration of T3 was significantly decreased (20%) in the forebrain of 
fetuses in the low exposure group, and unaltered in the fetal forebrains from the high 
exposure group. 
Concentrations of T4 were reduced by 44% in the forebrains of female weanlings 
from the high PCB exposure group. The concentration of T4 was unaffected by PCB 
treatment in the forebrains of male weanlings, and no reductions in T3 concentrations 
were observed in the forebrains of male and female weanlings on day 21 postpartum. 
Brain Type II 5 '-thyroxine deiodinase activity (5 'D-II) 
The activity of 5'D-II in fetal forebrain homogenates was significantly increased 
relative to controls by 35% and 100% in the low and high PCB dose group, respectively 
(Figure 5.1). In forebrain homogenates from female neonates from the low PCB 
treatment group on day 21 of gestation 5'D-II activity was significantly decreased by 
48% relative to controls and the high dose group. A similar pattern was seen in 5'D-II 
activity in the forebrains of male neonates, however the activity in the low dose group 
was significantly lower only from the high dose group. The level of 5'D-II activity was 
unaffected by perinatal PCB exposure in the forebrains of adult offspring. 
Inhibition studies were conducted to investigate the effect of several model 
compounds on 5'D-II activity, because the pattern of 5'D-II activity in female weanling 
forebrain homogenates following perinatal PCB exposure was unexpected (decreased 
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40 
mg Aroclor 1254 
per kg per day 
25 
Fetal Male Female Male Female 
GD20 PND21 PND90 
Figure 5.1 
Type II thyroxine 5' deiodinase (5'D-II) activity in forebrain homogenates from fetuses, 
neonates and adult offspring following maternal exposure to Aroclor 1254 on day 10 to 16 of 
gestation. An asterix (*) indicates a statistically significant difference with controls (P<0.05). 
GD20: gestation day 20, PND21 postnatal day 21, PND90, postnatal day 90. 
Table 5.6 
Effect of rT3, PCBs or PCB metabolites on Type II thyroxine 5' deiodinase activity in 
forebrain homogenates 
Compound 
Aroclor 1254 
3,3',4,4'-
tetrachlorobiphenyl 
3,3',4',5-
tetrachloro-4-biphenylol 
2,3,3',4,5'-
pentachloro-4 ' -bipheny lol 
3,3\5'-
triiodothyronine (rT3) 
Concentration 
Added (uM) 
0.1 
1.0 
0.1 
1.0 
0.1 
1.0 
0.1 
1.0 
0.1 
1.0 
Activity 
(% of control) 
110 
93 
98 
105 
101 
111 
103 
97 
44 
22 
The results are the average of duplicate incubations. 
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activity when brain T4 levels were similar to controls and no increase in activity when 
brain T4 levels were depressed). 
The activity of 5'D-II in incubations of control female weanling brain 
homogenates was unaffected by the addition of 0.1 or 1.0 uM Aroclor 1254, 3,3',4,4'-
tetrachlorobiphenyl, 3,3',4',5-tetrachloro-4-biphenylol and 2,3,3',4,5'-pentachloro-4'-
biphenylol to the incubation mixture (Table 5.6). The positive control, rT3, added to the 
incubations at a concentration of 0.1 and 1.0 uM reduced 5'D-II activity by 56% and 
77%, respectively. 
Hepatic microsomal T4 glucuronidation 
Maternal (day 20 of gestation) hepatic microsomal T4 uridine 
diphosphoglucuronyl transfrase (T4-UDPGT) activity was significantly induced (520% of 
controls) only by the highest maternal PCB dose (Figure 5.2). A significant negative 
correlation was observed between maternal T4-UDPGT activity and plasma TT4 levels 
(R: -0.83, PO.001) and plasma FT4 levels (R: -0.71, P<0.001). Fetal (day 20 of 
gestation) hepatic microsomal T4-UDPGT activity was significantly reduced by 56% 
mg Aroclor 1254 
per kg per day 
25 
Maternal Fetal Male Female Male Female 
GD20 PND21 PND90 
Figure 5.2 
Hepatic microsomal T4 uridine diphosphoglucuronyl transferase (T4-UDPGT) activity from dams, 
fetuses, neonates and adult offspring following maternal exposure to Aroclor 1254 on day 10 to 
16 of gestation. The activity is expressed as pmol T4-glucuronide (T4G) formed per minute per 
mg microsomal protein (mean + SEM). An asterix (*) indicates a statistically significant 
difference with controls (PO.05). GD20: gestation day 20 (N=6), PND21: postnatal day 21 
(N=8-10), PND90: postnatal day 90 (N=10). 
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relative to controls by the highest maternal PCB treatment. At 21 days postpartum male 
weanling hepatic microsomal T4-UDPGT activity was significantly induced relative to 
controls by both the low and high PCB exposure (30% and 120% increase, respectively). 
Female weanling was significantly increased relative to controls by 30% in both PCB-
treatment groups. On day 90 postpartum, no treatment related effects were observed in 
T4-UDPGT activity from male offspring, while T4-UDPGT activity was significantly 
lower than controls by more than 40% in females from both PCB-exposed groups. No 
significant correlations were observed between fetal, weanling and young adult T4-
UDPGT activity and plasma thyroid hormone levels. 
Discussion 
In this study we examined the hypothesis that PCB induced hypothyroxinemia 
during the perinatal period may result in decreases in brain T3 levels in the rat. The 
mechanisms involved in the reduction of plasma and brain thyroid hormone levels were 
also examined by measuring brain and plasma PCB and hydroxy-PCB levels as well as 
hepatic microsomal T4 glucuronidation. 
Brain and plasma PCB and hydroxy-PCB levels 
The results demonstrate that the exposure of pregnant rats to the technical PCB 
mixture Aroclor 1254, results in the highly selective accumulation of one hydroxylated 
PCB metabolite, 4-OH-2,3,5,3',4'-pentachlorobiphenyl (4-OH-pentaCB), in maternal, 
fetal and neonatal plasma. The placenta does not form a barrier for this compound, for 
the concentrations were higher in fetal plasma than in maternal plasma on day 20 of 
gestation. Compared to the levels of 2,2',4,4',5,5'-hexachlorobiphenyl (CB 153), 4-OH-
pentaCB readily enters the brain of fetal rats, however, this metabolite could not be 
detected in the brains of Aroclor 1254-exposed neonatal or adult offspring. This 
observation indicates that after birth the blood-brain barrier effectively excludes the 
accumulation of 4-OH-pentaCB in the brain and that 4-OH-pentaCB that had entered the 
fetal brain is highly diluted in neonates due to rapid postnatal brain growth and/or is 
mobilized from brain tissue. 
The high levels of 4-OH-pentaCB in the plasma relative to the total PCB 
concentration suggest that 4-OH-pentaCB also has a high affinity binding site in the 
plasma. We hypothesize that 4-OH-pentaCB is transported over the placenta to the fetus, 
and that the fetus is then not able to eliminate the compound from its circulation, 
resulting in the accumulation in the fetal plasma. The accumulation of hydroxylated 
PCB metabolites in the fetus has been previously demonstrated after maternal exposure 
to 4-chlorobiphenyl (Lucier et al. 1978) and 3,3',4,4'-tetrachlorobiphenyl (Darnerud et 
al. 1986, Morse et al. 1995). 
In a study by Shain et al. (1986) total brain PCB levels (based on a congener 
specific analysis of 67 different PCB congeners) in newborns was reported as 788 ppb 
and in day 21 weanlings as 3000 ppb on a fresh wt basis following continous dietary 
exposure to 30 ppm Aroclor 1254 from day 0 of gestation. The dosing regimen in this 
study resulted total PCB levels in the fetal brain that are comparable to the newborn rat 
data from Shain et al (1986): 275 ppb and 1235 ppb on a fresh wt basis in the fetal 
brain following 5 and 25 mg/kg on day 10 to 16 of gestation. However, in the current 
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study levels of total PCBs in the brain of weanlings are considerably lower than those 
previously reported (Shain et al. 1986), in which continous dietary exposure to 30 ppm 
resulted in 3000 ppb on a fresh wt basis. This difference is due to the fact that in the 
current study dams were exposed only during gestation, while in the former study 
exposure occured during gestation and lactation. 
Effect of PCB exposure on plasma thyroid hormone levels 
Maternal PCB exposure produced a transient decrease in plasma total thyroxine 
(TT4), free thyroxine (FT4) and triiodothyronine (T3) in the dams and their offspring. 
Despite that lactational transfer of PCBs is much greater than placental transfer (Shain et 
al. 1986), the reductions of plasma TT4 and FT4 were most severe in the fetus following 
maternal PCB exposure. Plasma levels of CB-153 in this study also indicate that 
although substantial levels of PCBs were present in fetal blood, neonatal exposure via 
lactation was considerably higher. 
The reductions of fetal plasma TT4 and FT4 were not secondary to reductions in 
maternal plasma TT4 and FT4 levels, for the maternal transfer of T4 accounts for only 
17% of the fetal T4 pool in the late gestational Wistar rat fetus (Calvo et al. 1990, 
Morreale de Escobar et al., 1989). Furthermore, major reductions in fetal plasma TT4 
and FT4 levels were observed after maternal exposure to the low dose of Aroclor 1254, 
a dose which resulted in only minor reductions in maternal plasma thyroid hormone 
levels. 
The selective accumulation in the fetal plasma of a hydroxylated PCB metabolite, 
2,3,3',4',5-pentachloro-4-biphenylol (4-OH-pentaCB) is probably responsible for the 
decreases observed in fetal plasma TT4 and FT4 levels. In vitro, meta and para 
hydroxylated PCB metabolites bearing a structural resemblance to thyroxine can displace 
thyroxine from transthyretin (TTR), the major plasma thyroxine binding protein in the 
rat (Lans et al. 1993, Rickenbacher et al. 1986). Unpublished observations from our 
laboratory indicate that 4-OH-pentaCB binds to TTR with a 10-fold higher affinity than 
T4. Decreased binding of T4 to TTR due to the presence of 3,3',4',5-tetrachloro-4-
biphenylol in plasma following exposure to 3,3',4,4'-tetrachlorobiphenyl has been 
demonstrated in the rat (Brouwer and van den Berg, 1986, Brouwer et al. 1990). Recent 
research from our laboratory shows that gestational exposure of rats to 3,3',4,4'-
tetrachlorbiphenyl leads to a significant accumulation of 3,3'4',5-tetrachloro-4-
biphenylol in fetal plasma, resulting in decreased fetal plasma TT4 and FT4 levels in the 
absence of decreases in maternal plasma TT4 and FT4 levels. (Morse et al, 1995). High 
levels of 4-OH-pentaCB were also found in neonatal plasma on postnatal day 4, and 
may also have contributed to the decreases observed in neonatal plasma TT4 and FT4 
levels. 
Although not addressed in the current study, the secretion of T4 by the fetal 
thyroid may also have been depressed following maternal PCB exposure. In a previous 
study, the dietary exposure of pregnant and lactating rats to Aroclor 1254 resulted in 
ultrastructural alterations in the fetal thyroid gland indicating interference in the colloid 
droplet-lysozyme interaction, which would impair thyroid hormone secretion (Collins 
and Capen, 1980a). Further support for the decreased secretion of T4 and T3 by the 
thyroid following PCB exposure has been given in studies which examined the kinetics 
of [125I]-T4 and [125I]-T3 in rats (Byrne et al. 1987, Sepkovic and Byrne, 1984). 
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Hepatic microsomal T4 glucuronidation 
In the current study, the reductions in maternal and neonatal plasma TT4 and FT4 
levels may in part be due to the observed induction of hepatic microsomal T4 
glucuronidation in maternal and neonatal rats. The administration of Aroclor 1254 to 
thyroidectomized rats implanted with osmotic pumps to deliver T4 results in decreased 
plasma thyroxine levels (Barter and Klasson, 1992) presumably by increased bilary 
excretion of T4 glucuronides (Bastomsky, 1977). However, the relationship between 
hepatic microsomal T4 glucuronidation and plasma TT4 levels was weak in weanling 
rats, indicating that the contribution of hepatic glucuronidation was relatively minor. 
In contrast to a previous study in which T4-UDPGT activity was induced in fetal 
rat hepatic microsomes following maternal exposure to coplanar compounds, (Morse et 
al. 1993a) in this study fetal T4-UDPGT activity was significantly reduced by maternal 
exposure to Aroclor 1254. Therefore, hepatic glucuronidation of T4 in the fetus did not 
play a role in decreasing fetal plasma TT4 levels in the current study. 
It has been previously shown that PCB exposure results in a decrease of plasma 
T4 levels in the absence of increased T4 glucuronidation in non-thyroidectomized rats. 
The work by Collins and Capen (1980b) demonstrated that reductions in plasma T4 
levels in homozygous Gunn rats were identical to the reductions found in heterozygous 
Gunn rats following Aroclor 1254 exposure. Since the homozygous Gunn rats are 
severely deficient in T4 glucuronidation and heterozygous Gunn rats exhibited a 5 fold 
increase in bilary T4 glucuronides after PCB exposure, the authors suggested that also 
the secretion of T4 by the thyroid is reduced by PCBs. 
Effect of PCB exposure on the regulation of brain thyroid hormones 
The results show that while reductions in fetal or weanling rat plasma TT4 or FT4 
levels result in decreased brain T4 levels following maternal PCB exposure, brain T3 
levels are affected only to a minor extent (Figure 5.3). The reductions in brain T4 levels 
were most severe in the fetus, and the induction of 5'D-II activity in the fetal forebrain 
can account for the maintenance of forebrain T3 levels in the fetus. The induction of 
forebrain 5'D-II activity is a well charactereized response of the rat brain to decreased 
T4 levels (Silva and Matthews, 1984, Ruiz de Ona et al. 1988, Obregón et al. 1991). It 
has been proposed that type III thyronine 5-deiodinase (5-D-III) regulates cerebellar T3 
levels by regulating the deiodination of T3 to T2 (Silva and Matthews, 1984). 
In female weanling rats normal forebrain T3 levels were maintained, despite a 
significant reduction in forebrain T4 levels and the absence of induced 5'D-II activity in 
forebrain homogenates following in utero and lactational exposure to the high dose of 
Aroclor 1254. In addition, female weanling forebrain T3 levels were also maintained 
despite slight decreases in forebrain T4 levels and a decrease in 5'D-II activity following 
in utero and lactational exposure to the low dose of Aroclor 1254. The maintenance of 
forebrain T3 levels in female weanlings is therefore probably not regulated by 5'D-II 
activity following maternal PCB exposure. As in the cerebellum, a decrease in 5-D-III 
activity may maintain T3 levels in the forebrain when 5'D-II activity is improperly 
regulated. 
The decrease in 5'D-II activity in brain homogenates from weanling rats from the 
low PCB dose group is difficult to explain. We eliminated competitive inhibition by 
PCBs or metabolites by examining 5'D-II activity with brain homogenates from control 
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weanling rats with concentrations of PCBs or metabolites that were more than 1000-fold 
higher than the concentrations found in brain tissue in this study. It is also possible that 
PCBs or their metabolites may act on the inactivation of 5'D-II by stimulating the 
binding of the enzyme to F-actin filaments, and thus increasing the internalization of the 
enzyme, which is a well-characterized response of the enzyme to T4 (Farwell and 
Leonard, 1992, Farwell et al. 1993, Safran et al. 1993). However, preliminary results 
using the primary astrocyte system described by Farwell and Leonard (1992) for 
detecting 5'D-II inactivation or inhibition revealed no effects of Aroclor 1254, individual 
PCB congeners or PCB metabolites on 5'D-II activity at concentrations of 1 mM in the 
culture medium. 
Plasma TSH levels 
No increase of plasma TSH levels was found as a response to decreased plasma 
thyroid hormones in fetal or neonatal rats. Elevated plasma TSH levels have been found 
in adult male hooded rats exposed to Aroclor 1254 and 2,3,7,8-TCDD, in Rhesus 
monkeys exposed to 2,3,4,7,8- pentachlorodibenzofuran, and marmoset monkeys 
exposed to 3,3',4,4'-tetrachlorobiphenyl (Bastomsky, 1976, Bastomsky, 1977, Van den 
Berg et al. 1988, Brewster et al. 1988). It has been recently demonstrated that the TSH 
elevation observed after dietary exposure of adult male Sprague-Dawley rats is lower 
than expected on the basis of plasma TT4 and FT4 reductions (Barter and Klaasen, 
1994). We know of no previous reports in the litertature of the effects of pre- and 
postnatal exposure to a polychlorinated biphenyl mixture on TSH concentrations in rats. 
Fetal Wistar rats have been shown to respond to chemically induced (methimazole) 
hypothyroidism with 5-fold increases in plasma TSH on day 21 of gestation (Morreale 
de Escobar et al. 1993). There is no apparent reason to explain the lack of increased 
TSH secretions in the current experiment on the basis of the plasma thyroid hormone 
levels, because plasma T4 and not T3 levels are thought to be primarily responsible for 
regulating fetal plasma TSH levels (Morreale de Escobar et al. 1993), and the levels of 
fetal plasma TT4 and FT4 were severely reduced in the high dose group. Furthermore, in 
male neonates (day 4 postpartum) 50% reductions in both plasma TT4 and TT3 levels 
did not result in elevated TSH concentrations. The abnormal regulation of of TSH 
secretion in fetal and neonatal rats, and of 5'D-II activity in the brains of neonatal rats 
cannot be explained by our current knowledge of processes involved in the interactions 
between PCBs and thyroid hormones. It is conceivable that either PCB congeners in the 
Aroclor mixture or their metabolites interact with the nuclear T3 receptor in the pituitary 
and modify the response of TSH release. Interactions of polyhalogenated cyclic 
compounds with T4 binding have been demonstrated in crude nuclear extracts 
(McKinney et al. 1987) and both Aroclor 1254 and the PCB congener 3,3',4,4',5-
pentachlorobiphenyl reduce the level of c-erbA mRNA which encodes for the thyroid 
hormone nuclear receptor in vitro (Hornhardt et al. 1994). 
Significance of the findings 
If one assumes that T3 is the biologically active thyroid hormone during brain 
development, one can question if the slight but significant decreases in fetal brain T3 
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Figure 5.3 
Schematic representation of the effects on thyroid hormone homeostasis following the 
accumulation of the PCB metabolite 2,3,4',5',5-pentachloro-4-biphenylol in fetal rat plasma. The 
metabolite binds to fetal transthyretin, displacing T4 and thereby decreasing plasma TT4 and FT4 
concentrations. Subsequently, the transfer of T4 to the fetal brain is limited, decreasing brain T4 
concentrations, with an increase in Type II thyroxine 5'-deiodinase activity, so that brain T3 
concentrations are maintained. Due to the lack of a functional blood-brain barrier, 2,3,4',5',5-
pentachloro-4-biphenylol also accumulates in the fetal brain with unknown toxicological 
consequences. 
levels on day 20 of gestation observed in this study only in the low dose group 
following maternal PCB exposure are sufficient to result in alterations in brain 
development. However, several considerations should be made before concluding that 
PCB-induced hypothyroxinemia is not involved in PCB-induced developmental 
neurotoxicity. 
The thyroidectomy of dams results in the thyroid hormone deficiency of embryos 
prior to the onset of fetal thyroid hormone production (Morreale de Escobar et al. 1985, 
Porterfield and Hendrich, 1992). Once fetal thyroid hormone secretion begins after day 
17 of gestation only marginal effects are observed on the concentration of T4 and T3 in 
the fetal brain despite maternal thyroidectomy (Ruiz de Ona et al. 1991) because the 
fetus is then only partially dependent on maternal thyroid hormones (Morreale de 
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Escobar et al, 1988, 1989, 1990). However, the progeny of thyroidectomized dams 
exhibit permanent behavioral defects (Hendrich et al. 1984, Attree et al. 1992), and 
alterations in brain biochemistry (Pickard et al. 1993, Ruiz de Elvira et al. 1989, 
Hadjzadeh et al. 1990), which indicate a requirement for thyroid hormones before the 
onset of fetal thyroid secretion. Considering the higher sensitivity of the fetus than the 
dam for the induction of hypothyroxinemia on day 20 of gestation, we can not rule out 
that brain levels of T3 were significantly decreased at previous time points. This issue 
should be addressed by examining the effects of prenatal PCB exposure on the levels of 
thyroid hormones in the embryonic and fetal tissues up to day 18 of gestation. In 
addition, levels of brain thyroid hormones should also be examined between 10 to 15 
days after birth, a period in which hypothyroidism can result in decreased myelinisation 
(Rodriguez-Pen a et al. 1993). 
Regardless of whether or not functional decreases in brain thyroid hormone 
concentrations occur, the transport to and accumulation of hydroxylated PCB metabolites 
in the fetal brain may also pose a threat to brain development. Para-hydroxylated PCB 
metabolites bind 10-fold stronger to T4 receptors in nuclear extracts than T4 itself 
(McKinney et al. 1987) en bezitten estrogene eigenschappen (Jansen et al. 1993, Korach 
et al. 1988). Therefore these metabolites may directly alter brain cell differentiation 
and/or proliferation. 
In conclusion, maternal exposure to the PCB mixture Aroclor 1254 results in the 
substantial accumulation of mainly one hydroxylated metabolite (2,3,3',4',5-pentachloro-
4-biphenylol) in the fetal plasma, and thereby probably contributes to the decreases 
observed in fetal plasma thyroxine levels. Decreases in plasma T4 levels resulted in 
marked decreases in fetal brain T4 levels, which are compensated in part by increased 
5'D-II activity, so that decreases in brain T3 levels are less dramatic. Based on the 
current knowledge of the developmental regulation of thyroid hormone function, the 
developing central nervous system may be at risk for PCB induced alterations in brain 
thyroid hormone concentrations. Also the selective accumulation of 4-OH-pentaCB in 
the fetal brain warrants toxicological investigation. 
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FETAL, NEONATAL AND LONGTERM ALTERATIONS IN HEPATIC 
RETINOID LEVELS FOLLOWING MATERNAL POLYCHLORINATED 
BIPHENYL EXPOSURE IN RATS 
Abstract 
This study was undertaken to investigate the effects of perinatal polychlorinated 
biphenyl (Aroclor 1254) exposure on hepatic and plasma retinoid levels in fetal rats, 
their dams and neonatal and adult offspring. Pregnant Wistar rats were treated with 0, 5, 
or 25 mg Aroclor 1254/kg body weight from day 10 to 16 of gestation. Hepatic 
retinoids (retinol, retinyl palmitate and retinyl stéarate) levels were determined in fetuses 
and dams from day 20 of gestation, in male and female neonates 21 days postpartum 
and in young adult offspring 90 days after birth. Retinol levels were determined in fetal 
and maternal plasma (gestation day 20) and plasma from the offspring 21 and 90 days 
after birth. 
Maternal and fetal plasma retinol levels were decreased by 35% and 38% on day 
20 of gestation following exposure to the highest dose of Aroclor 1254. Male, but not 
female neonatal plasma retinol levels were significantly decreased (23%) in the high 
dose group. No effects of PCB treatment were seen on plasma retinol levels in the 
offspring 90 days after birth. 
Only slight reductions in fetal and maternal hepatic retinol and retinyl palmitate 
concentrations were observed after prenatal PCB exposure. Male neonatal hepatic retinyl 
palmitate levels were reduced by 25% and 50% in the 5 mg and 25 mg Aroclor 1254/kg 
dose group, respectively, while female neonatal hepatic retinyl palmitate levels were 
significantly reduced only in the high dose group. Ninety days after birth, male hepatic 
retinyl palmitate levels were only slightly reduced in the highest dose group, however, 
hepatic retinol concentrations were significantly reduced by 50% in both PCB treatment 
groups. Female adult offspring exhibited significant reductions in hepatic retinyl 
palmitate levels (25%) in both PCB treatment groups, while hepatic retinol levels 
exhibited an unusual increase of more than 100% of controls in the low dose group, 
while levels in the high dose group were similar to controls. This study demonstrates 
that even a relatively low maternal dose of Aroclor 1254 results in long-term alterations 
in retinoid status of the offspring in the rat. 
Dennis. C. Morse, Abraham Brouwer, 
Toxicology and Applied Pharmacology, in press 
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Introduction 
Polychlorinated biphenyls, -dibenzo-p-dioxins and -dibenzofurans have been 
demonstrated to alter retinoid status in various experimental animals and wildlife species 
(reviewed by Zile, 1992). In general, exposure to polyhalogenated aromatic hydrocar-
bons (PHAHs) results in decreased hepatic stores of retinol and retinyl esters while 
extrahepatic stores (with the exception of the kidney) of retinoids appear to be affected 
to a lesser extent (Hâkansson et al. 1991, Brouwer et al. 1988a). The relative effects of 
PHAH exposure on tissue retinoid levels are dependent on retinoid status (Hâkansson et 
al. 1991a), the species or strain of experimental animal used (Puhvel et al. 1991, 
Hâkansson et al, 1991b), and the time after exposure (Azais et al, 1987). The structure-
activity relationship for the effects of PHAHs on tissue retinoid levels is not yet clear 
(Chen et al, 1992), and is likely to involve multiple mechanisms, such as the 
modulation of hepatic retinol ester hydrolase activity (Mercier et al. 1990), 
acylCoA:retinol acyl transferase (Jensen et al. 1987) and interactions of hydroxylated 
PCB metabolites with the plasma retinol-binding protein-transthyretin complex (Brouwer 
and Van den Berg, 1986, Brouwer et al. 1988b). 
Some of the effects of exposure to PHAH resemble those of retinoid deficiency, 
for example negative reproductive outcome, (Peterson et al. 1993, Takahashi et al. 
1975), keratinisation of epithelia (Chopra, 1983) and impaired immune function (Safe, 
1994, Mark et al. 1983). Specific targets in the developing organism, such as the 
craniofacial area and the central nervous system, are sensitive to retinoid and PHAH 
induced teratogenicity (Abbott and Birnbaum, 1989, Tilson et al, 1990, Peterson et al. 
1993, Durston et al, 1989). In addition, PHAHs are well known tumor promotors 
(Silberhorn, 1990), while retinoid status can modulate PHAH induced carcinogenesis 
(Flodstrom et al, 1991). Both polyhalogenated aromatic hydrocarbons and retinoic acid 
effect cellular responses through the regulation of gene expression mediated by their 
respective and distinct nuclear receptors (Petkovitch, 1992, Poland and Knutson, 1982). 
In addition, the coadministration of retinoic acid to pregnant mice increases the 
incidence of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Abbott and Birnbaum, 
1990). Moreover, retinoic acid and retinol are potent inhibitors of dioxin-induced 
differentiation of human keratinocytes in vitro (Berkers et al. in press). 
Pre- and postnatal exposure to PHAHs forms a potential risk for alterations in 
retinoid homeostasis during a period of tissue differentiation. However, very little 
information is available on the effect of PHAH exposure on plasma retinol and hepatic 
retinoid stores during development in mammals. The exposure of lactating rats to 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), results in the reduction of hepatic retinoid 
stores in neonates, an effect resembling that of the exposure of adult rats to TCDD 
(Hâkansson et al. 1987, Lans et al. 1990). To our knowledge, no information is 
available on the effects of maternal PHAH exposure on the plasma and hepatic retinoid 
levels in the fetal or adult offspring. 
In this study we examined the effects of perinatal exposure to the polychlorinated 
biphenyl mixture Aroclor 1254 on circulating and hepatic retinoid levels in pregnant rats 
and their fetuses, as well as neonatal and adult offspring. Retinol was analysed in the 
plasma, and retinol, retinyl palmitate and stéarate were analysed in the livers. Body 
weight gain, relative organ weights and reproductive parameters were also monitored. 
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Material and Methods 
Chemicals 
Aroclor 1254 was kindly donated by Dr. Martin van den Berg, Research Institute 
of Toxicology, University of Utrecht, The Netherlands. The following chemicals were 
purchused from Merck, Darmstadt, Germany: Tris, diisopropylether, HCl, NaCl and 2,6-
di-fért-butyl-4-methylphenol (BHT, chemicals were analytical grade). Methanol (HPLC 
quality) was purchased from Janssen Chimica, Tilburg, the Netherlands. Retinol, retinyl 
acetate and retinyl palmitate were purchased from Fluka Chemie, Bornem, Belgium. 
Animals 
Wistar WU rats, 100 females and 50 males, (14 weeks old) were purchased from 
Charles River Sutzfeld, Germany. The rats were allowed to acclimatize for 2 weeks and 
were maintained at 50 % humidity and 21°C on bedding in macrolon cages with a 12 
hour light cycle. Rat chow (Hope Farms, Woerden, the Netherlands) and tap water were 
supplied ad libitum. After the acclimatization period two females were placed in a cage 
with one male overnight from 17:00 to 9:00 the next day. The females were examined 
each morning by vaginal smear. When spermatazoa were found the animal was housed 
separately and this was termed day 0 of gestation. Animals were pre-assigned to a 
particular dose group on a rotating basis. Maternal body weight gain was monitored 
throughout gestation and lactation. On day 10 of gestation the pregnant female rats were 
transferred to a macrolon cage with a grated steel support to facilitate the collection of 
PCB-contaminated feces and to prevent contamination of the animal facilities. 
Pregnant females received a daily oral dose of 0, 5 or 25 mg Aroclor 1254 per 
kg body weight dissolved in cornoil (2 ml/kg body weight) from day 10 of gestation to 
day 16 of gestation. Rats were weighed each day before administration of Aroclor 1254 
or corn oil alone. On day 20 of gestation (GD20) 6 pregnant rats were sacrificed per 
treatment group under ether anesthesia. Maternal blood was collected from the vena 
cava, and maternal livers were removed, washed in 0.9% NaCl, blotted dry, weighed 
and frozen in liquid nitrogen. Fetuses were removed, sex was determined, the placental 
cord was cut and clamped, and the fetuses were washed in 0.9% NaCl, blotted dry and 
weighed. Fetal blood was collected by decapitation and the fetal livers were removed 
and frozen in liquid nitrogen. Fetal livers and blood were pooled per dam for analysis. 
Blood was collected in heparinized tubes and stored on ice until plasma was prepared by 
centrifugation. Livers were stored at -80 °C and plasma at -20 °C until analysis. 
The remaining rats were transferred to bedding material on GD20 and were given 
paper tissues to make a nest. The rats were inspected each morning at 8:00 h and 
afternoon at 18:00 h for nests. Pups found during the morning inspection were termed 1 
day old, pups born between the morning and afternoon inspection were termed 0 day 
old. Pups were examined for sex, weighed on day 0 postpartum when possible, and 
always on day 1, 4 and 7 postpartum and thereafter on a weekly basis. On postnatal day 
4 (PND4) nests were reduced to 4 males and 4 females. When this was not possible, 
nests were made up of a total of 8 males and females from the same dam, and if 
necessary, an extra pup from another nest from the same treatment group and same age 
was used to achieve a total of 8 pups per nest. Pups were individually marked by 
incision in the ear, and pups transferred from one nest to another were never used for 
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any analysis. 
On postnatal day 21 (PND21), 8-10 nests were sacrificed per treatment group. 
Dams and neonates were sacrificed by decapitation, trunk blood was collected in 
heparinized tubes, and livers were removed and stored as described above. Neonatal 
livers were pooled per sex for analysis. Trunkblood was collected separately for each 
neonate. The thymus was also removed from each rat and weighed. 
The neonates from the remaining nests were weaned on PND21 and male and 
female rats were housed separately in groups of 2-4 rats per cage. The remaining 
animals (10 nests per treatment group) were sacrificed 90 days (PND90) after birth. 
Trunk blood was collected separately for each rat, and 1 liver per sex was analysed per 
nest. Pooled fetal plasma and livers were analysed for retinoids. For day 21 postpartum 
one of the plasma and pooled liver samples per sex were used for retinoid analysis. For 
day 90 postpartum one plasma and one liver sample were used for retinoid analysis. The 
animal used for retinoid analysis had been assigned on day 4 postpartum to eliminate 
bias. 
Extraction and analysis of retinoids 
Plasma and hepatic retinoids were analysed according to Brouwer et al. (1989) 
with some modifications. For the extraction of hepatic retinoids, livers were homogeni-
zed in 50 mM Tris-HCl buffer, pH 7.5, 3 ml buffer/g liver using an ultra-Turrax 
followed by homogenization in a Potter tube with a teflon pestle. Plasma samples or 
liver homogenates (50 ul) were vortexed with 50 ul methanol containing the internal 
standard (500 ng retinyl acetate/ml for plasma, 1 |ag/ml for livers) and 0.1 % BHT (w/v) 
as an anti-oxidant. Plasma and liver retinoids were then extracted overnight at -20 °C 
with 100 (j.1 diisopropylether. The ether phase was removed and filtered over a 0.45 um 
filter (Millipore, Etten Leur, the Netherlands), then evaporated under nitrogen and 
resuspended in 80 ^1 methanol (0.1% BHT). Extractions were carried out in duplicate 
and some series of measurements were repeated to verify the accuracy of the data. 
Extraction efficiencies were routinely above 80%. 
Twenty \x\ aliquots of resuspended extracts were analysed with HPLC using a 
CI8 analytical column (Pecosphere, 3 urn particle size, 3.3 cm length and 4.6 mm 
internal diameter, Perkin Elmer). A Merck-Hitachi HPLC system was used consisting of 
a L6200 pump, L4200 uv-vis detector, AS-2000A autosampler and a D2500 integrator. 
A wavelength of 326 nm was used for the detection of retinoids. Plasma extracts were 
analyzed isocratically with 85% methanol and 15% water with a flow rate of 1 ml/min 
and data collection for 10 minutes. Hepatic retinoids were analysed by 85% methanol, 
15% water for 1.5 minutes, followed by a gradient to 100% methanol for 2.5 minutes, 
and subsequent elution of the retinyl esters at 100% methanol for 12 minutes. The 
column was then re-equilibrated at 85% methanol, 15% water for 6 minutes. Retinol was 
quantified in the plasma extracts, while retinol, retinyl palmitate and retinyl stéarate 
were quantified in liver extracts based on calibration curves using retinol or retinyl 
palmitate as standards. 
Statistical analysis 
Treatment effects were analysed by one-way analysis of variance follwed by 
Duncan's multiple range test (p<0.05) and differences between control values of male 
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and female animals were analysed with the student's t-test using the software package 
SPSS/PC+™ (SPSS Inc., Chicago, IL). The data are presented as the means + SEM. 
Results 
Body weights, organ weights and reproduction 
No effect of Aroclor 1254 treatment was observed on the number of implantati-
ons, resorptions, late fetal death, mean fetal body weight, nest size, sex ratio or postnatal 
survival (data not shown). No gastrointestinal bleeding was observed in the control or 
Aroclor 1254 exposed fetuses. The relative liver weight in fetuses was not affected by 
maternal Aroclor 1254 exposure. There were no treatment related effects on maternal 
body weight during gestation or after birth. Maternal relative liver weights on GD20 
were increased by 7% and 14% by the 5 mg/kg and 25 mg/kg dose group, respectively, 
however the differences were not statistically significant (data not shown). 
Male and female body weight gain of the offspring were slightly, but significant-
ly, reduced by maternal exposure to 25 mg Aroclor 1254/kg body weight from PND4 to 
PND90 (Figure 6.1, only male data is shown). Body weight gain in the male and female 
offspring from the 5 mg/kg dose group was identical to controls at all time points and 
the data is not shown. Body weight reductions relative to controls in male offspring 
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Figure 6.1 
Body weights of male offspring from control and Aroclor 1254-exposed dams, mean + SEM, 
following maternal exposure to 0 or 25 mg Aroclor 1254/kg on day 10-16 of gestation. A) 
neonatal body weight (N=18-20) up to PND21, B) body weight (N=10) from week 4 (PND28) 
to week 13 (PND90). An asterisk (*) indicates a significant difference from controls, P<0.05. 
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Figure 6.2 Cumulative food 
consumption of male and female 
offspring (from PND28 to 
PND90), N=10, mean + SEM, 
following maternal exposure to 
0, 5 or 25 mg Aroclor 1254/kg 
on day 10-16 of gestation. An 
asterisk (*) indicates a significant 
difference from controls, 
PO.05. 
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from the 25 mg Aroclor 1254/kg dose group were 17% on PND4 and 11% on PND90 
(Figure 6.1 A and B). Total food consumption from 28 to 90 days of age was 
significantly lower in both male (6.2%) and female (8.3%) offspring from the high dose 
group than controls (Figure 6.2). Effects on female body weight gain (data not shown) 
in the 25 mg Aroclor 1254 dose group were similar to those in male offspring. 
Relative liver weights were significantly increased by the high dose of Aroclor 
1254 on PND21 in both male and female offspring (29% and 30% respectively), but not 
8on PND90 (Table 6.1). Relative thymus weight was slightly reduced in male and 
female neonates on PND21 in the high dose group (14% and 9.8%, respectively) but no 
effect of maternal treatment with Aroclor 1254 was observed on relative thymus weight 
90 days after birth in the offspring (Table 6.1). Relative liver weights were unaffected 
on PND90 after maternal Aroclor 1254 exposure, however, absolute liver weights were 
significantly lower than controls in male and female adult offspring from the high dose 
group (data not shown) as a result of significantly lower body weight gain. 
Plasma and hepatic retinoids 
Control values of hepatic retinoids are given in Table 6.2. Hepatic retinol concen-
trations increase from 2.09 ng/g liver in the fetus to 4.85 ng/g (females) and 5.83 (ig/g 
(males) on day 21 after birth, with an additional 4 fold increase by day 90 after birth. 
The most dramatic increase of retinoids during development is seen in the hepatic retinyl 
esters. Concentrations of retinyl palmitate increase more than 10 fold from fetal values 
to 21 day old neonates, and then again more than 10 fold from day 21 to day 90 after 
birth. The hepatic concentration of retinyl stéarate shows a similar pattern of develop-
ment as retinyl palmitate. While concentrations of retinyl palmitate and retinyl stéarate 
are nearly identical for both sexes on day 21 postpartum, female control offspring 
exhibit significantly higher concentrations than their male littermates 90 days after birth. 
Retinyl palmitate concentrations were 66% higher and retinyl stéarate concentrations 
were 54% higher in female relative to male adult offspring. 
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Table 6.1 
Relative organ weights of male and female offspring following maternal exposure to 
Aroclor 1254 on day 10 to 16 of gestation. 
Dose 
mg Aroclor 
1254/kg 
0 
5 
25 
PND21 
Male 
4.11+0.05 
4.40+0.06 
5.30+0.10* 
PND90 
Liver (%body weight) 
Female Male 
4.14+0.04 3.94+0.10 
4.34+0.05 3.90+0.06 
5.39+0.11* 4.00+0.08 
Female 
3.36+0.06 
3.28±0.06 
3.37+0.05 
Male 
Thymus (%body weight) 
Female Male Female 
0 
5 
25 
0.50+0.02 
0.49+0.01 
0.43+0.01* 
0.51+0.02 
0.53+0.01 
0.46+0.02* 
0.16+0.01 
0.18+0.01 
0.17+0.01 
0.20+0.01 
0.20+0.01 
0.18+0.01 
Pregnant rats were treated with Aroclor 1254 on day 10-16 of gestation, An asterisk (*) indicates 
a significant difference from controls, P<0.05, N=8-10. PND21: postnatal day 21, PND90: 
postnatal day 90. 
Maternal hepatic retinol and retinyl stéarate concentrations were unaffected by 
Aroclor 1254 exposure (Figure 6.3 and 6.4). Maternal hepatic retinyl palmitate 
concentrations were significantly decreased by 20% on day 20 of gestation by exposure 
to 25 mg/kg Aroclor 1254 (Figure 6.5). When the results were adjusted for liver weight, 
no significant effects were observed in the maternal livers. Fetal hepatic retinol 
concentrations were decreased 24% and 15% relative to controls by maternal treatment 
with 5 and 25 mg Aroclor 1254 per kg, respectively, but this decrease was significant 
only in the low dose group (Figure 6.3). Fetal retinyl palmitate and stéarate 
concentrations were significantly decreased in the 25 mg Aroclor 1254/kg (Figure 6.4 
and 5). Also, total fetal hepatic stores of retinol, retinyl palmitate and retinyl stéarate 
were all significantly decreased relative to controls by about 30% in fetal livers from the 
25 mg/kg treatment group (Table 6.3). Fetal and maternal plasma retinol concentrations 
were significantly reduced relative to controls (38% and 35%, respectively) following 
exposure to 25 mg Aroclor 1254/kg (Table 6.4). 
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Table 6.2 
Control levels of hepatic retinoids from maternal rats and their fetal, neonatal and adult 
offspring. 
GD20 
Maternal 
Fetal 
PND21 
Male 
Female 
PND90 
Male 
Female 
retinol 
12.6+1.1 
2.1±0.2 
5.8+0.5 
4.9+0.6 
21.5+1.6 
18.5+1.4 
retinyl 
palmitate 
ug/g liver 
817+20 
7.36+0.8 
80.7+2.5 
75.7+5.0 
733+30 
1215+65* 
retinyl 
stéarate 
89.7+2.9 
1.1+0.1 
8.8+0.3 
8.2+0.7 
105+5 
162+9* 
N 
6 
6 
8 
10 
10 
10 
The values presented are the means + SEM. An asterisk (*) indicates a significant difference 
between male and female offspring, P<0.05. GD20: gestation day 20, PND21: postnatal day 21, 
PND90: postnatal day 90. 
Significant reductions of 35% in male and female neonatal (PND21) hepatic 
retinol concentrations (Figure 6.3) were observed in the high Aroclor dose group. 
However, although there is a trend for a decrease on PND 21, no significant reductions 
in total retinol stores per liver were observed (Table 6.3), probably as a consequence of 
increased liver size. Significant decreases in retinyl palmitate (Figure 6.5) and retinyl 
stéarate (Figure 6.4) concentrations (50% and 46%, respectively) as well as total stores 
(42% and 38%, respectively, Table 6.3) were observed in male neonates from the 
highest dose group. In female neonates only the total store of hepatic retinyl palmitate 
was significantly reduced by 38% relative to controls in the highest dose group (Table 
6.3), while both retinyl palmitate and retinyl stéarate concentrations were significantly 
reduced in the highest dose group (49% and 36%, respectively, Figure 6.4 and 6.5). A 
slight but significant reduction (23%) of plasma retinol relative to controls was observed 
in male neonatal offspring from the high exposure group, however the decrease in 
female neonates was not significant (Table 6.4). 
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Table 6.3 
Hepatic retinoid content in maternal rats and their fetal, neonatal and adult offspring following 
maternal Aroclor 1254 exposure. 
Dose 
Aroclor 
1254 mg/kg 
Maternal (GD20) 
0 
5 
25 
Fetal (GD20) 
0 
5 
25 
Male (PND21) 
0 
5 
25 
Female (PND21) 
0 
5 
25 
Male (PND90) 
0 
5 
25 
Female (PND90) 
0 
5 
25 
retinol 
p.g/liver 
135+12 
116+12 
136+6 
Hg/liver 
0.33+0.04 
0.28+0.02 
0.24+0.01* 
(xg/liver 
11.6+1.5 
11.0+2.4 
8.6+2.3 
jig/liver 
9.0+1.1 
8.7+0.6 
6.9+0.3 
Hg/liver 
298+27 
176+17* 
167+20* 
(j.g/liver 
131+7.5 
297+34.1* 
129+18.0 
retinyl 
palmitate 
mg/liver 
8.75+0.27 
7.99+0.37 
7.92+0.87 
Hg/liver 
2.28+0.32 
1.83+0.07 
1.62+0.08* 
|ig/liver 
161+13 
146+13 
93+9* 
(ig/liver 
141+14 
142+10 
88+9* 
mg/liver 
10.2+0.6 
9.7+0.5 
8.2+0.4* 
mg/liver 
8.69+0.30 
6.82+0.39* 
6.62+0.40* 
retinyl 
stéarate 
mg/liver 
0.96+0.05 
0.91+0.06 
1.00+0.07 
(xg/liver 
0.33+0.04 
0.28+0.02 
0.24+0.01* 
|xg/liver 
17.4+1.4 
16.5+1.2 
10.8+1.2* 
|xg/liver 
15.3+1.6 
18.4+1.4 
12.0+1.3 
mg/liver 
1.45+0.08 
1.31+0.06 
1.14+0.07* 
mg/liver 
1.16+1.6 
1.26+1.4 
1.18+1.3 
N 
5 
6 
6 
6 
6 
6 
8 
8 
8 
10 
8 
8 
10 
10 
10 
10 
10 
10 
Pregnant rats were treated with Aroclor 1254 on day 10-16 of gestation. The data presented are 
the means + SEM, an asterisk (*) indicates a significant difference from controls, PO.05. GD20: 
gestation day 20, PND21: postnatal day 21, PND90: postnatal day 90. 
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Figure 6.3 Hepatic retinol concentrations, expressed as percentage of control values, mean + 
SEM, from dams, their fetuses, male and female offspring (N=6-10), following maternal 
exposure to Aroclor 1254 on day 10-16 of gestation. An asterisk (*) indicates a significant 
difference from controls, P<0.05. GD20: gestation day 20, PND21: postnatal day 21, PND90: 
postnatal day 90. 
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Figure 6.4 Hepatic retinyl stéarate concentrations, expressed as percentage of control values, 
mean + SEM, from dams, their fetuses, male and female offspring (N=6-10), following maternal 
exposure to Aroclor 1254 on day 10-16 of gestation. An asterisk (*) indicates a significant 
difference from controls, P<0.05. GD20: gestation day 20, PND21: postnatal day 21, PND90: 
postnatal day 90. 
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Figure 6.5. Hepatic retinyl palmitate concentrations, expressed as percentage of control values, 
mean + SEM, from dams, their fetuses (N=6), male and female neonates (N=8-10), and adult 
offspring, (N=10), following maternal exposure to 0, 5 or 25 mg Aroclor 1254/kg on day 10-16 
of gstation. An asterisk (*) indicates a significant difference from controls, PO.05. GD20: 
gestation day 20, PND21: postnatal day 21, PND90: postnatal day 90. 
Effects from perinatal exposure to Aroclor 1254 on retinoid homeostasis in male 
and female offspring persisted into adulthood. In male offspring from the high dose 
group, the hepatic retinyl palmitate and retinyl stéarate concentrations were significantly 
lower than controls by 16% (Figure 6.4 and 6.5). Total male hepatic stores of retinyl 
palmitate and stéarate were significantly decraesed by 20% and 21%, respectively (Table 
6.3). The concentration of male hepatic retinol was significantly decreased (40% and 
35%, Figure 6.3) and the total amount of hepatic retinol was decreased (41% and 44%) 
relative to controls by maternal treatment with 5 and 25 mg Aroclor 1254/kg, 
respectively (Table 6.3). In adult females the concentration of retinyl palmitate, but not 
retinyl stéarate, were significantly decreased by 25 and 26% relative to controls in the 
low and high exposure group (Figure 6.4 and 6.5). Decreases in total hepatic stores of 
retinyl palmitate in adult female offspring were 22% and 24% in the 5 mg and 25 mg 
Aroclor 1254/kg treatment groups, respectively (Table 6.3). Suprisingly, hepatic retinol 
concentrations and total retinol were increased by 230% in the lowest exposure group 
relative to controls or the high exposure group (Figure 6.3). When new aliquots of adult 
female liver homogenates were extracted and analyzed by HPLC to confirm the data, 
nearly identical results were obtained (data not shown). 
97 
Maternal PCB exposure and retinoid homeostasis 
Table 6.4 
Plasma retinol concentrations in maternal rats and their fetal, neonatal and adult offspring 
following maternal Aroclor 1254 exposure. 
GD20 
Maternal 
Fetal 
PND21 
Male 
Female 
PND90 
Male 
Female 
Dose 
0 
233+19 
383+29 
193+6 
279+21 
297+26 
369+67 
(mg Aroclor 1254/kg) 
5 
ng retinol/ml plasma 
263+18 
332+34 
184+9 
289+13 
301+22 
339+43 
25 
151+25* 
237+10* 
148+10* 
236+16 
322+11 
247+15 
Pregnant rats were treated with Aroclor 1254 on day 10-16 of gestation. The data presented are 
the means + SEM, an asterisk (*) indicates a significant difference from controls, P<0.05. GD20: 
gestation day 20, N=6, PND21: postnatal day 21, N=8-10, PND90: postnatal day 90, N=10. 
Discussion 
This study demonstrates that pre- and postnatal exposure of rats to a mixture of 
polychlorinated biphenyls produces prenatal, postnatal and long-term alterations in 
hepatic retinoid status. Plasma retinol concentrations were decreased by maternal 
Aroclor 1254 exposure in fetal and neonatal offspring, but not in adult offspring. 
Alterations in hepatic retinoid levels were observed in the fetus, but the most prominent 
alterations were observed postnatally. The observed decreases in hepatic retinoid stores 
are not simply a result of decreased food intake, for decreases in hepatic retinoids were 
also observed in offspring from the 5 mg Aroclor 1254/kg dose group in which food 
intake and body weight gain were the same as in control animals. The low dose used (5 
mg Aroclor/kg) exerted no overt toxicity in the offspring, for the relative thymus and 
liver weights were unaffected in this treatment group. However, similar doses of Aroclor 
1254 (5 repeated doses of 8 mg/kg) administered postnatally have a negative effect on 
reproductive parameters in male (Sager et al. 1987) and female rats (Sager and Girard, 
1994). Lower doses of Aroclor 1254 administered to pregnant monkeys (0.1 and 0.4 
mg/(kg x day)) are fetotoxic (Truelove et al. 1982). 
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By examination of the individual retinoids in the livers of male or female rats, 
sex-related differences in control levels and the response to perinatal PCB exposure 
could be observed. For example, female hepatic retinol concentrations were increased to 
240% of controls, while male hepatic retinol concentrations decreased significantly 
relative to controls in the adult offspring exposed perinatally to 5 mg Aroclor 1254/kg. 
Sex related differences in plasma retinol concentrations have been reported in control 
rats, however, liver retinoid concentrations (measured as total retinol) did not differ 
between sexes (Pasatiempo et al. 1989). 
Despite the direct exposure of the dams to repeated doses of Aroclor 1254 during 
gestation, no effect was observed in total hepatic retinol or retinyl esters in the dams 4 
days after the last administration. The decreases in maternal hepatic retinyl palmitate 
concentrations were offset by increases in maternal liver weight. Decrease in maternal 
plasma retinol levels may also be responsible for the decreases observed in fetal plasma 
retinol concentrations by reduced transplacental transport of retinol. The reductions in 
fetal plasma retinol levels were accompanied by slight reductions in the hepatic storage 
of retinol, retinyl palmitate amd retinyl stéarate in the fetuses. Retinoid homeostasis is 
highly regulated in pregnant mice and rats to control the passage of retinol to the 
offspring (Moore, 1971), which may explain the difference in response to PCB exposure 
between the neonates in this study and the pregnant and fetal rats. The increased 
sensitivity of neonatal rats relative to the fetuses for decreases in hepatic retinoid stores 
following maternal Aroclor 1254 exposure could also be due to the limited placental 
transfer of PCBs in comparison to lactational exposure (Shain et al. 1985). 
In this experiment we observed a selective accumulation of hydroxylated PCB 
metabolites in maternal and fetal plasma (unpublished observations) which may explain 
the decreases in maternal and fetal plasma retinol concentrations. Decreases in plasma 
retinol concentrations have been shown to occur as a result of the binding of an 
hydroxylated metabolite of 3,3',4,4'-tetrachlorobiphenyl to transthyretin, the major 
thyroid hormone transport protein in the plasma of rats (Brouwer and Van den Berg, 
1986, Brouwer et al. 1988b). TTR normally forms a complex with retinol binding 
protein, however, the binding of 4-OH-3,3',4',5-tetrachlorobiphneyl to TTR disturbs the 
TTR-RBP binding, leading to decreased plasma levels of thyroid hormones, RBP and 
retinol (Brouwer et al. 1988b). 
Following maternal rat TCDD exposure significant decreases in maternal and 
neonatal hepatic retinoid concentrations have also been observed (Lans et al. 1990, 
Hâkansson et al. 1987), however, in the one report in which it was studied, decreases in 
hepatic retinoid concentrations were not accompanied by decreases in total hepatic 
retinoid content until after weaning (Hâkansson et al, 1987). The study was hampered 
by low group size which made finding a statistically significant effect difficult, and 
therefore it cannot be excluded that pre- and postnatal exposure to TCDD will also 
result in early decreases in retinoid homeostasis. 
We know of no study in which the residual effects of pre- and postnatal PHAH 
exposure on retinoid status in adult offspring have been examined. A previous study in 
which Sprague-Dawley rats were contiuously exposed to diet containing 100 ppm of a 
polybromiated biphenyl mixture (Firemaster BP-6) from day 8 of gestation up to 16 
weeks after birth revealed significant decreases in total retinoids from 4 to 14 weeks 
after birth (McCormack et al. 1982). The concentration of individual retinoids was not 
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investigated. Since in that experiment dietary PBB exposure was continued after 
weaning resulting in significant liver enlargement up to 16 weeks postpartum, the 
decreases in total hepatic retinoid concentrations may actually reflect a dilution of the 
retinoids present and not altered storage of retinol and a reduction of the total amount of 
retinoids present. 
The mechanisms resulting in decreased hepatic retinoids following the activation 
of the Ah receptor by the binding of PCBs or TCDD have not been clearly elucidated, 
although enzymes involved in the storage and mobilization of retinol from the liver have 
been implicated (for a review see Zile, 1992). However, reductions in plasma retinol 
appear not to be related to Ah-receptor responsiveness, for TCB induces reductions in 
plasma retinol in both C57BL and DBA2 mice, and the DBA2 strain is the most 
sensitive (Brouwer and Van den Berg, 1984, Brouwer et al. 1985). Furthermore, when 
administered in equimolar doses, several PCBs which do not bind to the Ah-receptor, 
like 2,2',5,5'-tetrachlorobiphenyl, 3,3',5,5'-tetrachlorobiphenyl, 2,2',3,3',5,5'-hexachloro-
biphenyl reduce plasma retinol concentrations (Chen et al. 1992). TCDD administration 
generally results in the increase of plasma retinol in experimental animals (Zile, 1992). 
The analysis of storage and transport forms of vitamin A (retinyl esters and 
retinol) in the liver and plasma does not address the question whether gene transcription 
mediated by the retinoic acid receptor is actually affected by exposure to polyhalogena-
ted aromatic compounds. In the current study there would appear to be sufficient hepatic 
reserves of retinoids to maintain normal tissue concentrations of retinoic acid, one of the 
biologically active forms of the vitamin. However, extrahepatic tissue concentrations of 
retinol can also be altered by PCB or TCDD administration (Brouwer et al. 1988a, 
1989), and the in vitro glucuronidation of retinoic acid has also been shown to be 
induced following TCDD exposure in rats (Bank et al. 1989). It is possible that the most 
sensitive period for mammals for toxic effects related to altered vitamin A homeostasis 
is during development. Vitamin A (measured as total retinoids) accumulates in three 
phases during fetal development in the rat, the highest concentration per conceptus is 
reached between days 7-9 of gestation, while only late in gestation vitamin A is stored 
in the liver (Takahashi et al. 1977). An analysis of biologically active forms of specific 
embryonal/fetal tissue retinoids (all-trans-retinoic acid, oxo-retinoic acid metabolites) 
throughout gestation following PCB or PCDD exposure could reveal alterations in 
retinoid homeostasis with direct relevance for developmental toxicity. 
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LONG-TERM ALTERATIONS OF NEUROCHEMICAL MARKERS IN THE 
OFFSPRING OF RATS EXPOSED TO POLYCHLORINATED BIPHENYLS 
Abstract 
Pregnant Wistar WU rats were exposed to 0, 5 and 25 mg of the technical 
polychlorinated biphenyl (PCB) mixture Aroclor 1254 per kg body weight on day 10 to 
16 of gestation. Pregnant rats were sacrificed on gestation day 20 to observe effects on 
fetal body and brain weights. Male and female offspring were sacrificed on postnatal 
day 21 and 90 (PND21 and PND90) and examined for treatment related effects on 
neurochemical parameters. The concentrations of the neuronal and glial cell markers, 
synaptophysin and glial fibrillary acidic protein (GFAP), were measured in diverse brain 
regions from the offspring using immunochemical techniques. The level of calcineurin 
activity was measured in cerebellar homogenates. In addition, ethoxyresorufin-O-
deethylase activity was determined in hepatic microsomes as a measure of a well-
characterized response to PCB-exposure. 
The major alterations of GFAP levels following maternal PCB treatment were 
significant increases in the lateral olfactory tract (LOT) and the cerebellum (CB) and 
significant decreases in the brainstem (BS) of the offspring on PND21 and 90. 
Synaptophysin levels were significantly decreased relative to controls in the LOT, 
prefrontal cortex (PFC) and striatum (ST) of the offspring on PND90. In the BS, 
synaptophysin levels were significantly decreased relative to controls in male and female 
weanlings on PND21 and males on PND90, however significant increases were observed 
in the BS of females on PND90. No effect of maternal PCB treatment was observed on 
levels of GFAP and synaptophysin in the dorsal hippocampus on PND21 and 90. 
Calcineurin activity was decreased in the female CB on PND21, but a significant 
increase in activity was observed in the female CB on PND90. No effect of maternal 
PCB treatment was observed on the cerebellar calcineurin activity in male offspring on 
PND21 and 90. EROD activity was highly induced in maternal microsomes from both 
PCB treatment groups, but only slightly induced in fetal hepatic microsomes. On PND21 
weanling hepatic microsomal EROD activity was highly induced following gestational 
and lactational PCB exposure, however on PND90 EROD activity was unaffected by 
maternal PCB treatment in male offspring and significantly decreased in female 
offspring. 
The results of the present study indicate that gestational and lactational exposure 
to the technical PCB mixture results in long term alterations in a neuronal and glial cell 
markers in specific brain regions of rats. These marker proteins may be useful for 
determining the strucure-activity relationships in PCB-induced developmental 
neurotoxicity. 
Dennis C. Morse, Annemieke Plug, Wendelien Wesseling, Kor J. van den Berg, 
Abraham Brouwer. 
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Introduction 
The pre- and postnatal exposure of laboratory animals to polychlorinated 
biphenyls (PCBs) results in developmental behavioral neurotoxicity, and is one of the 
most sensitive functional responses to PCB (Tilson et al. 1990, review). In Taiwan, 
human exposure to rice oil containing PCBs and polychlorinated dibenzofurans 
(PCDFs), with subsequent transplacental exposure of the offspring, resulted in neurode-
velopmental effects that have persisted up to 12 years after birth (Chen and Hsu, 1994). 
Studies on the effects of background exposure to PCBs in the United States (Rogan et 
al. 1986, Gladen et al. 1988, Jacobson et al. 1985, Jacobson and Jacobson, 1993) have 
demonstrated associations with the level of exposure and delays in neurological and 
cognitive development in human infants. 
The mechanisms and structure-activity relationships involved in the developmen-
tal neurotoxicity of PCBs and PCDFs are unknown, but may be distinct from the Aryl 
hydrocarbon (Ah) receptor mediated toxic effects in adult animals. The Ah-receptor 
mediates almost all of the toxic effects of the coplanar PCBs, PCDDs and PCDFs 
(Poland and Knutson, 1982), but there is evidence that the Ah receptor may not be 
involved in some aspects of neurotoxicity in adult animals (Seegal et al. 1992). 
Several hypotheses have been forwarded to explain the developmental 
neurotoxicity of these compounds, for example that pre- and postnatal alterations in 
brain thyroid function may affect neuromuscular development (Rogan et al., 1986, 
Morse et al. 1993) and the interaction of di-ortho substituted PCBs with the enzyme 
tyrosine hydroxylase, resulting in decreases in dopamine levels in vitro and in vivo in 
adult animals. (Seegal et al. 1992). 
In order to test these hypotheses it is helpful to identify specific markers for 
different brain cell populations which are sensitive to gestational and lactational PCB 
exposure. Recent advances in the use of specific marker proteins in neurotoxicology 
(O'Callaghan and Jensen, 1992, Goldey et al. 1994, Gramsbergen and van den Berg, in 
press) and developmental neurobiology (Rami and Rabié, 1990, Leclerc et al. 1989), can 
be applied to investigation of cellular and biochemical responses in developmental 
neurotoxicology. The regional brain levels of glial fibrillary acidic protein (GFAP) and 
synaptophysin can be used to follow the normal ontogeny of astrocytes and 
synaptogenesis as well as the influence of hormonal imbalances like hypothyroidism or a 
developmental neurotoxin (triethyltin) on brain development (Rami and Rabié, 1990, 
O'Callaghan and Miller, 1988). 
To gain insight in the cellular and biochemical processes of PCB-induced 
developmental neurotoxicity we investigated the effect of transplacental and lactational 
exposure of the rat to the technical PCB mixture Aroclor 1254 on the development of 
GFAP and synaptophysin levels in homogenates of discrete brain regions. A marker for 
the effects of prenatal hypothyroidism in the cerebellum, calmodulin-dependent 
phosphatase activity (Ruiz de Elvira et al., 1989) was also studied. A well characterized 
response of laboratory animals to PCB exposure, the induction of hepatic microsomal 
ethoxyresorufin-O-deethylase activity (Safe, 1994) was measured for comparison with 
the neurochemical effects. 
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Material and Methods 
Materials 
Aroclor 1254 was kindly donated by Dr. Martin van den Berg, RITOX, Utrecht, 
the Netherlands. Bovine serum albumin (Fraction V) was purchased from Sigma 
Chemical Co., St. Louis, U.S.A. The following chemicals were purchased from Merck, 
Darmstadt, Germany: isopropanol, diethylether, sodium acetate, sodium bicarbonate, 
sodium carbonate, sodium chloride, sodium hydroxide, Tris, Tween 20 and glycine. 
Bovine glial fibrillary acidic protein (GFAP, 981150), monoclonal anti-GFAP (814369), 
NADPH and p-nitrophenylphosphate were purchased from Boehringer, Mannheim, 
Germany. Alkaline phosphate conjugate (315-055-003) was purhased from Jackson 
Immunoresearch. Polyclonal anti-GFAP (Z334), monoclonal mouse anti-synaptophysin 
(M776), rabbit anti-mouse (Z259) was purchased from Dako, Denmark. [125I]-protein A 
and Hybond nitro-cellulose were purchased from Amersham, Amersham U.K. 
The BCA protein assay reagent was obtained from Pierce. The Bio-Rad protein 
assay reagent, SDS and 2-mercaptoethanol were purchased from Bio-Rad Laboratories, 
München, Germany. Calmodulin from bovine brain, methylumbilleferyl phosphate and 
methylumbilleferone were purchased from Fluka Chemie, Buchs, Switzerland. 
Animals 
Wistar WU rats, 100 females and 50 males, (14 weeks old) were purchased from 
Charles River Sutzfeld, Germany. The rats were allowed to acclimatize for 2 weeks and 
were maintained at 50 % humidity and 21 °C on bedding in macrolon cages with a 12 
hour light cycle. Rat chow (Hope Farms, Woerden, the Netherlands) and tap water were 
supplied ad libitum. After the acclimatization period two females were placed in a cage 
with one male overnight from 17:00 to 9:00 the next day. The females were examined 
each morning by vaginal smear. When spermatazoa were found the animal was housed 
separately and this was termed day 0 of gestation. Animals were pre-assigned to a 
particular dose group on a rotating basis. Maternal body weight gain was monitored 
throughout gestation and lactation. On day 10 of gestation the pregnant female rats were 
transferred to a macrolon cage with a grated steel support to facilitate the collection of 
PCB-contaminated feces and to prevent contamination of the animal facilities. 
Pregnant females received a daily dose by gavage of 0, 5 or 25 mg Aroclor 1254 
per kg body weight dissolved in cornoil (2 ml/kg body weight) from day 10 of gestation 
to day 16 of gestation. Rats were weighed each day before administration of Aroclor 1254 
or corn oil alone. Pregnant rats were transferred to bedding material on gestation day 20 
(GD20) and were given paper tissues to make a nest. The rats were inspected each 
morning at 8:00 h and afternoon at 18:00 h for litters. Pups found during the morning 
inspection were termed 1 day old, pups born between the morning and afternoon 
inspection were termed 0 day old. Pups were examined for sex, weighed on day 0 
postpartum when possible, and always on day 1, 4 and 7 postpartum and thereafter on a 
weekly basis. On postnatal day 4 (PND4) litters were reduced to 4 males and 4 females. 
When this was not possible, litters were made up of a total of 8 males and females from 
the same dam, and if necessary, an extra pup from another litter from the same treatment 
group and same age was used to acheive a total of 8 pups per litter. Pups were 
individually marked by incision in the ear, and pups transferred from one litter to another 
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were never used for any analysis. 
On GD20, 6 pregnant females per treatment group were sacrificed by 
exsanguination under ether anethesia. The fetuses were removed, blotted dry and 
weighed. The fetal brains were removed, separated into the forebrain and cerebellum and 
weighed. Fetal livers and maternal livers were removed and frozen on a block of dry ice, 
then stored at -80°C until microsomes were prepared. On postnatal day (PND21), 8-10 
litters were sacrificed per treatment group. Dams and weanlings were sacrificed by 
decapitation, and livers were removed, weighed, snap-frozen in liquid nitrogen and stored 
at -80 °C. Weanling livers were pooled per sex for analysis. Brains were rapidly removed 
and dissected on an ice-cold plate in lateral olfactory tract, prefrontal cortex, striatum, 
hypothalamus, dorsal hippocampus, cerebellum and brainstem. The brain regions were 
immediately frozen on a block of dry-ice, weighed and stored at -80°C. Weanlings from 
the remaining litters were weaned on PND21 and male and female rats were housed 
separately in groups of 2-4 rats per cage. The remaining animals (10 litters per treatment 
group) were sacrificed 90 days (PND90) after birth and livers and brain regions were 
removed, weighed and stored as described above. 
Ethoxyresorufin-O-deethylase (EROD) activity 
Hepatic microsomes were prepared as previously described (Morse et al. 1993). 
EROD activity was measured with hepatic microsomes essentially according to Burke et 
al. (1977). adapted for use as with 96 well plates and a fluorospectrophotometric plate 
reader (CytoFluor 2350, Millipore). The reaction conditions (in a total volume of 200 /il) 
were 0.1 Tris-HCl buffer, pH 7.8, 1 mg BSA/ml, 0.1 mM NADPH, 0.4 /*M 
ethoxyresorufin (ER), microsomal protein concentrations were varied between 100 /tg/ml 
for controls and 1 /tg/ml for weanlings from the 25 mg Aroclor 1254/kg treatment group. 
The reaction mixtures were preincubated at 37°C for 2 minutes, the reaction was started 
by the addition of ER, and incubations were stopped after 5 minutes at 37 °C by the 
addition of 50 /xl 1 N NaOH. The formation of the product resorufin was detected 
fluorimetrically and compared to a calibration curve (0-150 nM resorufin) made up in in 
the Tris-HCl buffer with 0.8 mg BSA/ml and 0.8 N NaOH. Incubations were carried out 
in duplicate and corrected for a blank without NADPH. Hepatic microsomal protein 
concentrations were determined according to Bradford (1976). 
Calmodulin-dependent phosphatase activity 
Calmodulin-dependent phosphatase activity was determined fluorimetrically in 
cerebellar supernatants using methylumbilleferone phosphate as a substrate according to 
Ruiz de Elvira et al. (1988). Cerebella were homogenized in a Potter tube with 10 
volumes (v/w) ice-cold Tris-HCl buffer, pH 7.0, 0.2 mg BSA/ml, 0.01% (v/v) 
mercaptoethanol and 2 mM EDTA. The homogenate was centrifuged at 1500g and 4°C 
for 30 min. The supernatant was removed and stored at -80°C until analysis. Final 
incubation conditions (in 400 pi) were 10 ng supernatant protein/ml, 12.5 mM Tris-HCl 
buffer, pH 7.0 and 15 juM methylumbelliferyl phosphate as substrate for basal 
phosphatase activity, while 60 nM calmodulin (previously saturated with Ca2+) was added 
to detect the sum of calmodulin-dependent and basal phosphatase activity. The reaction 
mixtures were preincubated at 24°C for 2 minutes, the reaction was started by the 
addition of the substrate, and after 5 min at 24°C, the reaction was terminated by the 
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addition of 2 ml ice-cold 0.2 M NaOH-glycine buffer, pH 10.4. The production of the 
dephosphorylated product, methylumbelliferone, was detected fluorimetrically with an 
excitation wavelength of 361 nm and an emmision wavelength of 444 nm and compared 
to a calibration curve produced by incubating 0-1 ßM methylumbelliferone with 10 mg 
BS A/ml and 12.5 mM Tris-HCl buffer, pH 7.0 as above and terminating the incubation 
after 5 minutes in the same manner. The difference between the total activity with 
calmodulin and the basal phosphatase activity represents the calmodulin-dependent 
phosphatase activity. Incubations were carried out in duplicate. Protein concentrations 
were determined according to Bradford (1976). 
Glial fibrillary acidic protein (GFAP) 
GFAP concentrations were determined in several brain regions (lateral olfactory 
tract: LOT, prefrontal cortex: PFC, striatum: ST, hypothalamus: HT, dorsal 
hippocampus: HC, cerebellum: CB, brainstem: BS) in duplicate using a sandwich ELISA 
method adapted from O'Callaghan (1991) and described in detail by Van den Berg and 
Gramsbergen (1993). Tissue samples were homogenized in 10 volumes (w/v) of a hot 
(90°C) 1% (w/v) SDS solution with a sonicator and stored at -20°C until analysis. The 
samples were diluted before analysis with phosphate buffered saline containing 0.02% v/v 
Tween-20. The dilutions used for the brain regions were: cerebellum, 793 fold; striatum, 
143 fold; brainstem, 533 fold; hypothalamus, 143 fold for PND21 and 861 fold for 
PND90; lateral olfactory tract, 506 fold; prefrontal cortex, 231 fold. The calibration 
curve ranged from 4 to 250 ng GFAP/ml. Protein concentrations were determined with 
the bicinchoninic acid method from Pierce. 
Synaptophysin 
Synaptophysin levels in brain regions (LOT, PFC, ST, HT, CB, BS) were 
determined in triplicate using a modification of the dot-blot method described by Brock 
and O'Callagan 1987). All steps were carried out at room temperature unless otherwise 
stated. The same tissue homogenates described above (except the dorsal hippocampus) 
were diluted to a protein concentration of 50 /xg/ml in PBS and 20 fa of the diluted 
homogenate was absorbed to Hybond nitrocellulose in a Dot Blot apparatus (Biorad, 
Richmond CA). Samples from all treatment groups from one sex, one brain region and 
one timepoint were incubated per filter. The proteins were fixed to the filter by incubation 
with a 2.5% glutaraldehyde (w/v) solution in 0.2 M Na-acetate solution for 15 minutes. 
The filter was washed 5 times with demineralized water and then once with PBS (5 min). 
The remaining sites on the filter were blocked by an incubation of 1 h (37 °C) with PBS 
containing 2.5% w/v BS A. The filter was then incubated with monoclonal mouse anti-
synaptophysin, (diluted 1:200 with PBS) with 0.1% (v/v) Tween-20 and 1% (w/v) BSA. 
The filter was then washed 3 times with PBS (5 min). Subsequently, the filter was 
incubated with the second antibody, rabbit-anti-mouse, (diluted 1:100 with PBS) with 
0.1% (v/v) Tween-20 and 1% (w/v) BSA for 30 min at 37°C. The filter was then washed 
3 times with PBS (5 min). The incubation with 125I-protein A (8 /*Ci/8 ml PBS with 0.1% 
v/v Tween-20) was carried out at room temperature for an hour. The filter was washed 3 
times 5 minutes and 2 times 15 minutes with PBS, then dried at 40°C. The radioactivity 
on the filter was quantified directly with a Matrix 96 counter (Packard) and corrected for 
background counts. The fixation of the proteins, subsequent washing and blokking of the 
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filter was carried out in a plastic box with 50 ml of the respective solutions. The 
incubations with antibodies and subsequent wash steps were carried out in a slowly 
rotating 500 ml plastic bottle with an 8 ml volume of the respective solutions. As purified 
synaptophysin was unavailable for a standard, the results obtained are expressed as 
percentage of control values based on the cpm 125I-protein A/pig protein. 
Statistical analysis 
Treatment-related effects were first evaluated with a one-way analysis of variance 
followed by a least significant difference test to find significant differences between the 
treatment groups. Data are presented as the mean+SEM. 
Results 
Reproduction, body weight, relative and absolute brain weight 
Reproductive parameters, including maternal body weight gain before and after 
birth, fetal body weight, number of live fetuses, late gestational death, number of 
resorptions, number of live pups born, male to female ratio and postnatal death were not 
affected by maternal PCB exposure (data not shown). 
Male and female fetal body weights, absolute and relative liver, forebrain and 
cerebellum weights were unaltered by in utero exposure to Aroclor 1254 on gestation day 
20 (GD20, data not shown). Maternal exposure to the lower dose (5 mg/kg) of Aroclor 
1254 on day 10 to 16 of gestation did not result in significant effects on body weights, 
absolute or relative forebrain and cerebellum weights of male and female offspring 21 and 
90 days after birth (Table 7.1). On PND21 slight but significant reductions in male 
weanling forebrain and cerebellum weights (4.6 and 5.8% respectively) were observed in 
offspring from dams exposed to 25 mg Aroclor 1254/kg bw. Relative forebrain and 
cerebellum weights were unaffected by maternal PCB exposure on PND21 in both male 
and female offspring. 
On PND90 male and female body weights were significantly reduced by 7.1% 
and 8.7% respectively (PO.01) following maternal exposure to 25 mg Aroclor 1254/kg 
bw. Absolute forebrain weight was significantly reduced in male offspring from the high 
dose group (6.4%, PO.0001), reductions in forebrain weights from female offspring 
from the high dose group were lower (2.5%) and did not attain statistical signifigance. 
Relative forebrain weight were significantly increased (8.6%, PO.05) in females from 
the high dose group on PND90. Both absolute and relative cerebellum weight was 
unaffected by maternal PCB exposure on PND90 in both male and female offspring. 
EROD activity 
The effect of maternal PCB exposure on EROD activity of hepatic microsomes 
from maternal rats and their fetal, weanling and adult offspring is presented in Table 
7.2. Maternal hepatic microsomal EROD activity was induced 20 fold by the lowest 
PCB dose and more than 200 fold by the highest PCB dose relative to controls on 
GD20. Fetal (GD20) EROD activity was barely detectable in microsomes from the 
control and low dose group (0.2 pmol/(mg protein x min), but was induced 5 fold in the 
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Table 7.1 
Body weight, absolute and relative brain weight in the offspring of PCB exposed dams 
Dose mg Aroclor 1254/kg body weight 
0 5 25 
male offspring 
body wt (g) 
forebrain wt (g) 
cerebellum wt (g) 
rel. FB wt (%) 
rel. CB wt(%) 
female offspring 
body wt (g) 
forebrain wt (g) 
cerebellum wt (g) 
rel. FB wt (%) 
rel. CB wt (%) 
47.8+1.56 
0.952+0.010 
0.172+0.002 
1.997+0.076 
0.364+0.001 
46.27+1.753 
0.915±0.014 
0.167+0.003 
2.033+0.096 
0.367+0.002 
PND21 
48.5±1.5 
0.948+0.014 
0.173+0.003 
1.981±0.060 
0.359+0.001 
47.13+1.233 
0.910+0.009 
0.163±0.003 
1.911+0.070 
0.350+0.001 
45.2±1.3 
0.908+0.001** 
0.162+0.004* 
2.053+0.066 
0.368+0.001 
43.46+1.286 
0.884+0.010 
0.152+0.003 
2.042+0.065 
0.368+0.006 
male offspring 
body wt (g) 
forebrain wt (g) 
cerebellum wt (g) 
rel. FB wt (g) 
rel. CB wt (g) 
female offspring 
body wt (g) 
forebrain wt (g) 
cerebellum wt (g) 
rel. FB wt (%) 
rel. CB wt (%) 
352.4+5.0 
1.323±0.011 
0.273+0.004 
0.382+0.005 
0.077+0.001 
214.9+3.4 
1.217+0.012 
0.248+0.005 
0.568+0.009 
0.116+0.003 
PND90 
353.6+9.3 
1.304+0.013 
0.264+0.006 
0.373+0.013 
0.075+0.002 
213.3±6.0 
1.201±0.025 
0.247+0.006 
0.581±0.012 
0.118+0.004 
327.5+3.8** 
1.238+0.013**** 
0.260±0.007 
0.395+0.006 
0.080+0.002 
196.2+3.5** 
1.186+0.016 
0.238+0.005 
0.617+0.015* 
0.118+0.003 
FB: forebrain, CB: cerebellum, * PO.05, ** PO.01, *** P<0.001, **** PO.0001, 
N=8-10 on postaatal day 21 (PND21) and N=10 on postnatal day 90 (PND90). Pregnant 
rats were treated with 0, 5 or 25 mg Aroclor 1254/kg body weight on day 10 to 16 of 
gestation. 
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Table 7.2 
EROD activity in hepatic microsomes from dams, fetuses, weanling and adult offspring 
following exposure of pregnant rats to PCBs. 
Dose mg Aroclor 1254/kg body weight 
0 5 25 
GD20 
fetal" 
maternalb 
0.20+0.04 
0.051+0.004 
0.17+0.03 
1.04+0.19 
1.03+0.19*** 
11.1+0.8**** 
PND21 
maleb 
femaleb 
0.068+0.011 
0.063+0.011 
3.33+0.18** 
3 41+0 33**** 
11.60+0.18**** 
9.30+0.34**** 
PND90 
maleb 
femaleb 
0.019±0.002 
0.047+0.004 
0.019+0.001 
0.021+0.003**** 
0.023+0.001 
0.036+0.003* 
a) pmol RR/(min x mg protein), b) nmol RR/(min x mg protein), * PO.05, ** P<0.01, 
*** PO.001, **** P<0.0001, N=6 on gestation day 20 (GD20), N=8-10 on postnatal 
day 21 (PND21) and N=10 on postnatal day 90 (PND90). Pregnant rats were treated 
with 0, 5 or 25 mg Aroclor 1254/kg body weight on day 10 to 16 of gestation. 
high dose group (1.0 +0.2 pmol resorufin/mg x min). The induction of EROD activity in 
male and female weanling (PND21) hepatic microsomes was nearly identical, an 
induction of 50 fold and 150 fold was observed in the low and high dose groups, 
respectively. Maternal PCB exposure had no effect on hepatic EROD activity in adult 
male offspring (PND90), although in adult female offspring hepatic EROD activity was 
decreased by 55% (PO.0001) and 23% (P<0.05) by the low and high PCB dose, 
respectively. 
Calmodulin-dependent phosphatse activity 
Effects on the level of calmodulin-dependent phosphatase activity were observed 
only in the cerebella of the female offspring (Figure 7.1). On PND21 a significant 
decrease in cerebellar calmodulin-dependent phosphatase activity was observed of 38% 
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Figure 7.1 Calmodulin-
dependent phosphatase activity 
(nmol methylumbelliferone (MU) 
formed/(min x mg protein) in 
cerebellar supernatants from 
weanling and adult offspring 
from pregnant rats treated with 0, 
5 or 25 mg Aroclor 1254/kg 
body weight on day 10 to 16 of 
gestation. ** PO.01, *** 
PO.001, N=8-10 on postnatal 
day 21 and N=10 on postnatal 
day 90. 
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(PO.001) and 24% (PO.01) in female weanlings from the low and high dose group, 
while in adult female offspring (PND90) calmodulin-dependent phosphatase activity 
increased 31% (PO.05) and 54% (PO.001) in the low and high dose group. 
Glial Fibrillary Acidic Protein (GFAP) 
The effects of maternal PCB exposure on the levels of GFAP (|ag GFAP/mg total 
protein in the SDS brain homogenates) in brain regions from weanling and young adult 
offspring are presented in Table 7.3. For illustrative purposes, the major effects of 
maternal PCB exposure on regional GFAP levels (lateral olfactory tract, cerebellum and 
brainstem) of weanling and adult offspring are presented in Figure 7.2a-c as percentage 
of control values. No treatment-related effects were observed in GFAP levels in the 
hypothalamus and dorsal hippocampus. 
Lateral olfactory tract (LOT) 
On PND21 the most consistent effects on GFAP levels were observed in the 
LOT, for maternal PCB exposure resulted in significant increases in GFAP 
concentrations of 22% (PO.01) and 42% (PO.001) in the LOT from female weanlings 
from the low and high PCB dose group, respectively. In male weanlings a significant 
increase (35%, PO.05) in GFAP concentrations in the LOT were observed in the low 
PCB group, while a slight and statistically non-significant increase (18%) was observed 
in GFAP levels in the LOT from male weanlings from the high dose group. On PND90 
increases in GFAP levels relative to controls in the LOT from male offspring were 
highly significant in both the low (34%, PO.001) and high (32%, PO.001) PCB 
treatment groups. In female offspring on PND90 GFAP levels in the LOT were 
increased significantly increased relative to controls (63%, PO.001) only in the high 
PCB dose group. 
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Cerebellum (CB) 
On PND21 a significant increase in GFAP concentrations (35% relative to 
controls, PO.001) in the CB were observed only in female weanlings from the high 
dose group. However, on PND90 levels of GFAP were significantly elevated relative to 
controls in female offspring from both the low (29%, P<0.0001) and high exposure 
group (35%o, PO.0001) and in young adult males from the high dose group (33%), 
PO.001). 
Brainstem (BS) 
In contrast to the LOT and CB, decreases were observed in GFAP concentrations 
in the BS of offspring from PCB-exposed dams. The only significant decrease observed 
on PND21 in GFAP concentrations in the BS was in females from the low dose group 
(23% relative to controls, PO.05). On PND90 significant decreases in BS GFAP 
concentrations were observed in male and female offspring from the low dose group 
(42% and 31%, respectively) and from the high dose group (39% and 29%), 
respectively). While BS GFAP levels increased 56% and 22% in male and female 
control offspring between PND21 and 90, no increases in BS GFAP concentrations were 
observed in the PCB-exposed offspring over the same period (Table 7.3). 
Prefrontal cortex (PFC) and striatum (ST) 
Less consistent alterations in GFAP levels were observed in the PFC and ST in 
the offspring following maternal PCB exposure. GFAP concentrations were elevated in 
the PFC in male and female weanlings, but these increases were not statistically 
significant. On PND90 GFAP levels were significantly increased in the PFC of male 
weanlings from the low dose group (31%, P<0.01) and of female weanlings from the 
high dose group (46%, PO.05). 
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Figure 7.2a. Relative levels of 
glial fibrillary acidic protein 
(GFAP, % of controls) in the 
lateral olfactory tract of weanling 
and adult offspring from 
pregnant rats treated with 0, 5 or 
25 mg Aroclor 1254/kg body 
weight on day 10 to 16 of 
gestation. * PO.05, ** PO.01, 
*** PO.001 , N=8-10 on 
postnatal day 21 and N=10 on 
postnatal day 90. 
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Significant increases in ST GFAP levels were observed in male, but not female 
weanlings from both the low and high PCB treatment groups (50%, PO.05 and 74%, 
PO.01 , respectively). On PND90 reductions in ST GFAP levels were observed in both 
male and female offspring from the high dose group (19% and 28%, P<0.05, 
respectively). 
Figure 7.2b Relative levels of 
glial fibrillary acidic protein 
(GFAP, % of controls) the 
cerebellum of weanling and adult 
offspring from pregnant rats 
treated with 0, 5 or 25 mg 
Aroclor 1254/kg body weight on 
day 10 to 16 of gestation. *** 
PO.001, **** P<0.0001, N=8-
10 on postnatal day 21 and N=10 
on postnatal day 90. 
Figure 7.2c Relative levels of 
glial fibrillary acidic protein 
(GFAP, % of controls) in the 
brainstem of weanling and adult 
offspring from pregnant rats 
treated with 0, 5 or 25 mg 
Aroclor 1254/kg body weight on 
day 10 to 16 of gestation. * 
PO.05, ** P<0.01, *** P<0.001, 
**** P<0.0001, N=8-10 on 
postnatal day 21 and N=10 on 
postnatal day 90. 
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Table 7.3 
Regional brain GFAP levels (u-g/mg protein) in weanling and adult offspring following 
exposure of pregnant rats to PCBs. 
Dose mg Aroclor 1254/kg body weight 
0 5 25 
PND21, Males 
LOT 
PFC 
STR 
HC 
HTH 
CB 
BS 
PND90, Males 
LOT 
PFC 
STR 
HC 
HTH 
CB 
BS 
PND21, Females 
LOT 
PFC 
STR 
HC 
HTH 
CB 
BS 
PND90, Females 
LOT 
PFC 
STR 
HC 
HTH 
CB 
BS 
1.31+0.08 
0.97+0.06 
0.34+0.03 
1.83+0.23 
0.74+0.05 
1.00+0.04 
2.01+0.08 
2.06+0.13 
1.41+0.09 
0.69+0.03 
1.59+0.18 
3.30+0.37 
3.24+0.11 
3.14+0.29 
1.16+0.04 
0.76±0.07 
0.52+0.04 
1.28+0.08 
0.59+0.06 
0.76+0.05 
2.23+0.19 
1.44+0.10 
0.82+0.06 
0.76+0.07 
1.18+0.06 
3.29+0.45 
4.78+0.30 
2.72+0.22 
1.77+0.15* 
1.19+0.08 
0.51+0.07* 
1.69+0.29 
0.77+0.03 
1.09+0.06 
1.95+0.09 
2.77+0.15*** 
1.85+0.10** 
0.65+0.04 
1.54+0.13 
4.15+0.29 
3.58+0.16 
1.83+0.07**** 
1.41+0.09** 
0.77+0.08 
0.56+0.07 
1.39+0.11 
0.64+0.05 
0.79+0.07 
1.71+0.10* 
1.76+0.09 
1.09+0.11 
0.71+0.04 
1.24+0.17 
3.21+0.46 
6.18+0.15**** 
1.89+0.11** 
1.55±0.08 
1.15+0.11 
0.59+0.09** 
1.72+0.31 
0.71+0.04 
1.11+0.13 
1.80+0.10 
2.71+0.07*** 
1.65+0.06 
0.56+0.03* 
1.60+0.16 
3.71+0.42 
4.31+0.25*** 
1.93+0.09*** 
1.65+0.10*** 
0.94+0.07 
0.50+0.06 
1.39+0.13 
0.75+0.05 
1.02+0.06*** 
1.87+0.17 
2.34+0.21*** 
1.20+0.15* 
0.55+0.04* 
1.47+0.18 
3.14+0.52 
6.45+0.16**** 
1.93+0.13** 
LOT: lateral olfactory tract, PFC: prefrontal cortex, ST: striatum, HTH, hypothalamus, HC: 
dorsal hippocampus, CB: cerebellum, BS: brainstem, * PO.05, ** P<0.01, *** P<0.001, **** 
P<0.0001, N=8-10 on postnatal day 21 and N=10 on postnatal day 90. Pregnant rats were treated 
with 0, 5 or 25 mg Aroclor 1254/kg body weight on day 10 to 16 of gestation. 
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Synaptophysin. 
Relative concentrations of synaptophysin in the LOT, PFC and BS of offspring 
on PND21 and 90 after maternal PCB exposure are shown in Figure 7.3a-c, while data 
from the female ST and hypothalamus (HTH) are shown in Table 7.4. 
Lateral olfactory tract 
In the LOT synaptophysin concentrations were decreased by 26% (PO.001) and 
18% (0.001) in male and female weanlings (PND21) from the high PCB dose group 
(Figure 7.3a). ON PND90 reductions were still observed in synaptophysin concentrations 
in the LOT from female offspring from the high dose group (27% relative to controls, 
P<0.001), but a slight, but significant increase was observed in LOT synaptophysin 
concentrations (15%, PO.05) in male offspring. 
Prefrontal Cortex 
On PND90 synaptophysin levels in the PFC (Figure 7.3b) were significantly 
decreased by 17% (PO.0001) and 31% (PO.0001) in male offspring from the low and 
high PCB dose group respectively, while in female offspring from PND90 significant 
decreases in PFC synaptophysin concentrations were observed only in the high PCB 
dose group (14%, PO.001). No effects of maternal PCB exposure were observed on 
synaptophysin concentrations in the PFC on PND21 in either male or female weanlings. 
Brainstem 
In the BS synaptophysin concentrations (Figure 7.3c) were significantly 
decreased on PND21 in male weanlings from the high dose group (38%, PO.0001) and 
in female weanlings from both the low (29%, PO.01) and high dose groups (18%, 
PO.01). 
Figure 7.3a Relative levels of 
synaptophysin (% of controls) in 
the lateral olfactory tract of 
weanling and adult offspring 
from pregnant rats treated with 0, 
5 or 25 mg Aroclor 1254/kg 
body weight on day 10 to 16 of 
gestation. * PO.05, ** PO.01, 
*** PO.001, N=8-10 on 
postnatal day 21 and N=10 on 
postnatal day 90. 
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On PND90 synaptophysin levels were lower relative to controls in the BS of male 
weanlings from both the low and high PCB dose groups (20%, PO.05 and 31%, 
P<0.01, respectively). In contrast to the male offspring, on PND90 synaptophysin levels 
in the BS of female offspring were significantly increased by 47% (PO.05) and 109% 
(PO.0001) relative to controls in the low and high PCB dose group, respectively. 
Other brain regions 
Effects on striatal syanaptophysin levels were observed in female offspring from 
the high PCB dose group, with reductions of 24% (PO.05) in the high dose group on 
PND21 and reductions of 23% (PO.05) and 26% (PO.01) on PND90 in the low and 
high PCB dose group, respectively. Also in the hypothalamus reductions in 
synaptophysin concentrations were observed in the female offspring, with a 27% 
(PO.01) and 35% (PO.001) decrease relative to controls on PND21 in the low and 
high PCB dose group, respectively, and a 29% (PO.05) decrease in the low PCB dose 
group on PND90. Relative levels of synaptophysin in the male ST and HTH were 
unaffected by maternal PCB exposure on PND21 and 90 (data not shown). Cerebellar 
concentrations of synaptophysin were unaltered following maternal PCB exposure in 
both male and female offspring on PND21 and 90 (data not shown). 
Figure 7.3b Relative levels of 
synaptophysin (% of controls) 
in the prefrontal cortex of 
weanling and adult offspring 
from pregnant rats treated 
with 0, 5 or 25 mg Aroclor 
1254/kg body weight on day 
10 to 16 of gestation. * 
PO.05, **** PO.0001, N=8-
10 on postnatal day 21 and 
N=10 on postnatal day 90. 
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Figure 7.3c Relative levels of 
synaptophysin (% of controls) 
in brainstem of weanling and 
adult offspring from pregnant 
rats treated with 0, 5 or 25 mg 
Aroclor 1254/kg body weight 
on day 10 to 16 of gestation. 
* PO.05, ** PO.01, *** 
PO.001, **** PO.0001, 
N=8-10 on postnatal day 21 
and N=10 on postnatal day 
90. 
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Table 7.4 
Regional brain synaptophysin levels (% of control) in weanling and adult female 
offspring, following exposure of pregnant rats to PCBs. 
Dose mg Aroclor 1254/kg body weight 
0 5 25 
PND21 
Striatum 
Hypothalamus 
100+9 
100+5 
102+8 
73+3 
76+5* 
65+8.2*** 
Striatum 
Hypothalamus 
100+6 
100+7 
PND90 
77+7* 
71+8* 
74+5** 
83+19 
* PO.05, ** PO.01, *** PO.001, N=8-10 on postnatal day 21 (PND21) and N=10 on 
postnatal day 90 (PND90). Pregnant rats were treated with 0, 5 or 25 mg Aroclor 
1254/kg body weight on day 10 to 16 of gestation. 
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Discussion 
The current study was undertaken to evaluate the sensitivity of several 
neurochemical markers for the developmental neurotoxicity of the polychlorinated 
biphenyl mixture (Aroclor 1254) in male and female offspring of the rat. Long term 
effects (up to PND90) of maternal PCB exposure were observed in the regional brain 
levels of glial fibrillary acidic protein, synaptophysin concentrations and calmodulin-
dependent phosphatase activity. These effects were observed at a PCB dose that had no 
effect on the reproductive parameters examined (5 mg Aroclor 1254/kg bw) and at a 
PCB dose which had a slight effect on body weight gain, food consumption and 
forebrain weight in the offspring (25 mg Aroclor 1254/kg bw). However, it is unlikely 
that the biochemical effects observed at the higher maternal PCB dose are due to 
undernutrition, for undernutrition affects the growth rate of all processes in the brain to 
the same extent (Peeling and Smart, 1994, review). A sensitive and well characterized 
response of experimental animals to PCB exposure, the induction of hepatic microsomal 
ethoxyresorufin-O-deethylase (EROD) activity (Safe, 1994), occurred in fetal, maternal 
and weanling rats, but this effect was absent in young adult rats, indicating that residual 
PCB levels were no longer causing direct effects in the liver. However, residual effects 
of PCBs in the brain cannot be ruled out. 
In this study the differential effects on synaptophysin and GFAP levels in the 
diverse brain regions indicates that several mechanisms are involved in the alteration of 
brain development, following maternal PCB exposure. The alterations in regional brain 
GFAP and synaptophysin levels can be evaluated in terms of 1) reactive gliosis 
following direct damage of the neurons or glia, or 2) as a hormone-dependent alteration 
in the regulation of brain development. Correspondingly, it has been previously 
proposed that the developmental neurotoxicity of PCBs may be due to direct effects of 
PCBs on neuronal cells (Seegal et al. 1992) or indirectly due to PCB-induced endocrine 
imbalances (Rogan et al. 1986). 
Reactive gliosis can occur as a response to either mechanically induced trauma 
(Eng, 1988) or chemically induced neuronal loss (O'Callaghan and Jensen, 1992) 
resulting in increases in GFAP levels and decreases in synaptophysin levels. Increases in 
GFAP concentrations accompanied by decreases in neurotypic proteins following 
neurotoxicant treatment have been associated with neuronal damage in the developing 
(O'Callaghan and Miller, 1988, 1989) and adult central nervous system (Brock and 
O'Callaghan, 1987). 
The effects in GFAP and synaptophysin levels that best resemble the result of 
neuronal damage or death are found primarily in the lateral olfactory tract and prefrontal 
cortex and to a lesser extent in the cerebellum. The lack of effect of transplacental and 
lactational PCB exposure on synaptophysin levels in the presence of significant increases 
in GFAP levels in certain brain regions may indicate that neuronal damage was limited 
to a small subpopulation of neurons, or to neurons containing low levels of 
synaptophysin. 
The mechanisms involved in the neuronal damage and/or delayed synaptogenesis 
and increased GFAP levels in the LOT and PFC following maternal PCB exposure are 
unclear. The effects observed in the current study in the lateral olfactory tract and the 
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prefrontal cortex, which are indicative of neuronal damage or death and subsequent 
astrogliosis, could be due to a developmental delay of neurogenesis and astrogliogenesis 
in the brainstem. The brainstem is one of the first brain regions to exhibit a neuronal 
growth spurt (Rodier, 1980, 1988) and contains raphe nucleus cell bodies which project 
to the frontal cortex (Kosofsky and Molliver, 1987). A delay of the innervation of 
cortical neurons could result in their premature death, manifesting itself as decreased 
concentrations of synaptophysin and increased concentrations of GFAP. This hypothesis 
is in part supported by the observation that serotonin metabolism is primarily affected in 
the LOT and PFC (unpublished data) in this study. The serotonergic system is one of 
the main systems projecting from the brainstem to the frontal cortex and lateral olfactory 
tract (Molliver, 1987). In the current study the relatively low levels of GFAP on PND90 
and of synaptophysin on PND21 in the brainstem may be indicative of delayed 
development following maternal PCB exposure. 
The alterations in GFAP and synaptophysin levels in the LOT and PFC observed 
in this study may be a result of direct effects of PCBs in these brain regions, in vitro 
studies have demonstrated direct effects of PCBs on dopamine metabolism in the 
neuroendocrine cell line PC 12 (Seegal et al. 1992), which may correspond to decreases 
in regional brain dopamine levels in vivo in adult rats and macaques (Seegal et al, 1991, 
Seegal et al., 1994). The mechanistic significance of this finding for the developing 
nervous system has not yet been determined, and no significant decreases of regional 
brain dopamine levels were observed in this study (unpublished observations). 
Disruption of calcium homestasis in rat cerebellar granular cells (Kodavanti et al. 1993) 
and adenosine triphosphatse activity in mitochondrial and synaptosomal fractions (Maier 
et al. 1994) has been demonstrated in vitro with relatively high PCB concentrations (in 
the uM range), while no in vivo counterpart of these effects by PCBs has yet been 
demonstrated. Although PCB congeners induced biochemical effects in PC 12 and 
cerebellar granular cells, no cytotoxicity was observed with cell culture media 
concentrations up to 200 uM (Kodavanti et al. 1993, Seegal et al. 1991), which exceeds 
the highest brain PCB concentration in this study by a factor of 60,000 (Eva Klasson 
Wehler, personal communication). It is therefore unlikely that brain PCB residues 
resulted directly in neuronal degeneration, although alterations in neuronal migration and 
differentiation caused directly by PCBs cannot be ruled out. 
It has been proposed that PCB-induced alterations in pre- and postnatal thyroid 
hormone levels and metabolism may be involved in PCB induced developmental 
neurotoxicity (Rogan et al., 1986, Morse et al. 1993). Maternal PCB exposure has been 
associated with decreased plasma thyroid hormones, (Collins and Capen, 1980, Morse et 
al. 1993, Ness et al., 1993) and altered brain thyroid homone metabolism (Morse et al. 
1993) in fetal and weanling rats. Decreases in fetal and weanling brain thyroid hormone 
levels have also been observed in this study (Morse et al. manuscript submitted for 
publication). In humans, negative correlations have been observed between PCB, PCDD 
and PCDF concentrations in milk fat and maternal plasma thyroid hormone levels during 
gestation and lactation, and higher PCB, PCDD and PCDF levels were associated with 
decreases in neonatal plasma thyroid hormone levels (Koopman-Essenboom et al. 1994). 
Hormonal modifications of regional brain GFAP levels have been observed in 
both developing and adult rodents. Decreases in GFAP immunoreactivity in the 
hippocampus and cerrebellum, (Faivre-Sarrailh et al. 1991), and the parietal cortex 
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(Granholm et al. 1985) and the delayed synaptogenesis in the dentate gyrus as evaluated 
by synaptophysin immunoreactivity have been associated with delayed brain maturation 
following neonatal hypothyroidism. 
Additional evidence for endocrine-related effects of PCBs on brain development 
can be derived from effects observed in the hypothalamus in the current study. We 
found no evidence for reactive gliosis in male or female offspring from PND21 or 90, 
while synaptophysin levels were significantly reduced in the hypothalamus of female 
offspring on PND21 and 90. This effect may reflect the influence of some PCB 
congeners with estrogenic properties (Korach et al. 1988, Jansen et al. 1993) on 
neuronal plasticity in the hypothalamus (McEwen, 1992). Furthermore, hippocampal 
GFAP surface density is lower in adult female rats than in males, but this difference can 
be abolished by androgenization of female weanlings (Garcia-Segura et al., 1988), 
thereby establishing a role of gonadal hormones in GFAP levels. Estradiol also 
modulates GFAP immunoreactivity in the arcurate nucleus in adult female rats (Garcia-
Segura, 1994). 
Although it has been demonstrated that maternal PCB exposure can result in 
decreased circulating thyroid hormones in the fetal, neonatal and weanling rats (Morse et 
al. 1993) and that postnatal hypothyroidism can result in alterations in synaptogenesis 
and the distribution of GFAP immunoreactivity in the rat brain, the comparison of the 
effects reported in this study with previous reports on postnatal hypothyroidism is 
fraught with difficulties. The most significant problem is the existence of significant 
inconsitencies in the results of studies on the effect of postnatal hypothyroidism on the 
development of GFAP immunoreactivity in the rat brain (Kâlmân et al. 1991). For 
example, while little effect was observed on GFAP immunoreactivity in serial sections 
from rats from an unspecified strain thyroidectomized on postnatal day 3 to 5, (Kalman 
et al. 1991), propylthiouracil treatment of Wistar rat dams from GD18 to PND35 
resulted in significant decreases in GFAP concentrations in the cerebellum of the 
offspring on PND35 (Faivre-Sarrailh, 1991). It is therefore possible that the results on 
GFAP levels after hypothyroidism are affected by the rat strain or the protocol for the 
induction of hypothyroidism, and an intrinsic neurotoxicity of propylthiouracil cannot be 
excluded. 
Partial support for the role of thyroid hormones in PCB-induced developmental 
neurotoxicity is that the activity of calmodulin-dependent phosphatase was significantly 
increased in the cerebellum of female, but not male offspring on PND21 and 90. This 
may be an indication of developmental alteration in the female cerebellum, for prenatal 
hypothyroidism results in increased calmodulin-dependent phosphatase activity in young 
adult rats (Ruiz de Elvira et al, 1989). 
In conclusion, this study demonstrates that gestational and lactational PCB 
exposure results in long-term alterations in glial and neuronal cell marker proteins in 
rats. The mechanisms involved in the alterations of these proteins are unclear, but may 
involve endocriene mechanisms. In addition, GFAP and synaptophysin may be useful 
markers for the investigation of the structure-activity relationships of the developmental 
toxicity of PCBs both in vivo and in vitro. 
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LONG-TERM ALTERATIONS IN REGIONAL BRAIN SEROTONIN 
METABOLISM FOLLOWING MATERNAL POLYCHLORINATED BIPHENYL 
EXPOSURE IN THE RAT 
Abstract 
Pregnant Wistar WU rats were administered PCBs (0, 5 or 25 mg Aroclor 1254 
per kg body weight) by gavage on day 10 to 16 of gestation. Levels of biogenic amines 
were measured in the lateral olfactory tract, prefrontal cortex, striatum, hippocampus and 
hypothalamus in male and female offspring 21 and 90 days after birth. 5-hydroxyindole 
acetic acid (5-HIAA) concentrations and the ratio of 5-HIAA/5-hydroxytryptamine (5-
HT, serotonin) were significantly increased in the lateral olfactory tract, prefrontal cortex 
and hippocampus on postnatal day 90 in male and female offspring following maternal 
PCB treatment. No effects were observed on regional brain levels of dopamine, 3,4-
dihydroxyphenylacetic acid, norepinephrine and homovanillic acid. The results indicate 
that pre- and postnatal exposure to Aroclor 1254 results in regionally specific long-term 
alterations in the serotonergic system. 
Dennis C. Morse, Richard F. Seegal, Karl O. Borsch, Abraham Brouwer 
submitted to Toxicology Letters 
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Introduction 
Transplacental and/or lactational exposure to background levels of 
polychlorinated biphenyls has been associated with cognitive and neurological alterations 
in human infants (Jacobson et al., 1990, Rogan et al., 1986). The pre- and postnatal 
exposure of laboratory animals to either individual PCB congeners or various 
commercial mixtures has confirmed the developmental neurotoxicity of PCBs (for a 
review see Tilson et al. 1990). However, the majority of the studies on the 
developmental neurotoxicity of PCBs has focussed on behavioral effects, so there is 
little information available on the neurochemical alterations underlying the behavioral 
changes. Neonatal exposure to a single oral dose of 41 mg 3,3',4,4'-tetrachlorobiphenyl 
per kg body weight has been reported to decrease neonatal and increase adult muscarinic 
receptor levels in the hippocampus of the mouse, which was accompanied by alterations 
in open field activity (Eriksson, 1988, Eriksson et al. 1991). The repeated oral exposure 
of CD-I mice to 32 mg 3,3',4,4'-tetrachlorobiphenyl per kg body weight on day 10 to 
16 of gestation resulted in decreases in striatal dopamine levels and receptor binding 
sites in the adult offspring (Agrawal et al. 1981). However, 3,3',4,4'-tetrachlorobiphenyl 
is toxic to the conceptus at a maternal dose of 4 mg/kg and reduces maternal body 
weight gain at 16 mg/kg in CD-I mice (Marks et al. 1989), which suggests that the dose 
used by Agrawal et al. (1981) was too high to specifically investigate developmental 
neurotoxicity. 
Subchronic exposure to commercial PCB mixtures with either a low or high 
degree of chlorination specifically affects the dopaminergic neurons in the basal ganglia 
of adult rats and primates (Seegal et al. 1991, Seegal et al. 1994), resulting in decreases 
in dopamine levels. Acute exposure to highly chlorinated PCB mixtures has a more 
diffuse effect, altering dopaminergic, serotonergic and adrenenergic neurotransmitter 
systems (Seegal et al, 1985, 1986a, 1986b). It has been reported that in utero and 
gestational exposure to Aroclor 1016, a commercial PCB mixture with a low degree of 
chlorine substitution, resulted in transient increases in striatal dopamine levels (Seegal, 
1994). However, in the majority of reports on the behavioral developmental toxicity of 
PCBs in experimental animals commercial PCB mixtures with a high degree of 
chlorination were used. We therefore investigated the effect of maternal exposure to the 
commercial PCB mixture Aroclor 1254 on regional brain biogenic amine levels in 
weanling and young adult rats. 
Methods 
Animals 
Wistar WU rats, 100 females and 50 males, (14 weeks old) were purchased from 
Charles River Sutzfeld, Germany. The rats were allowed to acclimatize for 2 weeks and 
were maintained at 50 % humidity and 21°C on bedding in macrolon cages with a 12 
hour light cycle (lights on from 08.00 to 20.00). Rat chow (Hope Farms, Woerden, the 
Netherlands) and tap water were supplied ad libitum. After the acclimatization period 
two females were placed in a cage with one male overnight. When spermatozoa were 
found the females were housed separately and this was termed day 0 of gestation. 
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Animals were pre-assigned to a particular dose group on a rotating basis. Maternal body 
weight gain was monitored throughout gestation and lactation. 
Pregnant females received a daily oral dose by gavage of 0, 5 or 25 mg Aroclor 
1254 per kg body weight dissolved in corn oil (2 ml/kg body weight) from day 10 of 
gestation to day 16 of gestation. Rats were weighed each day before administration of 
Aroclor 1254 or corn oil alone. The rats were inspected each morning at 8:00 h and 
each afternoon at 18:00 h for litters. Pups found during the morning inspection were 
defined as 1 day old, pups born between the morning and afternoon inspection were 
termed 0 day old. Pups were examined for sex, weighed on day 0 postpartum when 
possible, and always on day 1, 4 and 7 postpartum and thereafter on a weekly basis. On 
postnatal day 4 (PND4) litters were reduced to 4 males and 4 females. 
On postnatal day 21 (PND21), 8-10 litters were sacrificed per treatment group 
and on PND 90, 10 litters were sacrificed per treatment group. Dams and offspring were 
sacrificed by decapitation. Brains were rapidly removed and dissected by hand on an 
ice-cold plate into the following regions: lateral olfactory tract, prefrontal cortex, 
striatum, hypothalamus and dorsal hippocampus. The brain regions were immediately 
frozen on a block of dry-ice, weighed and stored at -80°C. Neonates from the remaining 
litters were weaned on PND21 and male and female rats were housed separately in 
groups of 2-4 rats per cage. The remaining animals were sacrificed 90 days (PND90) 
after birth and brain regions were removed, weighed and stored as described above. 
Measurement of biogenic amines 
Brain regions (lateral olfactory tract, prefrontal cortex, striatum, hypothalamus 
and dorsal hippocampus) were dissected, frozen, weighed and then stored at -80°C as 
described above until processing. The brain regions were thawed by the addition of 10 
volumes of ice cold 0.2 N perchloric acid containing 100 mg/1 of ethylene glycol-bis-(B-
aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), then homogenized with an 
ultrasonic tissue disrupter (Vibra cell™, Sonics&Materials Inc. Danbury, CT, USA) for 
30 seconds. 
The regional brain levels of the neurotransmitters dopamine (DA), 5-hydroxytryp-
tamine (5-HT), norepinephrine (NE) and their respective metabolites 
dihydroxyphenylacetic acid, 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid 
(HVA) were determined by HPLC separation and electrochemical analysis as previously 
described (Seegal et al. 1986c). 
Statistical analysis 
Data on regional brain biogenic amine levels were obtained from one male and 
one female offspring from 8-10 litters per treatment group and sacrifice time. Treatment-
related effects on male and female offspring were analysed separately, and were first 
evaluated with a one-way analysis of variance followed by a least significant difference 
test to find significant differences between the treatment groups. Data are presented as 
the mean+SEM. 
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Results 
Reproduction and body weight gain 
Maternal exposure to either 5 or 25 mg Aroclor 1254/kg had no effect on 
maternal body weight gain during gestation or lactation, the number of pups born or 
neonatal deaths. The low dose, 5 mg Aroclor 1254/kg, had no effect on body weight 
gain of the offspring, while 25 mg Aroclor 1254/kg resulted in slightly, but significantly 
lower body weights (approximately 8%) in both male and female offspring over the 
entire postnatal period (see Chapter 6). 
Regional brain biogenic amine concentrations 
Only data on the indolamines (5-HT and 5-HIAA) are presented, because there 
were no consistent significant effects found on the concentrations of dopamine, 
dihydroxyphenylacetic acid, norepinephrine and homovanillic acid or on DOP AC/DA 
ratios in the brain regions examined from offspring following maternal PCB exposure. 
Lateral olfactory tract (LOT) 
The effects of maternal exposure to Aroclor 1254 on indoleamine concentrations 
in the LOT are presented in Table 1. On PND 21 5-HIAA concentrations in the LOT of 
male and female neonates from the high PCB dose group were increased by 29% 
(PO.05) and 18% (PO.05), respectively. In the female neonates the increases in LOT 
5-HIAA levels were accompanied by a significant increase (16%, PO.05) in the 5-
HIAA/5-HT ratio. On PND 90 the 5-HIAA levels in the LOT were increased by 76% 
(PO.0001) and 86% (PO.001) respectively in male and female offspring from the high 
dose group, while in female offspring a 55% increase (PO.01) in 5-HIAA levels was 
found in the low PCB dose group. 5-HIAA/5-HT ratios were also significantly increased 
by 61% (P<0.005) and 68% (PO.001) in the LOT from male offspring from the low 
and high PCB dose group, respectively, and in female offspring by 47% (PO.05) and 
77% (PO.005) in the low and high PCB dose group, respectively. 5-HT levels in the 
LOT were generally unaffected by maternal PCB exposure, with the exception of an 
isolated decrease (35%, PO.05) in male offspring from the low PCB dose group on 
PND 90. 
Prefrontal Cortex (PFC) 
Indoleamine concentrations in the PFC, following maternal exposure to Aroclor 
1254 are presented in Table 2. On PND 90 significant increases in 5-HIAA 
concentrations were observed in male offspring (67%, PO.0001 and 125%, PO.0001) 
and in female offspring (57%, PO.01 and 79%, PO.001) in the low and high PCB 
treatment groups, respectively. 5-HIAA/5-HT ratios were also elevated in the PFC on 
PND 90 in male offspring (47%, PO.005 and 44%, PO.005, low and high PCB dose 
group, respectively) and in female offspring (51%, PO.005) from the high PCB dose 
group. In addition, 5-HT levels were also increased in the PFC from male offspring 
from the high dose group (58%, PO.0001) and female offspring from the low PCB dose 
group (30%, PO.05) on PND 90. No effects were observed on indoleamine 
concentrations in the PFC of the male and female neonates on PND 21 (data not 
shown). 
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Table 1. 
Lateral olfactory tract indolamine levels (ng/ mg tissue, fresh wt.) in offspring following 
maternal exposure to Aroclor 1254 
Dose, mg Aroclor 1254/kg 
5 25 
Male 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
Female 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
Male 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
Female 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
0.024+0.002 
0.031+0.002 
79.63+6.32 
0.028+0.001 
0.023+0.002 
131.0+9.62 
0.025+0.009 
0.054+0.004 
42.69+3.54 
0.022+0.002 
0.064+0.007 
36.81+4.56 
PND 21 
0.023+0.001 
0.031+0.003 
78.31+19.30 
0.027+0.001 
0.024+0.001 
114.8+6.81 
PND 90 
0.025+0.07 
0.035+0.003* 
68.59+5.02*** 
0.034+0.002** 
0.067+0.003 
54.11+3.31* 
0.031±0.003* 
0.031+0.002 
89.06+8.41 
0.033+0.002* 
0.020+0.002 
152.4+11.8* 
0.044+0.01***** 
0.059+0.007 
71.18+6.59**** 
0.041+0.004**** 
0.068+0.006 
65.00+7.46*** 
5-HIAA: 5-hydroxyindole acetic acid, 5-HT: 5-hydroxytryptamine, * P<0.05, ** P<0.01, *** 
P<0.005, **** P<0.001, ***** P<0.0001, N=8-10 on postnatal day 21 (PND21) and N=10 on 
postnatal day 90 (PND90). 
Striatum and dorsal hippocampus 
The only significant effects observed in the striatum on indolamine 
concentrations observed were an increase in 5-HIAA levels (57%, P<0.001) in male 
offspring from the high PCB dose group on PND 90. The concentration of 5-HIAA 
increased in the striatum of female offspring exposed maternally to PCBs by 13% and 
38% in the low and high PCB dose group respectively, but these increases were not 
statistically significant. 
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Table 2. 
Prefrontal cortex indolamine levels (ng/ mg tissue, fresh wt.) in offspring following 
maternal exposure to Aroclor 1254 
Dose, mg Aroclor 1254/kg 
0 5 25 
Male 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
Female 
5-HIAA 
5-HT 
5-HIAA/5-HT(%) 
0.012+0.001 
0.019+0.001 
63.46+6.07 
0.014+0.001 
0.020+0.001 
69.53+5.29 
PND90 
0.020+0.001***** 
0.022+0.001 
93.06+7.79*** 
0.022+0.003** 
0.026+0.008* 
88.07+10.5 
0.027+0.001***** 
0.030+0.001***** 
91.28+4.58*** 
0.025+0.002**** 
0.024+0.005 
105.0+8.80*** 
5-HIAA: 5-hydroxyindole acetic acid, 5-HT: 5-hydroxytrytamine, * P<0.05, ** P<0.01, *** 
P<0.005, **** P<0.001, ***** P<0.0001, N=10 on postnatal day 90 (PND90). 
Table 3. 
Striatal and hippocampal HIAA levels (ng/ mg tissue, fresh wt.) in offspring following 
maternal exposure to Aroclor 1254 
Dose, mg Aroclor 1254/kg 
0 5 25 
Male 
Female 
0.028+0.002 
0.032+0.002 
PND90, 
0.032+0.006 
0.036+0.004 
Striatum 
0.044+0.003**** 
0.044+0.005 
Male 
Female 
0.018+0.003 
0.019+0.001 
PND90, Hippocampus 
0.020+0.002 
0.035+0.004** 
0.026+0.002* 
0.030+0.002**** 
5-HIAA: 5-hydroxyindole acetic acid, * P<0.05, ** P<0.01, *** P<0.005, **** P<0.001, N=10 
on postnatal day 90 (PND90). 
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A 44% increase in hippocampal 5-HIAA levels was observed in male offspring 
from the high PCB dose group, while a 84% (PO.05) and a 58% (PO.001) increase 
was observed in female offspring from the low and high PCB dose groups, respectively. 
No significant alterations of indolamine concentrations or 5-HIAA/5-HT ratios were 
observed in the hypothalamus on PND 21 and 90. 
Discussion 
This study demonstrates that gestational and lactational exposure to the commer-
cial PCB mixture Aroclor 1254 at very low doses results in alterations in 5-hydroxytryp-
tamine (5-HT, serotonin) metabolism in several macrodissected brain regions in the 
offspring of the rat. The effects are characterized by increased concentrations of 
hydroxyindoleacetic acid (5-HIAA), the principle metabolite of 5-HT, and increased 5-
HIAA/5-HT ratios, indicative of an increase in 5-HT turnover rather than a decrease in 
5-HT synthesis (Seegal et al. 1986b). However, it is difficult to interpet our results 
solely in terms of increased neuronal activity, because the observed effects result from a 
combination of synthesis, release, re-uptake and metabolism of 5-HT. The increases in 
5-HIAA levels and 5-HIAA/5-HT ratios were seen mainly on PND 90 in the lateral 
olfactory tract (LOT) and prefrontal cortex (PFC), while in the striatum and 
hippocampus only increases in 5-HIAA levels were observed. On PND 21 slight 
increases in 5-HIAA levels were seen in the LOT in male and female offspring from the 
25 mg/kg dose group. The levels of other biogenic amines, norepinephrine, 3,4-
dihydroxyphenylacetic acid, dopamine and homovanillic acid were unaffected by 
maternal PCB exposure, suggesting a selective effect on the ontogeny of the 
serotonergic system. 
The LOT and frontal cortex are highly innervated by serotonergic projections 
from both the dorsal and median raphe nuclei in the brainstem and are among the first 
neuronal systems to project to the cortex during brain development in the rat (Kosofsky 
and Molliver, 1987). The striatum is innervated primarily by the dorsal raphe nucleus, 
while the hippocampus and hypothalamus are innervated by both the dorsal and median 
raphe nucleus (Kosofsky and Molliver, 1987). Since 5-HIAA levels were affected to the 
greatest extent in the LOT and PFC by maternal PCB exposure, it may be the timing of 
serotonergic innervation or axonal length that determines the sensitivity of a given brain 
region for the developmental neurotoxicity of Aroclor 1254. 5-HT neurons projecting 
from the dorsal raphe appear to play an important role in control of the emotional state 
and may be involved in perceptual integration (Molliver, 1987). Possible consequences 
of impairment of the serotonergic system include alterations of mood-related behaviors, 
such as appetite, sleep and attention (Willner, 1985). 
It seems highly unlikely that one specific mechanism is responsible for the 
complete spectrum of developmental neurotoxicity observed following maternal 
exposure to a mixture of PCBs, because PCBs and their metabolites produce a broad 
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spectrum of structure-dependent alterations in endocrine systems (Safe, 1994) which 
may influence brain development (McEwen, 1992) and hence alter the developmental 
expression of important neurotransmitters. 
One endocrine system that may be involved in PCB induced developmental 
neurotoxicity is the thyroid system. It has been suggested that PCB-induced decreases in 
fetal and neonatal brain thyroid hormone levels may result in altered brain development 
(Morse et al. 1993). Several studies have demonstrated that maternal PCB exposure 
results in decreased circulating thyroid hormone levels in either fetal or neonatal rats 
(Collins and Capen, 1980, Ness et al, 1993, Morse et al. 1993a, Morse et al. 1995a) 
and the importance of thyroid hormones for brain development is widely recognized 
(Porterfield and Hendrich, 1993). Significant decreases in fetal brain thyroxine levels 
were observed in this study (Chapter 5). 
Although we did not directly assess the relationship between PCB exposure, 
thyroid hormones and regional levels of 5-HT and 5-HIAA in this study, the effects 
observed on the levels of indoleamines in this study partly resemble the effects of pre-
and postnatal hypothyroidism in the rat. Neonatal hypothyroidism resulted in significant 
increases in 5-HT and 5-HIAA levels in many discrete brain nuclei in the forebrain, 
midbrain and hindbrain (Savard et al. 1984). In larger brain regions decreases of 5-HT 
accompanied by an increase in 5-HIAA levels were observed in the cerebellum, 
midbrain and striatal regions in contrast to an accumulation of 5-HT and 5-HIAA in the 
pons-medulla (Rastogi and Singhal, 1978). 
In addition, the estrogenic system may also be involved in PCB-induced 
developmental alterations in brain development. The coplanar PCB, 3,3',4,4'-tetrachloro-
biphenyl and 2,3,7,8-tetrachlorodibenzo-para-dioxin possess anti-estrogenic properties 
(Jansen et al. 1993, Spink et al. 1990), while some hydroxylated metabolites and 
diortho-PCBs are weakly estrogenic (Jansen et al. 1993, Korach et al. 1988). Estrogen 
receptors have been found in the dorsal raphe nucleus during fetal brain development 
(Stumpf et al. 1983), and it has been reported that neonatal treatment with sex steroids 
cause different alterations in 5-HT levels in the male and female rat brain (Giulian et al. 
1973). However, it is currently unclear if the effects observed on regional brain 
indoleamine concentrations in the current study are due to estrogenic or anti-estrogenic 
effects of PCBs and their metabolites. Firstly, the alterations in regional brain 
indoleamine concentrations were quantitatively and qualitatively similar in both male 
and female offspring. Secondly, Aroclor 1254 contains coplanar PCBs with anti-
estrogenic properties, di-ortho PCBs that are potentially estrogenic, and many congeners 
are metabolized in rodents to hydroxylated compounds that may be estrogenic (Bergman 
et al. 1994), making a prediction of the overall effect of a PCB mixture on the 
estrogenic system extremely difficult. 
Although acute PCB administration can increase serotonin turnover, it is 
plausible that the alterations in serotonin metabolism observed on PND21 and 90 are not 
due to direct effects of residual PCB levels for two reasons. The direct effects of PCBs 
in vitro or in adult animals following chronic and subchronic exposure are primarily 
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associated with alterations in dopamine metabolism (Seegal, 1992). The striatum is one 
of the most sensitive regions for alterations in dopamine metabolism following PCB 
exposure. In this study there was no evidence for alterations in dopamine metabolism in 
the striatum of PCB exposed offspring, either directly after weaning or in young adults. 
Secondly, brain PCB concentrations are significantly higher in weanling rats than in 
adult offspring following pre- and postnatal exposure (Shain et al. 1986) but the 
alterations in serotonin metabolism in this study are observed predominantly in young 
adult rats rather than weanling rats. Furthermore, acute administration of a mixture of 
Aroclor 1254 and 1260 to the rat resulted in transient increases in serotonin metabolism 
in the prefrontal cortex, hippocampus, medial-basal hippocampus and brainstem, but not 
in the lateral olfactory tract (Seegal et al. 1986b), the latter brain region being the most 
sensitive for persistent increases in serotonin metabolism in this study. In combination, 
the results from this study demonstrate that in utero and lactational exposure to low 
doses of Aroclor 1254 result in alterations in the normal developmental expression of 
the serotonergic system. 
The lack of effect on the dopaminergic and noradrenergic amines observed in the 
current study could be explained in several ways. Firstly, effects may be only observed 
in discrete brain nuclei and not in macrodissected brain regions. Secondly, pre- and 
postnatal exposure to Aroclor 1254 affects the developing brain by a different mecha-
nism than in the adult brain. Lastly, the administered dose was too low or Aroclor 1254 
does not contain (sufficient) amounts of PCB congeners that alter the concentration of 
dopaminergic and noradrenergic amines. For example, 3,3',4,4',5,5'-hexachlorobiphenyl, 
a poorly metabolized coplanar PCB, increases striatal dopamine levels in the offspring 
of pregnant rats treated with 1.8 mg/kg on day 1 of gestation (Dr. Beverly Kulig, 
personal communication). This PCB congener is present in very low levels in Aroclor 
1254 (less than 1 ppm, Kannan et al. 1987). Nonetheless, the negative data from the 
current study do not exclude effects on the dopaminergic and noradrenergic systems, for 
receptor concentrations and activity could be altered in the absence of effects on the 
neurotransmitter concentration. 
In conclusion, pre- and postnatal exposure to the commercial PCB mixture 
Aroclor 1254 results in alterations in 5-HT metabolism but not in dopamine metabolism, 
which indicates a significant difference between the mechanisms of Aroclor 1254-
induced developmental neurotoxicity and neurotoxicity induced in the adult animal. 
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GENERAL DISCUSSION 
Introduction 
The work described in this thesis was undertaken to gain insight in the processes 
involved in the developmental neurotoxicity of polychlorinated biphenyls. It has been 
previously hypothesized that the alteration of thyroid hormone status by PCBs may be in 
part responsible for the developmental neurotoxicity of these compounds in humans 
(Rogan et al. 1986). This is a logical hypothesis, given the well-described effects of 
PCBs on plasma thyroid hormone levels in adult animals, and the indisputable importan-
ce of thyroid hormones in brain development. 
Therefore the first goal was to determine the nature and mechanism of PCB-
induced decreases in circulating and brain thyroid hormone levels in fetal and neonatal 
rats (Chapter 2,3,4 and 5). We examined the effects of maternal PCB administration on 
the metabolism of thyroid hormone in the brain and liver of fetal, neonatal and adult 
offspring in relation to the level of thyroid hormone in the plasma and brain. Vitamin A 
status, which may be linked to thyroid hormone status following PCB exposure, was 
also examined in one reproduction study (Chapter 6). 
Since the kinetics and metabolism of PCBs may play a pivotal role in the 
alteration of thyroid hormones, a radiolabelled and easily metabolized PCB congener 
was used in in vivo (Chapter 2) and in vitro experiments (Chapter 3) to examine the 
kinetics and metabolism of a model compound in pregnant and fetal rats. The relevance 
of this model compound for complex PCB mixtures was ascertained following the 
administration of a commercial PCB mixture to pregnant rats (Chapter 5). 
Lastly, neurochemical analysis were conducted on the brains of the offspring 
following maternal PCB exposure to determine which brain regions, cell types and 
neurotransmitter systems are affected during brain development (Chapter 7 and 8). 
Biotransformation of PCBs to thyroid hormone antagonists 
The metabolism and distribution of [14C]-3,3',4,4'-tetrachlorobiphenyl ([14C]-
TCB) was examined in pregnant rats and their fetuses (Chapter 2 and 3, Morse et al, 
1995). The major metabolite found in adult liver and plasma, placental tissue, whole 
fetuses and fetal blood was 3,3',4',5-tetrachloro-4-biphenylol (4-OH-tetraCB). While 
maternal tissue levels of [14C]-TCB derived radioactivity significantly decreased by 65-
85% over a 7 day period, radioactivity in the fetus accumulated more than 100-fold over 
the same period. The fetal accumulation of radioactivity was due primarily to 4-OH-
tetraCB, and on day 20 of gestation, fetal plasma levels of 4-OH-tetraCB were 14 times 
higher than maternal plasma levels (14 (J.M vs 1 uM). 
In order to determine the source of 4-OH-tetraCB in the fetus, in vitro studies 
were carried out by incubating [14C]-TCB with maternal and fetal rat microsomes and 
analysing the reaction products with high pressure liquid chromatography and gas 
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chromatographic/mass spectrometric analysis. First, incubation conditions were optimi-
zed using male rat microsomes. Under optimal incubation conditions, hepatic 
microsomes from pregnant rats pretreated with TCB produced 4-OH-tetraCB as the 
major metabolite, while no metabolites were detected in incubations with microsomes 
from fetuses from pregnant rats pretreated with TCB. The results indicate that 4-OH-
tetraCB found in the fetal compartment is due to transplacental transport from 
maternally formed 4-OH-tetraCB. This is in agreement with the observation that the 
biotransformation of TCB is dependent on CYP1A1 induction, and no CYP1A1 activity 
was observed in fetal microsomes after maternal treatment with TCB. 
In late gestation, the high levels of 4-OH-tetraCB found in the fetal plasma were 
asssociated with decreases in fetal plasma thyroid hormone levels in the absence of 
significant decreases in maternal plasma thyroid hormones. 4-OH-tetraCB has a high 
affinity for transthyretin (the major plasma thyroid hormone transport protein in the rat) 
and competitively displaces thyroxine from this protein (Brouwer et al. 1990, Lans et al. 
1993). It was therefore concluded that the accumulation of 4-OH-tetraCB in the fetus is 
due to the high affinity of this metabolite for transthyretin, and results in significant 
decreases in fetal plasma thyroxine levels. 
Since the model compound 3,3',4,4'-TCB is present in only very low levels in 
the environment, it was of interest if the exposure of pregnant rats to a commercial PCB 
mixture (Aroclor 1254) would also result in the accumulation of phenolic metabolites in 
the fetal plasma (Chapter 5). Relatively high levels of hydroxylated PCB metabolites 
from penta, hexa and hepta-chlorinated biphenyls have been found in the plasma of rats 
exposed to Aroclor 1254 and in environmentally exposed humans (Bergman et al. 
1994). A significant accumulation of 4-OH-2,3,3',4',5-pentachlorobiphenyl (4-OH-
pentaCB) was found in the plasma of late gestational fetuses from pregnant rats exposed 
to Aroclor 1254 (up to 4.6 uM). This PCB metabolite has a 10-fold higher binding 
affinity for TTR than thyroxine, thereby confirming the relevance of work with the 
model compound, 3,3',4,4'-tetrachlorobiphenyl. In addition, relatively large amounts of 
4-OH-pentaCB were found in the fetal (0.46 uM), but not weanling rat brain, indicating 
that in the absence of a functional blood-brain barrier hydroxylated PCB metabolites 
may enter the brain. The toxicological significance of this finding deserves investigation. 
Effects of PCB exposure on thyroid homone levels and metabolism 
T4- Uridine-diphospho-glucuronyl transferase 
Decreases in plasma thyroid hormone levels in adult rodents may also be caused 
by the induction of the hepatic glucuronidation of thyroxine (Bastomsky, 1974, Barter 
and Klaasen 1992). The effect of a single maternal dose of 3,3',4,4',5,5'-
hexachlorobiphenyl (HCB) on day 1 of gestation and in combination with repeated 
maternal doses of TCB (day 2 to 18 of gestation) on maternal, fetal and neonatal hepatic 
microsomal and brain thyroxine metabolism is described in Chapter 4. The results 
indicated that although maternal administration of coplanar PCBs may result in the 
induction of fetal hepatic microsomal T4 glucuronidation, this induction did not cause 
the reductions in fetal plasma T4 levels. Only the combined dose of HCB with TCB 
resulted in significant decreases in fetal plasma T4 levels. This indicates that decreased 
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placental transport of maternally-derived T4 and the blockage of fetal thyroid hormone 
transport by 4-OH-tetraCB resulted in the decrease of fetal T4 levels. In neonates and 
dams, however, the induction of T4 glucuronidation by lactational exposure to coplanar 
PCBs may contribute to the observed decreases in plasma thyroxine levels. 
Maternal exposure to the commercial PCB mixture Aroclor 1254 also induced 
T4-UDPGT activity in hepatic microsomes from pregnant and weanling rats, but not in 
the fetus (Chapter 5). Since only the induction of maternal hepatic microsomal T4-
UDPGT correlated with reductions in plasma thyroid hormones, it was concluded that 
the induction of T4-UDPGT activity played only a minor role in the reductions of 
plasma thyroid hormones in fetal and weanling rats. Large reductions in plasma thyroid 
hormones have also been observed following dietary Aroclor 1254 exposure in homozy-
gous Gunn rats, which are deficient in T4-UDPGT activity (Collins and Capen, 1980a). 
The only long-term effect on thyroid hormone metabolism observed following maternal 
PCB exposure was a significant decrease in female hepatic microsomal T4 glucuronidati-
on in young adult offspring. 
Type II thyroxine 5 '-deiodinase 
As most of the biologically active hormone triiodothyronine (T3) is derived from 
T4 by deiodination in the brain by Type II thyroxine 5'-deiodinase (5'D-II, Silva and 
Larsen, 1982, Kaplan et al. 1983), it was of interest to examine the effects of PCB-
induced reductions in plasma T4 levels on 5'D-II activity. Decreases in brain T4 levels 
result in a slower turnover of the enzyme, yielding a higher activity per unit protein in 
brain homogenates (Leonard et al. 1984). This regulatory mechanism is important in 
maintaining brain T3 levels. In Chapter 4, the significant decreases in fetal, neonatal and 
weanling rat plasma T4 levels following coplanar PCB exposure were accompanied by 
significant increases in 5'D-II activity in brain homogenates. It was concluded that the 
increases in 5'D-II activity were in compensation for low T4 levels in the developing rat 
brain, which could be detrimental for normal brain development if insufficient T3 was 
formed from T4. 
Following maternal exposure to Aroclor 1254, reductions in fetal plasma T4 were 
also accompanied by increases in brain 5'D-II activity. However, in contrast to the 
effects observed with coplanar PCBs in weanling rats, 5'D-II activity was decreased in 
weanling rats with normal plasma and brain T4 levels, and equal to control values when 
plasma and brain T4 levels were decreased. This can not be explained by the current 
knowledge of 5'D-II regulation. 
Plasma and brain thyroid hormone levels 
In the current study, the effect of maternal PCB exposure on plasma thyroid 
hormone levels was transient, with only mild effects observed in weanling rats. Despite 
the significant lactational transfer of PCBs to the neonate, the effects on neonatal thyroid 
hormone homeostasis are less severe in neonates as in the fetus. Several mechanisms 
appear to be involved that may explain the difference in responses between fetuses and 
weanling rats: the induction of maternal hepatic T4 glucuronidation late in gestation, the 
accumulation of hydroxylated PCB metabolites in the fetus, and reduced placental 
transfer of T4. Also the dilution of the tissue PCB levels during postnatal growth and the 
fecal and urinary excretion of PCBs may reduce the severity of plasma T4 reductions in 
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weanling rats following gestational PCB exposure. For example, the continuous 
postnatal dietary exposure of maternal rats to Aroclor 1254 results in low plasma T4 
levels throughout the weaning period (Collins and Capen, 1980b). 
Despite severe decreases in fetal plasma and brain T4 levels following maternal 
PCB exposure, only marginal decreases were observed in fetal brain T3 levels. This 
indicates that the late gestational rat fetus can maintain brain T3 levels by an increase in 
5'D-II activity, and is at little risk for PCB-induced hypothyroidism, at least in the brain. 
The observation that plasma TSH levels did not increase following PCB-induced 
decreases in plasma T4 levels in the fetus and plasma T3 and T4 levels in the neonate 
suggests that the developing brain may have been euthyroid. However, the decreases in 
plasma T4 levels themselves could be expected to result in an increase in TSH levels. 
Similar decreases in plasma T4 levels in late gestational fetal Wistar rats following 
maternal treatment with methimazole have been shown to result in an 600% increase in 
plasma TSH levels (Morreale de Escobar et al. 1993), and it is likely that fetal TSH 
levels are modulated predominately by plasma T4 rather than T3. In adult rats, significant 
increases in plasma TSH levels have been observed following dietary exposure to 
Aroclor 1254 that resulted in that decreases in plasma T4, but not T3 at the same time 
point (Barter and Klaassen, 1994). A weak effect of PCBs on TSH secretion has been 
observed following a relatively high dietary exposure to Aroclor 1254, after which the 
rise in plasma TSH was suprisingly low in comparison to the rise in plasma TSH 
following dietary exposure to polychlorinated naphthalenes, which induced similar 
decreases in plasma T4 levels as PCBs (Barter and Klaassen, 1994). 
In conclusion, maternal PCB exposure during gestation results in a large decrease 
of fetal brain T4 levels, but only marginal decreases in T3 levels in the late gestational 
rat fetus. It is possible that earlier in gestation, before 5'D-II activity can compensate for 
decreases in brain T4 levels, significant reductions in brain T3 levels are induced by 
maternal PCB treatment. 
Retinoids 
Analogous to thyroid hormones, retinoids play a crucial role in brain develop-
ment, although their most important effects are during early and mid-gestation (Adams, 
1993). To evaluate retinoid status, plasma and hepatic retinol and retinylesters were 
determined following maternal Aroclor 1254 exposure. The reductions in plasma retinol 
levels may be caused by the accumulation of 4-OH-pentaCB in the plasma, analogous to 
the disruption of the binding of retinol binding protein to transthyretin by 4-OH-tetraCB 
following exposure to 3,3',4,4'-tetrachlorobiphenyl. Although the effects of maternal 
PCB exposure on retinoid homeostasis in the fetus, neonate and young adult offspring 
appear to be minor, the regulation of retinoid homeostasis exhibited long-term alterations 
in the PCB exposed group. 
Alterations in neurochemistry 
In Chapter 8 and 9 the effects of maternal PCB (Aroclor 1254) exposure were 
examined on the ontogeny of biogenic amines, a glial cell marker (glial fibrillary acidic 
protein, GFAP) and a neuronal cell marker (synaptophysin) in diverse brain regions. 
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Biogenic amines 
Of the biogenic amines examined, only the levels of 5-hydroxytryptamine (5-
HT, serotonin) and its metabolite, 5-hydroxy-indoleacetic acid (5-HIAA) were altered by 
pre- and postnatal PCB exposure. It is notable that in adult animals the dopaminergic 
system is the most sensitive for exposure to commercial PCB mixtures, while we found 
no effects on the levels of dopamine or its major metabolite in the brains of PCB-
exposed offspring (Seegal et al. 1985, 1986a, 1986b, 1991). Pre- and postnatal exposure 
to the lightly chlorinated PCB mixture Aroclor 1016 resulted in transient increases in 
striatal dopamine levels (Seegal, 1994). Therefore the effects of PCB exposure on 
regional brain monoamine metabolism during development do not resemble the effects 
in adult animals. 
In general, the effects can be characterized by an increase in 5-HIAA 
concentrations and the 5-HIAA/5-HT ratio in the lateral olfactory tract and prefrontal 
cortex, and an increase in 5-HIAA levels in the striatum and hippocampus on postnatal 
day 90. Since the effects on the serotonergic system are almost absent on day 21 
postpartum when exposure to PCBs via lactation ceased, there appears to be a delayed 
effect on the ontogeny of serotonin metabolism. 
GFAP and Synaptophysin levels 
The most consistent effects of maternal PCB exposure on GFAP levels were 
observed in the lateral olfactory tract and the brainstem. Increases in GFAP 
concentrations were observed in both male and female offspring 21 and 90 days after 
birth. Increases were also observed in cerebellar GFAP levels on 21 and 90 days 
postpartum. In the brainstem of male and female offspring maternal PCB exposure 
prevented the increase in GFAP concentrations that was observed in control offspring, 
indicating a delay in the ontogeny of brainstem GFAP expression. 
Synaptophysin levels in the brain of the offspring were affected in a more 
complex manner than GFAP following maternal PCB exposure. Following maternal 
PCB exposure, the most sensitive brain regions from both sexes for decreases in 
synaptophysin concentrations on postnatal day 21 were the lateral olfactory tract and the 
brainstem. However, in young adult animals brainstem synaptophysin levels were 
significantly decreased in males and significantly increased in females. Synaptophysin 
levels were also significantly decreased in the striatum and hypothalamus of female, but 
not male offspring following maternal PCB exposure. 
The mechanisms involved in the alterations of GFAP and synaptophysin levels in 
the brains of the PCB-exposed offspring are not yet been elucidated. Increases in GFAP 
levels accompanied by decreases in synaptophysin levels in the lateral olfactory tract and 
prefrontal cortex are characteristic of reactive gliosis following neuronal loss 
(O'Callaghan and Miller, 1989). The decreases in GFAP and synaptophysin levels in the 
brainstem in weanling rats may be indicative of a developmental delay in brainstem 
maturation. The raphe nuclei in the brainstem contain serotonergic neurons which 
project to the lateral olfactory tract and the prefrontal cortex (Kosofsky and Molliver, 
1987). It is therfore conceivable that the alterations in serotonergic matabolism as well 
as GFAP and synaptophysin levels in the lateral olfactory tract and prefrontal cortex 
result from a developmental delay in the serotonergic innervation of these brain regions. 
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Relevance of the conducted research for human development and future toxicologi-
cal research 
Thyroid hormones 
In a recently published study of 105 mother-infant pairs, elevated maternal body 
burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls (levels in 
milk fat) were shown to be associated with alterations of human thyroid hormone status 
(Koopman-Esseboom et al. 1994). The effects are characterized as negative correlation 
of PCDD, PCDF and PCB congeners with maternal plasma TT3 before delivery and 
maternal plasma TT4 and TT3 after delivery, and a positive correlation with plasma TSH 
levels in the infants in the second week and third month after birth. In infants with a 
higher exposure, plasma TT4 levels were significantly lower (10%) and TSH levels were 
significantly higher (37%). Maternal body burden of three PCB congeners (CB 118, CB 
138 and CB 153) was positively correlated with umbilical plasma TSH levels. In a 
similar study with 38 mother-infant pairs an increase in infant plasma TSH levels and 
plasma TT4 levels was observed in infants with a higher exposure to the total toxic 
equivalents of PCDDs and PCDFs (Pluim et ai, 1992). 
The relative effects of PCBs, PCDFs and PCBs on plasma thyroid hormone 
levels observed by Koopman-Esseboom et al. (1994) in mother-infant pairs are generally 
the same as observed in adult mice, rats and monkeys at much higher doses. In contrast 
to the decreases observed in late gestational fetal rat plasma TT4 and FT4 following 
maternal exposure to Aroclor 1254, no effect was observed of maternal body burden on 
umbilical cord TT4 and FT4 levels. 
It is unlikely that the alterations in thyroid hormone homeostasis associated with 
maternal PCB and PCDD levels observed in human newborns and infants will result in 
developmental alterations of the nervous system. Compensatory mechanisms, such as the 
induction of Type II 5'-thyroxine deiodinase in the brain, should offset decreases in 
plasma and brain T4 levels. In the late gestational rat, near normal brain T3 levels were 
maintained despite severe decreases in plasma and brain T4 levels following maternal 
PCB exposure. However, the potential exists for significant reductions in fetal thyroid 
hormone levels earlier in gestation before compensatory mechanisms have fully 
developed or in specific brain regions not examined in this study. 
There are several important aspects in which the thyroid hormone transport 
differs between humans and rats with possible consequences for the effects of PCBs. 
The main thyroid hormone transport protein in humans is TBG, while in rats TTR is the 
major protein (Robbins, 1991). Although under certain circumstances TBG may be 
present in rats, it has a low affinity for T4 (Rouaze-Romet et al. 1992). Hydroxylated 
PCB metabolites bind only very weakly to TBG, so it is possible that the impact of 
hydroxylated PCB metabolites on plasma T4 levels in humans may be minor. However, 
the fetal mouse has both TTR and TBG as transport proteins, and mouse TBG has 
similar binding properties to human TBG (Vrancks et al. 1990), so the mouse may be a 
better model than the rat for studying the effects of PCBs on thyroid hormone transport. 
Recent research has shown that following maternal TCB exposure 4-OH-tetraCB 
accumulates in the fetal mouse, binds to TTR, resulting in the decrease of fetal plasma 
T4 levels (unpublished results, D.C. Morse and P.O. Darnerud). Therefore, it is possible 
that transplacental transport of hydroxylated PCBs in humans results in the decrease 
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plasma and brain thyroid hormone levels before the rise of fetal hypothalamic-pituitary 
function in mid-gestation. 
While it is generally accepted that thyroid hormone deficiency in neonates and in 
late gestation has a negative effect on brain development in the rat as well as humans, 
the effects of thyroid hormone deficiency earlier in gestation are not clearly understood 
(Morreale de Escobar et al. 1993, review, Porterfield and Hendrich, 1993, review). 
Thyroid hormone and their receptors have been found in human fetuses by 10 weeks of 
gestation (Fisher, 1985), although the functional significance of these observations is 
currently unclear. The finding of Pharoah et al. (1972) that neurological damage of 
endemic cretinism could be prevented if iodized oil was given to the mother before the 
second trimester of pregnancy supports a role of thyroid hormones in brain development 
in this period. 
Therefore several questions remain to be answered: does maternal PCB exposure 
result in significant decreases in brain thyroid hormones in early and mid-gestation in 
rodents and humans, and whether such decreases are relevant for brain development. 
Effects on neurochemical development 
Gestational and lactational exposure to a commercial PCB mixture, Aroclor 1254 
resulted in long-term effects on the neurochemical development of the progeny of rats 
(Chapter 7 and 8). The study does not support the hypothesis that PCB-induced pre- or 
postnatal hypothyroidism was the cause of the neurochemical alterations (Chapter 5). 
The study does give an indication which neurotransmitter systems, which cell types and 
which brain areas may be affected by in utero and lactational exposure to a higher 
chlorinated PCB mixture, providing a solid base for further research. 
One of the questions which has interested researchers in PCB-induced toxicity for 
nearly 20 years is which PCB congeners are responsible for the toxicity of these 
compounds. This question has only been adequately answered for the immunotoxicity 
and some developmental endpoints (teratogenesis and fetotoxicity) in which the 
interaction of the PCB congeners with the Ah-receptor plays an important role. 
To date, reports have been published on the behavioral neurotoxicity of only two 
individual PCB congeners, 3,3',4,4'-tetrachlorobiphenyl and 3,3',4,4',5-
pentachlorobiphenyl, both of which are coplanar PCBs with a high affinity for the Ah-
receptor. 3,3',4,4'-tetrachlorbiphenyl was shown to be a developmental neurotoxin in 
mice following high dose gestational exposure, reducing striatal dopamine and dopamine 
receptor levels in mice, delaying advoidance behavior and inducing neuropathological 
alterations in the cranial roots (Tilson et al. 1979, Chou et al. 1979, Agrawal et al. 
1981). Postnatal exposure of mice to 3,3',4,4'-tetrachlorobiphenyl has also been shown 
to affect hippocampal muscarinic receptor levels and alter spontaneous activity 
(Eriksson, 1988, Eriksson et al. 1991). Due to the rapid metabolism of 3,3',4,4'-
tetrachlorobiphenyl and accumulation of hydroxylated metabolites in the fetus no 
conclusions can be drawn as to the role of the parent compound or its metabolites in the 
developmental neurotoxicity of this PCB congener (Morse et al. 1995). 
On the other hand, exposure of pregnant rats to poorly metabolizable 3,3',4,4',5-
pentachlorobiphenyl delayed the onset of spontaneous activity and neuromuscular 
maturation in the offspring, which was related to delay in body weight gain. However, 
the development of reflexes and visual discrimination was not affected by maternal 
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exposure to 3,3',4,4',5-pentachlorobiphenyl (Bernhoft et al. 1994). Taken together, these 
data may indicate that highly toxic coplanar PCBs may not be direct developmental 
neurotoxins in rodents. If this is the case, it is questionable if the use of individual PCB 
congeners in studies on the effects on neurochemical and behavioral development will 
resolve novel structure-activity relationships within the same time-frame as the structure-
activity relationships for immunotoxicity or CYP1A1 induction in adult animals. First, 
the reproductive studies involved are much more lengthy and costly than acute studies 
with adult animals. Secondly, there is no general agreement on experimental protocols 
(timing and length of PCB administration, neurochemical and behavioral endpoints) 
between researchers working in this field, frustrating the comparison of data. Thirdly, it 
is very likely that complex interactions of Ah-receptor binding, PCB metabolism, fetal 
accumuation of metabolites and hormonal alterations affect brain development in vivo, 
so that the structure-activity relationships for individual congeners will not predict the 
effects of complex mixtures. 
Therefore it may be more useful to characterize the effects of environmentally 
relevant mixtures in terms of dose-response studies, neurochemical and behavioral 
endpoints and species sensitivity. Environmentally relevant mixtures can be obtained by 
extracting contaminated foodstuffs or constructing mixtures using synthetic standards. 
Although mixtures will vary somewhat in their composition, the results of such studies 
may be more relevant for regulatory purposes than data based on studies with individual 
congeners. Cell culture techniques using glial cell or dissociated neural cell cultures may 
be useful in investigating structure-activity relationships of the direct effects of 
individual PCB congeners on brain development. Parameters that have been first 
demonstrated to be affected in vivo should be analysed in vitro. 
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Main conclusions: 
1) PCB congeners (3,3',4,4'-tetrachlorobiphenyl, 2,3,3',4,4'-pentachlorobiphenyl and 
2,3',4',4,5-pentachlorobiphenyl) can be metabolized to hydroxylated metabolites which 
accumulate in the fetal plasma and brain and cause severe reductions in late gestational 
fetal plasma and brain thyroxine levels in rats. 
2) The reductions in brain T4 levels in late gestational fetal rats are effectively compen-
sated by increases in Type II thyroxine 5'-deiodinase activity, so that only marginal 
decreases in brain T3 levels are observed following maternal exposure to a commercial 
PCB mixture. This is an indication that PCB-induced decreases in plasma T4 levels are 
not responsible for alterations in the development of the central nervous system. 
3) Maternal exposure to the commercial PCB mixture (Aroclor 1254) specifically alters 
the development of serotonin metabolism in the brain of the offspring in rats. Since the 
dopamine metabolism exhibits a greater sensitivity and persistency for the administration 
of Aroclor 1254 in adult rodents and macaques than serotonin metabolism, the mecha-
nism of PCB-induced developmental neurotoxicity is distinct from the mechanism of 
alterations in biogenic amine metabolism in adult animals. 
4) The development of both neuronal and glial cells is affected in the brains of offspring 
from pregnant rats treated with Aroclor 1254. The alteration in astrocyte development in 
the brainstem of PCB-exposed offspring is not a response to neuronal death, for levels 
of glial fibrillary acidic protein (GFAP) are decreased, while increased neuronal death is 
generally accompanied by increases in GFAP expression. It is therefore likely that PCBs 
affect brain development by altering cell differentiation and proliferation. 
5) Since the brainstem is one of the first structures to develop in the brain, the observed 
alterations in brainstem development following pre- and postnatal PCB exposure 
probably have a negative effect on the subsequent development of other brain structures. 
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Inleiding 
Het onderzoek dat in dit proefschrift beschreven wordt, is uitgevoerd om inzicht 
te verkrijgen in de processen die een rol spelen bij de neurotoxiciteit van PCB's tijdens 
de ontwikkeling. Er werd al eerder verondersteld dat de veranderingen in 
schildklierhormoon status na blootstelling aan PCB's voor een deel verantwoordelijk zijn 
voor de ontwikkelings-neurotoxiciteit van deze stoffen in mensen (Rogan et al., 1986). 
Dit is een logische hypothese, gezien de goed omschreven effecten van PCB's op 
plasma schildklierhormoon-niveaus in volwassen dieren, en het onomstreden belang van 
schildklierhormonen op de hersenontwikkeling. 
Het eerste doel van dit onderzoek was om de aard en het mechanisme van PCB-
geïnduceerde verlagingen van schildklierhormoon-spiegels in plasma en hersenen van 
foetale en neonatale ratten te bepalen (Hoofdstuk 2,3,4 en 5). De effecten van maternale 
PCB blootstelling op het schildklierhormoon-metabolisme in de hersenen en lever van 
foetale, neonatale en volwassen nakomelingen werden onderzocht in samenhang met de 
schildklierhormoon-niveaus in plasma en hersenen. De vitamine A status, die gekoppeld 
kan zijn aan de schildklierhormoonstatus, werd eveneens onderzocht in een 
reproductiestudie (Hoofdstuk 6). 
Omdat de kinetiek en het metabolisme van PCB's een belangrijke rol kunnen 
spelen bij de effecten op schildklierhormoon-niveaus, werd een radioactief gelabelde en 
snel metaboliseerbare PCB congeneer als modelstof gebruikt in in vivo (Hoofdstuk 2) en 
in vitro experimenten (Hoofdstuk 3). In deze experimenten werd de kinetiek en het 
metabolisme van de modelstof onderzocht in zwangere en foetale ratten. De 
toepasbaarheid van deze stof als model voor complexe PCB-mengsels werd onderzocht 
in een experiment waarin zwangere ratten blootgesteld werden aan een commercieel 
PCB mengsel (Hoofdstuk 5). 
Tot slot werden neurochemische analyses uitgevoerd in de hersenen van 
nakomelingen na maternale PCB blootstelling om vast te stellen welke hersenregio's, 
celtypen en neurotransmittersystemen beïnvloed werden tijdens de hersenontwikkeling 
(Hoofdstuk 7 en 8). 
Biotransformatie van PCB's tot schildklierhormoon antagonisten 
Het metabolisme en de distributie van [14C]-3,3',4,4'-tetrachlorobiphenyl ([14C]-
TCB) werden onderzocht in zwangere ratten en hun foetussen (Hoofdstuk 2 en 3, Morse 
et al., 1995). De "belangrijkste" metaboliet die gevonden werd in maternale lever en 
plasma, placentaal weefsel, foetussen en foetaal bloed was 3,3',4',5-tetrachloro-4-
biphenylol (4-OH-tetraCB). Ondanks een afname van 65-85% van radioactiviteit in de 
maternale weefsels binnen 7 dagen, werd in dezelfde periode een 100-voudige toename 
in radioactiviteit waargenomen in de foetus. De foetale accumulatie van radioactiviteit 
was grotendeels toe te schrijven aan 4-OH-tetraCB. Op dag 20 van de dracht waren 
foetale plasma concentraties van 4-OH-tetraCB 14 maal hoger dan maternale plasma 
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concentraties (14 \JIM versus 1 |aM). 
In vitro studies werden uitgevoerd door [14C]-TCB te incuberen met maternale en 
foetale lever-microsomen waarna de reactieproducten geanalyseerd werden met hoge 
druk vloeistof chromatografie en gas chromatografïe/mass spectrometrie om de herkomst 
van 4-OH-tetraCB in de foetus te bepalen. De in vitro incubatie condities werden 
hiervoor geoptimaliseerd met microsomen van mannelijke ratten. Met deze optimale in 
vitro incubatie omstandigheden, produceerden lever-microsomen van drachtige ratten 
voorbehandeld met TCB, het 4-OH-tetraCB als de voornaamste metaboliet van TCB. 
Lever-microsomen van foeten, die maternaal blootgesteld waren aan TCB, waren niet in 
staat om TCB om te zetten tot fenolische metabolieten. Deze resultaten bevestigen de 
hypothese dat het 4-OH-tetraCB dat gevonden werd in de foetus afkomstig is van het 
moederdier. Dit is in overeenstemming met de observatie dat de biotransformatie van 
TCB afhankelijk is van cytochroom P4501A1 (CYP1A1) inductie, en geen CYP1A1 
activiteit werd gevonden in foetale microsomen na behandeling van zwangere ratten met 
TCB. 
Tegen het eind van het dracht waren de hoge concentraties 4-OH-tetraCB in de 
foetale plasma geassocieerd met verlagingen in de foetale plasma schildklierhormoon-
niveaus terwijl de maternale plasma schildklierhormoon-niveaus niet verlaagd waren. 4-
OH-tetraCB heeft een hoge affiniteit voor transthyretine (TTR, het belangrijkste 
transporteiwit voor schildklierhormoon in het plasma van de rat) en verdringt het 
schildklierhormoon (thyroxine, T4) van dit eiwit (Brouwer et al. 1990, Lans et al. 1993). 
Er werd geconcludeerd dat de accumulatie van 4-OH-tetraCB in de foetus veroorzaakt 
wordt door de hoge affiniteit van deze metaboliet voor het TTR, waardoor verlagingen 
in foetale schildklierhormoon niveaus optreedt. 
Omdat de modelstof 3,3',4,4'-tetrachlorobifenyl (TCB) in zeer kleine 
hoeveelheden in het milieu aanwezig is, was het van belang om te bepalen of de 
blootstelling van drachtige ratten aan het commerciële PCB mengsel (Aroclor 1254) 
eveneens resulteerde in de accumulatie van fenolische metabolieten in het foetale 
plasma. Relatief hoge concentraties van gehydroxyleerde PCB-metabolieten die 
afkomstig waren van penta-, hexa- en hepta-gechloreerde biphenylen, zijn gevonden in 
plasma van volwassen ratten die blootgesteld waren aan Aroclor 1254 en in plasma van 
mensen met achtergrondsblootstelling aan PCB's (Bergman et al. 1994). Een significante 
accumulatie van 4-OH-2,3,3',4',5-pentachlorobifenyl (4-OH-pentaCB) werd gevonden in 
het plasma (tot 4.6 (jM) van foeten van drachtige ratten blootgesteld aan Aroclor 1254 
(Hoofdstuk 5). Deze PCB metaboliet heeft een 10 maal hogere bindingsaffiniteit voor 
TTR dan schildklierhormoon, vergelijkbaar met de 4-OH-TCB metaboliet, waarmee 
tevens de relevantie van de kinetiek van de modelstof TCB in zwangere ratten wordt 
bevestigd (Hoofdstuk 2). Verder werden relatief grote hoeveelheden 4-OH-pentaCB in 
foetale hersenen (0.46 |oM) gevonden, maar niet in de hersenen van pas gespeende 
ratten. Dit suggereert dat in de afwezigheid van een functionele bloed-hersenbarriere 
gehydroxyleerde PCB metabolieten de hersenen kunnen binnendringen. Het 
toxicologisch belang van deze bevinding verdient verder onderzoek. 
Invloed van PCB's op schildklierhormoon niveaus en metabolisme 
TfUridine-difosfo-glucuronyl transferase 
Verlagingen in plasma schildklierhormoon-niveaus kunnen veroorzaakt worden 
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door de inductie van glucuronidase van thyroxine (T4) in de lever (Bastomsky, 1974, 
Barter and Klaassen, 1992, 1994). Het effect op het maternale, foetale en neonatale 
schildklierhormoon-metabolisme in de hersenen en lever na een éénmalige maternale 
dosering met 3,3',4,4',5,5'-hexachlorobifenyl (HCB) op dag 1 van de dracht en in 
combinatie met herhaalde doseringen van TCB (dag 2 tot en met 18 van de dracht) is 
beschreven in Hoofdstuk 4. De resultaten duiden erop dat maternale blootstelling aan 
een coplanaire PCB de foetale T4-UDPGT activiteit induceert, hoewel deze inductie niet 
verantwoordelijk is voor de verlagingen in foetale plasma T4 niveaus. Alleen de 
gecombineerde dosis van HCB en TCB resulteerde in significante verlagingen in T4 
niveaus in foetaal plasma. Dit suggereert dat het verlaagde transplacentale transport van 
maternaal T4 in combinatie met de blokkade van foetaal plasma T4 transport door 4-OH-
tetraCB resulteert in de verlaging van foetale plasma T4 niveaus. In tegenstelling tot de 
foetus, werden verlagingen van maternale en neonatale plasma T4 concentraties door 
HCB waarschijnlijk wel veroorzaakt door de inductie van T4-UDPGT in de lever. 
Maternale blootstelling aan het commerciële PCB mengsel Aroclor 1254 
resulteerde ook in een inductie van T4-UDPGT in maternale en neonatale ratten, maar 
niet in de foetus (Hoofdstuk 5). Omdat de inductie van T4-UDPGT activiteit alleen in 
zwangere ratten correleerde met verlaagde plasma T4 waarden, werd er geconcludeerd 
dat de inductie van T4-UDPGT activiteit een ondergeschikte rol speelt in de verlaging 
van plasma T4 concentraties in foetale, neonatale en gespeende ratten. Sterke verlagingen 
van plasma T4 concentraties zijn ook gevonden als een gevolg van Aroclor 1254 
blootstelling in homozygote Gunn ratten, een rattestam die deficiënt is in T4-UDPGT 
activiteit (Collins and Capen, 1980). Het enige lange-termijn effect op T4-UDPGT 
activiteit in de PCB-blootgestelde nakomelingen was een significante verlaging in 
microsomale T4-UDPGT activiteit in levers van net volwassen vrouwtjes. 
Type II thyroxine 5 '-dejodase activiteit 
De belangrijkste bron van het biologisch actieve hormoon triiodothyronine (T3) in 
de hersenen is de dejodering van T4 door het type II thyroxine 5'-dejodase enzym (5'D-
II, Silva and Larsen, 1982, Kaplan et al. 1983). Verlagingen in T4 niveaus in de 
hersenen leiden tot een lagere omzetting van dit enzym, zodat een hogere specifieke 
activiteit wordt bereikt (Leonard et al. 1984). Deze regulatie is belangrijk voor het 
handhaven van T3 niveaus in de hersenen. Het was daarom interessant om te bepalen 
wat het effect was van PCB-geïnduceerde verlagingen in plasma T4 niveaus op 5'D-II 
activiteit in de hersenen. Zoals beschreven in Hoofdstuk 4 leidden verlagingen in plasma 
T4 niveaus door coplanaire PCB's in foetale, neonatale en pas gespeende ratten tot een 
significante verhoging van 5'D-II activiteit in hersenhomogenaten. Er werd 
geconcludeerd dat de verhogingen in 5'D-II activiteit als compensatie dienden voor de 
verlaagde T4 niveaus in de hersenen. Indien de verhoging in 5'D-II activiteit in hersenen 
onvoldoende is om normale T3 concentraties te handhaven, kan dit nadelig zijn voor de 
hersenontwikkeling. 
Ook na maternale blootstelling aan Aroclor 1254, gingen verlagingen van foetale 
plasma T4 spiegels gepaard met verhogingen in 5'D-II activiteit in de hersenen van 
foetale ratten. In tegenstelling tot het effect van coplanaire PCBs, leidde maternale 
Aroclor 1254 blootstelling echter tot verlagingen in 5'D-II activiteit in de hersenen van 
pas gespeende ratten met normale plasma T4 niveaus (lage dosis), terwijl de 5'D-II 
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activiteit gelijk bleef aan controlewaarden bij verlaagde plasma T4 niveaus (hoge dosis). 
Deze tegenstrijdige effecten in pas gespeende ratten kunnen niet verklaard worden met 
de huidige kennis van de regulatie van 5'D-II activiteit. 
Schildklierhormoon niveaus in de hersenen en plasma. 
In de huidige studie waren de effecten van matemale Aroclor 1254 blootstelling 
op plasma schildklierhormoon niveaus niet langdurig, met slechts kleine verlagingen in 
pas gespeende ratten, terwijl geen effect meer werd gevonden in de volwassen 
nakomelingen. Ondanks een substantiële overdracht van PCB's tijdens de lactatie, waren 
de effecten op schildklierhormoon-niveaus in pas gespeende ratten veel minder 
dramatisch dan in de foetus. Verschillende mechanismen kunnen dit verschil in respons 
tussen foetale en pas-gespeende ratten verklaren: de inductie van maternale lever T4-
UDPGT activiteit, verlaagd placentaal transport van schildklierhormoon, en de 
accumulatie van gehydroxyleerde PCB metabolieten in de foetus. Ook het uitverdunnen 
van PCB-niveaus in weefsels tijdens postnatale groei en het uitscheiden van PCB's en 
metabolieten kunnen de verlagingen van plasma T4 spiegels doen verminderen. Continue 
pre- en postnatale maternale blootstelling aan Aroclor 1254 via het dieet resulteerde 
bijvoorbeeld in constante, lage plasma T4 gehaltes tijdens de eerste drie weken na 
geboorte. 
Ondanks sterke verlagingen van T4 niveaus in foetale plasma en hersenen na 
maternale PCB blootstelling, werden geen verlagingen van T3 niveaus gevonden in 
foetale hersenen. Hieruit blijkt dat de foetus laat in de dracht de T3 niveaus in de 
hersenen kan handhaven door een verhoging van de 5'D-II activiteit, waardoor weinig 
risico voor PCB-gei'nduceerde hypothyroidie in de hersenen bestaat. 
De waarneming dat plasma TSH (schildklierstimulerend hormoon) spiegels niet 
verhoogd waren na PCB-geïnduceerde verlagingen in plasma T4 niveaus in de foetus en 
neonaat suggereert dat het ontwikkelende brein euthyroid was. Vergelijkbare dalingen in 
plasma T4 niveaus in foeten van Wistar ratten behandeld met methimazole resulteren wel 
in 6-voudige verhogingen van plasma TSH spiegels (Morreale de Escobar, 1993), zodat 
het waarschijnlijk is dat foetale plasma TSH spiegels worden gemoduleerd door T4, maar 
niet door T3 niveaus in plasma. In volwassen ratten werden eveneens verhogingen van 
plasma TSH niveaus en verlagingen in plasma T4, maar niet in T3 niveaus waargenomen 
na Aroclor 1254 blootstelling (Barter and Klaassen, 1994). Eveneens waren deze 
verhogingen in plasma TSH spiegels relatief gering na PCB blootstelling, in vergelijking 
met de sterke verhogingen in plasma TSH spiegels na polychloornaftaleen blootstelling, 
terwijl de dalingen in plasma T4 niveaus gelijk waren voor beide behandelingen. Het is 
dus niet ondenkbaar dat PCB's een directe invloed kunnen hebben op de TSH afgifte. 
Er kan geconcludeerd worden dat maternale PCB blootstelling een sterke 
verlaging van T4 niveaus in foetale hersenen veroorzaken, terwijl slechts marginale 
verlagingen in T3 niveaus worden gevonden in foetussen laat in de dracht. Het is 
mogelijk dat maternale PCB blootstelling vroeger in de dracht, voordat 5'D-II activiteit 
T4 verlagingen in hersenen kan compenseren, significante verlagingen in T3 niveaus in 
hersenen zou kunnen induceren. 
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Invloed van maternale PCB-blootstelling op vitamine A status 
Analoog aan schildklierhormonen, spelen retinoiden een belangrijke rol in hersen-
ontwikkeling. Hun belangrijkste invloed is vroeg of midden in de dracht waargenomen 
(Adams, 1993). Om het effect van vroege PCB belasting op de retinoid-homeostase te 
onderzoeken, werden retinol in plasma en retinol en retinylesters in de lever bepaald na 
maternale Aroclor 1254 blootstelling. De waargenomen verlagingen in plasma retinol 
kunnen het resultaat zijn van de accumulatie van 4-OH-pentaCB in het plasma dat door 
binding aan het TTR, de binding van retinol-binding (RBP) eiwit aan TTR yerstoort. 
Dit is vergelijkbaar met de eerder beschreven verstoring van TTR-RBP binding door de 
4-OH-tetraCB metaboliet van 3,3',4,4'-tetrachloorbifenyl (Brouwer et al. 1986) 
Ondanks het feit dat de effecten van maternale PCB blootstelling op retinoid-homeostase 
in foeten, neonaten en volwassen nakomeling klein waren, was de verstoring langdurend. 
Omdat de retinoid-reserves niet uitgeput waren door maternale PCB-blootstelling, kan er 
waarschijnlijk wel genoeg retinylzuur (de meest actieve retinoid-vorm) gevormd worden 
voor celregulatie. 
Veranderingen in neurochemie 
In Hoofdstuk 8 en 9 werden de effecten van maternale PCB blootstelling op de 
ontogenie van enkele neurotransmitters, gliale en neuronale cel-eiwitten in diverse 
hersenregio's onderzocht. 
Neurotransmitters 
Maternale blootstelling aan Aroclor 1254 resulteerde in langdurige veranderingen 
in de gehaltes van 5-hydroxytryptamine (5-HT, serotonine) en de bijbehorend 
metaboliet, 5-hydroxy-indoolazijnzuur (5-HIAA) in specifieke hersenregio's van de 
nakomelingen. Gehaltes aan dopamine en noradrenaline waren niet veranderd na 
maternale blootstelling aan Aroclor 1254. Het is opmerkelijk dat het dopaminerge 
systeem het meest gevoelig blijkt te zijn voor blootstellingen aan PCB-mengsels 
(inclusief Aroclor 1254) in volwassen dieren, wat gekenmerkt wordt door een verlaging 
van dopamine gehaltes in de basale ganglia (Seegal et al., 1985, 1986a, 1986b, 1991). 
Pre- en postnatale blootstelling aan het laag gechloreerde PCB-mengsel Aroclor 1016 
resulteerde in een tijdelijke stijging van dopamine gehaltes in de striatum van de 
nakomelingen (Seegal, 1994). Hieruit kan geconcludeerd worden dat tijdens 
ontwikkeling het effect van PCBs op de gehaltes van biogene amines in bepaalde 
hersenregio's verschilt van het effect op volwassenen, en afhankelijk is van de 
chloreringsgraad van het PCB-mengsel. 
In het algemeen worden de effecten van vroege Aroclor 1254 blootstelling 
gekenmerkt door een toename van 5-HIAA concentraties en de 5-HIAA/5-HT ratio in de 
laterale olfactory tractus (LOT) en de prefrontale cortex, en een toename in 5-HIAA 
concentraties in het striatum en de hippocampus op dag 90 postnataal. Omdat deze 
effecten bijna afwezig zijn op dag 21 postnataal, is er waarschijnlijk een vertraagd effect 
op de ontwikkeling van het metabolisme van serotonine. 
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Concentraties van glial fibrillary acidic protein (GFAP) en synaptophysine 
Het meest consistente effect van matemale PCB blootstelling op GFAP 
concentraties werd waargenomen in de laterale olfactory tractus (LOT) en de 
hersenstam. GFAP concentraties waren verhoogd in de LOT van zowel PCB-
blootgestelde mannelijke en vrouwelijke nakomelingen 21 en 90 dagen na geboorte. 
Verhogingen in GFAP concentraties traden eveneens op in het cerebellum van PCB-
blootgestelde dieren op 21 en 90 dagen na geboorte. In tegenstelling tot de LOT en het 
cerebellum, remde PCB-blootstelling de toename van GFAP concentraties in de 
hersenstam van de nakomelingen. Dit effect op de hersenstam is een indicatie dat er een 
vertraging in de ontwikkeling van astrocyten in de hersenstam optreedt. 
Synaptophysine concentraties in de hersenen van nakomelingen werden door 
maternale PCB blootstelling op een complexere manier beïnvloed dan GFAP 
concentraties. De meest gevoelige hersenregio's voor verlagingen in synaptophysine 
concentraties na maternale PCB-blootstelling op dag 21 na de geboorte, waren de LOT 
en de hersenstam. In volwassen nakomelingen leidde pre- en postnatale PCB 
blootstelling tot een verlaging van synaptophysine gehaltes in de hersenstam van 
mannelijke nakomelingen, maar tot een verhoging in vrouwelijke ratten. Synaptophysine 
concentraties waren na maternale PCB blootstelling ook verlaagd in het striatum en de 
hypothalamus van vrouwelijke, maar niet van mannelijke nakomelingen. 
De mechanismen die betrokken zijn bij de veranderingen in GFAP en 
synaptophysine expressie in de hersenen van de PCB-blootgestelde nakomelingen zijn 
nog niet opgehelderd. De waargenomen verhogingen van GFAP en verlagingen van 
synaptophysine concentraties in de LOT en prefrontale cortex zijn karakteristiek voor 
gliosis (hypertrofie van astrocyten) als reactie op neuronale sterfte (O'Callaghan and 
Miller, 1989). De verlagingen van zowel GFAP en synaptophysine concentraties in de 
hersenstam kunnen een indicatie zijn voor een vertraagde ontwikkeling van de 
hersenstam. De raphe nuclei in de hersenstam bevatten serotonerge neuronen met 
uitlopers naar de LOT en de prefrontale cortex (Kosofsky and Molliver, 1987). Het is 
niet ondenkbaar dat de veranderingen in serotonine-metabolisme en GFAP en 
synaptophysine concentraties in de LOT en prefrontale cortex een gevolg zijn van een 
vertraagde serotonerge innervatie van deze hersenregio's. 
Relevantie van het onderzoek voor humane ontwikkeling en toekomstig 
toxicologisch onderzoek. 
Schildklierhormoon 
In een recent gepubliceerd onderzoek van 105 moeder-kind paren werd een 
verband gevonden tussen verhoogde maternale belasting aan polychloor-dibenzo-p-
dioxines (PCDD's), dibenzofuranen (PCDF's) en bifenylen (PCBs) en veranderingen in 
schildklierhormoonstatus (Koopman-Esseboom et al, 1994). De veranderingen worden 
gekenmerkt door een negatieve correlatie van verschillende PCDD, PCDF en PCB 
congeneren met maternale plasma T3 niveaus voor geboorte en maternale T3 en T4 
niveaus na geboorte, en een positieve correlatie met plasma TSH van de kinderen twee 
weken en drie maanden na geboorte. In zuigelingen met een verhoogde blootstelling 
waren plasma TT4 (total T4) niveaus significant verlaagd (10%) en plasma TSH spiegels 
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significant verhoogd (37%). Matemale belasting met drie PCB congeneren (PCB 118, 
138 en 153) correleerde positief met TSH concentraties in de navelstreng. In een 
vergelijkbare studie met 38 moeder-kind paren werden verhogingen van plasma TSH en 
TT4 concentraties waargenomen in kinderen met een hogere blootstelling aan totale 
toxische equivalenten van PCDD's en PCDF's (Pluim et al., 1992). 
Indien er sprake is van een oorzakelijk verband, lijken de effecten van PCDD's, 
PCDF's en PCB's op plasma schildklierhormoon niveaus bij mensen, zoals bescreven 
door Koopman-Esseboom et al. (1994), in het algemeen op de effecten waargenomen in 
volwassen muizen, ratten en apen bij hogere doseringen. In tegenstelling tot de 
verlagingen in TT4 en FT4 (free T4) in plasma van rattefoetussen laat in de dracht na 
maternale PCB blootstelling aan Aroclor 1254 (dit proefschrift), werd geen effect 
waargenomen van maternale PCB belasting op TT4 en FT4 concentraties in de 
menselijke navelstreng (Koopman-Esseboom et al, 1994). 
Het is onwaarschijnlijk in de mens dat de veranderingen in schildklierhormoon-
homeostase die samenhangen met maternale PCB en PCDD belasting zullen resulteren 
in ontwikkelingsstoornissen van het centrale zenuwstelsel. Compensatiemechanismen, 
waaronder de inductie van 5'D-II activiteit in de hersenen, kunnen de T3 concentraties 
waarschijnlijk op peil houden. In de foetale rattehersenen waren T3 spiegels niet 
beïnvloed na PCB blootstelling, ondanks sterke verlagingen van T4 concentraties in 
plasma en hersenen. Het is echter nog steeds mogelijk dat verlagingen in T3 
concentraties in foetale hersenen kunnen optreden voordat de compensatie mechanismen 
volledig zijn ontwikkeld. Eveneens is niet volledig uit te sluiten dat zeer lokale T3 
verlagingen kunnen optreden door onvoldoende compensatiemechanismen. 
Transport van schildklierhormonen in de rat en de mens verschillen van elkaar in 
sommige aspecten die consequenties kunnen hebben voor de mogelijke effecten van 
PCBs. Het belangrijkste schildklierhormoon-transporteiwit in de mens is thyroxine 
binding globulin (TBG), terwijl in ratten TTR het belangrijkste transporteiwit is 
(Robbins, 1991). Hoewel TBG onder bepaalde omstandigheden aanwezig is in 
ratteplasma, heeft dit eiwit een lage affiniteit voor T4 (Rouaze-Romet et al. 1992). 
Gehydroxyleerde PCB metabolieten binden zeer zwak aan humaan TBG (Lans et al., 
1994), dus is het waarschijnlijk dat de effecten van gehydroxyleerde PCB metabolieten 
op de humane plasma T4 niveaus in volwassenen zeer gering zullen zijn. De foetale 
muis heeft zowel TTR en TBG als transporteiwitten, waarbij muize-TBG vergelijkbare 
T4 bindende eigenschappen heeft als humaan TBG (Vrancks et al. 1990). Hierdoor is de 
muis een geschikt modeldier voor deze effecten van PCB's op de mens. Recent 
onderzoek heeft echter aangetoond dat na toediening van TCB aan zwangere muizen het 
4-OH-tetraCB metaboliet accumuleert in het plasma van de foetus. Hier bindt het aan 
TTR, wat vervolgens resulteert in verlagingen van foetale plasma T4 concentraties 
(Darnerud et al., submitted). Het is daarom mogelijk dat het transplacentale transport 
van gehydroxyleerde metabolieten die aanwezig zijn in het humane plasma resulteert in 
de accumulatie van deze metabolieten in de foetus. Een accumulatie van metabolieten in 
de foetus kan leiden tot verlagingen in schildklierhormoonniveaus in plasma en hersenen 
voordat in het tweede trimester de foetale hypothalamus-hypofyse functies toenemen. 
Terwijl algemeen wordt aangenomen dat een gebrek aan schildklierhormonen laat 
in de zwangerschap of in neonaten een negatieve invloed kan hebben op 
hersenontwikkeling, zijn de effecten van schildklierhormoon-deficié ntie eerder in de 
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zwangerschap niet uitgebreid onderzocht (Morreale de Escobar et al. 1993, review, 
Porterfïeld and Hendrich, 1993, review). In ratten resulteert thyroidectomie van de 
moederdieren in veranderingen in het gedrag en de neurochemie van de nakomelingen, 
wat suggereert dat schildklierhormoon nodig is voor de hersenontwikkeling voordat 
foetale schildklierhormoon secretie begint (Hendrich et al. 1984, Pickard et al. 1993). 
Schildklierhormonen en schildklierhormoon-receptoren zijn na week 10 van de 
zwangerschap aanwezig in de hersenen van humane foeten, maar het functionele belang 
hiervan is niet bewezen. De bevinding van Pharoah et al. (1972) dat de neurologische 
schade door endemisch cretinisme (tengevolge van een jodium tekort) voorkomen kon 
worden indien de moeders gejodeerde olie toegediend kregen voor het tweede trimester, 
ondersteunt de rol van het schildklierhormoon bij de hersenontwikkeling tijdens deze 
periode van de zwangerschap. 
Meerdere vragen moeten beantwoord worden voordat de rol van een veranderde 
schildklierhormoon-homeostase in PCB-gei'nduceerde neurotoxiciteit tijdens de 
ontwikkeling duidelijk wordt. Eerst zal vastgesteld moeten worden of materaale PCB 
blootstelling leidt tot verlagingen in de concentraties van T3 in de hersenen vroeger in de 
zwangerschap, en vervolgens of deze verlagingen van betekenis zijn voor de 
hersenontwikkeling. Ongeacht of PCB blootstelling functionele veranderingen in 
schildklierhormoon-gehaltes tot gevolg heeft, leidt het transport van gehydroxyleerde 
PCB's naar de foetus en de accumulatie daarvan in het plasma en de hersenen tot een 
andere vraag: wat is de biologische activiteit van deze metabolieten in het 
hersenweefsel? Gehydroxyleerde PCB's binden 10 maal sterker aan kernextracten dan T4 
(McKinney et al., 1987) en bezitten estrogene eigenschappen (Jansen et al. 1993, 
Korach et al. 1988). 
Invloed op neurochemische ontwikkeling 
Pre- en postnatale blootstelling van ratten aan een commercieel PCB mengsel, 
Aroclor 1254, resulteert in lange-termijn effecten op de nakomelingen. Deze studie geeft 
informatie over welke neurotransmittersystemen, celtypen en hersenregio's beïnvloed 
worden na blootstelling aan een hoog gechloreerd PCB mengsel. Dit kan van belang zijn 
voor verdere studies naar structuur-activiteits relaties en het bepalen van een NOAEL 
(no observed adverse effect level). 
Een van de vragen die onderzoekers al meer dan 20 jaar lang bezig houdt, is 
welke PCB congeneren verantwoordelijk zijn voor de toxiciteit van deze verbindingen. 
Deze vraag is voldoende beantwoord voor immunotoxiciteit en sommige 
ontwikkelingseffecten (teratogeniteit en foetale sterfte) waarbij de interactie van PCB 
congeneren met de Ah-receptor een belangrijke rol speelt. 
Tot op heden zijn er publicaties verschenen over de functionele neurotoxiciteit 
van slechts twee individuele PCB congeneren, namelijk 3,3',4,4'-tetrachlorobifenyl 
(TCB) en 3,3',4,4',5-pentachlorobifenyl, beiden coplanaire PCB congeneren met een 
hoge affiniteit voor de Ah-receptor. TCB bleek neurotoxisch te zijn in muizen na een 
hoge maternale blootstelling, en veroorzaakte verlagingen in dopamine en dopamine 
receptor concentraties in het striatum, neuropathologische veranderingen in de "cranial 
roots" en een vertraging van "avoidance" gedrag (Tilson et al. 1979, Chou et al. 1979, 
Agrawal et al. 1981). Postnatale blootstelling van muizen aan TCB beïnvloedde de 
muscarinerge receptor concentraties in de hippocampus en de spontane activiteit 
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(Eriksson, 1988, Eriksson et al. 1991). Door het snelle metabolisme van TCB en de 
accumulatie van gehydroxyleerde metabolieten in de foetus kunnen geen conclusies 
worden getrokken over de rol van de uitgangsstof of zijn metaboliet in de 
ontwikkelings-neurotoxiciteit van deze PCB congeneer. 
Blootstelling van zwangere ratten aan de slecht metaboliseerbare 3,3',4,4',5-
pentachloorbifenyl vertraagde de ontwikkeling van spontane activiteit en de 
neuromusculaire ontwikkeling in de nakomelingen. Deze effecten waren gerelateerd aan 
een groeivermindering. De ontwikkeling van reflexen en visuele discriminatie werd 
echter niet beïnvloed door maternale blootstelling aan 3,3',4,4',5-pentachloorbifenyl 
(Bernhoft et al. 1994). Tesamen suggereren deze data dat de toxische coplanaire PCB 
congeneren niet direct ontwikkelings-neurotoxisch zijn in knaagdieren. Hierdoor is het 
onwaarschijnlijk dat het gebruik van individuele PCB congeneren voor het bestuderen 
van de effecten op neurochemische parameters en gedrags-ontwikkeling nieuwe 
structuur-activiteits relaties zal voortbrengen op dezelfde termijn als de structuur-
activiteits relaties voor imuunotoxiciteit of CYP1A1 inductie in volwassen dieren. Ten 
eerste zijn reproductie-studies veel langduriger en duurder dan subacute studies met 
volwassen dieren. Ten tweede is er geen algemene overeenstemming voor experimentele 
protocollen (tij stip en duur van PCB blootstelling, neurochemische en gedrags 
eindpunten) tussen onderzoekers in dit veld, wat het vergelijken van data bemoeilijkt. 
Ten derde is het zeer waarschijnlijk dat complexe interacties van Ah-receptor binding, 
PCB metabolisme en hormonale veranderingen de hersenontwikkeling beïnvloeden, 
zodat de structuur-activiteits relaties voor individuele congeneren geen voorspelling 
zullen geven over het effect van complexe mengsels. 
Het verdient daarom de voorkeur om milieu-relevante mengsels te gebruiken voor 
dosis-respons studies, en om neurochemische- en gedrags-parameters en species-
gevoeligheid te bepalen. Milieu-relevante mengsels kunnen verkregen worden door het 
extraheren van PCB-gecontamineerde voedingscomponenten (b.v. visolie) of door het 
samenstellen van synthetische mengsels. Ondanks variaties in de samenstelling, kunnen 
de resultaten van studies met zulke mengsels relevanter zijn voor beleidsgerichte 
doeleinden dan resultaten van studies met individuele congeneren. Dit vraagt echter om 
een effect-gerichte normstelling en risicoschatting in plaats van risicoschatting op basis 
van individuele componenten. Celkweek-technieken die gebruik maken van gliale, 
neuronale of gemengde neurale cellen kunnen nuttig zijn voor het onderzoek naar 
structuur-activiteits relaties van de individuele PCB congeneren of directe effecten van 
PCB congeneren op de neurochemische ontwikkeling. Na het vaststellen van effecten 
van mengsels in vivo kan dan gebruik gemaakt worden van verwante effect-parameters 
in vitro. 
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CONCLUSIES 
1) Diverse PCB congeneren (3,3',4,4'-tetrachloorbifenyl, 2,3,3',4,4'-pentachloorbifenyl 
en 2,3',4,4',5-pentachloorbifenyl) kunnen gemetaboliseerd worden tot gehydroxyleerde 
metabolieten welke accumuleren in plasma en hersenen van de foetus. Vervolgens 
kunnen zij dramatische verlagingen in thyroxine concentraties in foetaal plasma en 
hersenen laat in de dracht veroorzaken. 
2) De verlagingen in thyroxine niveaus in de hersenen van de foetus worden effectief 
gecompenseerd door verhogingen in Type II thyroxine 5'-dejodase activiteit. Als gevolg 
hiervan zijn alleen marginale verlagingen in trijodothyronine concentraties in de foetale 
hersenen waargenomen na maternale blootstelling aan het commerciële PCB-mengsel 
Aroclor 1254. Dit is een indicatie dat PCB-ge'induceerde verlagingen in plasma T4 
niveaus niet verantwoordelijk zijn voor storingen in de ontwikkeling van het centrale 
. zenuwstelsel. 
3) Maternale blootstelling aan Aroclor 1254 verandert specifiek de ontwikkeling van het 
serotonine-metabolisme in de hersenen van de nakomelingen. De blootstelling van 
volwassen ratten en makaken aan Aroclor 1254 veroorzaakt echter veranderingen in het 
dopamine-metabolisme die gevoeliger en langduriger zijn dan veranderingen in het 
serotonine-metabolisme. Het mechanisme van PCB-geïnduceerde neurotoxiciteit tijdens 
de ontwikkeling is derhalve verschillend van het mechanisme van veranderingen in 
biogene amine-metabolisme in volwassen dieren. 
4) De ontwikkeling van zowel neuronale als gliale cellen wordt beïnvloed in de hersenen 
van nakomelingen van zwangere ratten die behandeld zijn met Aroclor 1254. De 
veranderingen in astrocyt-ontwikkeling in de hersenstam door PCB-blootstelling zijn niet 
het gevolg van neuronale sterfte, omdat de concentraties van glial fibrillary acidic 
protein (GFAP) verlaagd zijn, terwijl over het algemeen neuronale sterfte samengaat met 
verhogingen in GFAP. Daarom is het waarschijnlijk dat PCB's de hersenontwikkeling 
beïnvloeden via veranderingen in cel-differentiatie en proliferatie en niet door het direct 
induceren van neuronale sterfte. 
5) Aangezien de hersenstam een van de vroegst ontwikkelende hersenstructuren is, 
kunnen de veranderingen op de hersenstam zoals waargenomen na pre- en postnatale 
PCB-blootstelling, een negatieve invloed hebben op de verdere ontwikkeling van andere 
hersenstructuren. 
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